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Abstract 
Purpose:  People living with HIV (PLWH) struggle with medication adherence.  Antiretroviral 
therapy (ART) requires greater than 95% adherence to prevent HIV drug resistance and 
treatment failure.  Motivational interviewing (MI) is an effective counseling method designed to 
enhance health behavior change.  This project determined the effectiveness of a two-day 
introductory MI training course on participant MI knowledge, perception of MI effectiveness, 
perception of client behavior change, and likelihood of MI use in a Midwest outpatient HIV 
clinic.  
Participants:  Seven clinical and non-clinical members of the multidisciplinary care team 
completed the two-day MI training course.  Approximately 82% of the participants had never 
used MI previously. 
Methods and Materials:  This evidence-based practice project used a one-group, pretest-
posttest design using the Motivational Interviewing Survey. 
Analysis: Data analysis included descriptive statistics, Wilcoxon signed-ranks test for matched 
pairs, and Kendall’s tau rank correlation coefficient. 
Results:  Forty-one percent of the 17 care team members participated in the MI educational 
intervention.  There was a significant change in the MI Survey score after completion of the 
training course (Mdn Δ = 13.00, Z = -2.375, p = .018).  All seven participants reported that they 
would use MI in their daily work after attending MI training. 
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Impact:  These findings suggest that a two-day introductory MI course is effective in improving 
MI knowledge, perception of MI effectiveness, perception of behavior change, and likelihood of 
MI use.  The findings from the MI Survey and the implementation process contributed 
sustainability recommendations to use MI to promote ART adherence within this practice 
setting. 
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CHAPTER 1 
Introduction 
 
The advancement in antiretroviral therapy (ART) has had a profound impact on the 
quality and duration of life of people living with human immunodeficiency virus (HIV). Global 
ramifications of HIV infection are estimated to affect 35 million people (Joint United Nations 
Programme on HIV/AIDS, 2014). According to the Centers for Disease Control and Prevention 
(CDC; 2015), approximately 1.2 million people are infected with HIV in the United States. 
Although ART has contributed to an 80% decrease in the age-adjusted HIV mortality rate since 
1995, challenges still exist with the medical treatment of this disease (Kaiser Family Foundation, 
2012). It is reported that only 36 of 100 persons infected with HIV in the United States are on 
ART and only 28 of l00 persons have achieved low-level viremia (CDC, 2011).  Medication 
adherence is a vital component to the success of ART in decreasing viral replication; however, it 
is estimated that 40% to 60% of clients prescribed ART are less than 90% adherent to their 
regimen (Battaglioli-DeNero, 2007). Maximum adherence of greater than 95% is essential in 
preventing the development of drug-resistant HIV strains and treatment failure (DiIorio et al., 
2003; DiIorio et al., 2008; Krummenacher, Cavassini, Bugnon, & Schneider, 2011). The 
Department of Health and Human Services (DHHS; 2014) reported that, “achieving adherence to 
ART is a critical determinant of long-term outcome in HIV infected patients” (p. k-1).  Unlike 
other chronic diseases, such as hypertension or diabetes mellitus, ART may not remain effective 
following a period of interruption (DHHS, 2014).  In fact, inconsistent use of ART leads to 
uncontrolled HIV replication, drug resistance, and limitations in future pharmacologic options 
(DHHS, 2014). The indefinite nature of HIV treatment necessitates behavioral interventions as 
people living with HIV are faced with complex factors hindering medication adherence.  
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The purpose of this chapter is multifaceted.  First, the objective is to provide a brief 
introduction to the pathophysiology of HIV infection.  Second, an overview of ART will be 
introduced.  Next, this chapter will discuss HIV drug resistance and its role in treatment failure.  
Moreover, the implications of untreated HIV infection will be explored, and the health care issue 
of ART nonadherence will be highlighted. This chapter will conclude with the significance of 
this health care issue to nursing and introduce the proposed scholarly project to address ART 
nonadherence in a local HIV clinic.  
HIV Infection 
An understanding of the implications of nonadherence to ART in a person living with 
HIV is essential.  Therefore, it is paramount to have a foundational comprehension of the virus, 
transmission, and the disease progression of HIV. Human immunodeficiency virus is a retrovirus 
belonging to the Lentivirus genus of the Retroviridiae family.  There are two strains of HIV, 
HIV-1 and HIV-2.  HIV-1 is responsible for most human infections throughout the world, while 
HIV-2 infection is predominately found in West Africa (Lashley, 2010, p.4).  HIV-1 infects 
human cells that contain the CD4 receptor and one of the co-receptors, CCR5 or CXCR4.  
Human cells containing the CD4 receptor include T cells, macrophages, monocytes, and 
dendritic cells.  These cells can be found in rectal, penile, vaginal, and oral mucosa (Kirton, 
2011, p.74).  HIV has been found in the following bodily fluids and tissues: peripheral blood, 
lymph nodes, cerebrospinal fluid, brain tissue, bone marrow, semen, seminal fluid, cervical cells, 
and breast milk (Durham & Lashley, 2010, p.8).  Transmissibility of HIV from these fluids and 
tissues depends on the quantity of virus present, as well as the characteristics of the virus itself 
“such as the viral phenotype, clades and subtypes, its tropism, and the viral load” (Durham & 
Lashley, 2010, p.8).  The most common modes of HIV transmission include unprotected vaginal 
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and anal sexual intercourse, exposure to infected blood through needle sharing, perinatal 
transmission, and breastfeeding (Durham & Lashley, 2010, p.8).   
In the absence of treatment, HIV symptomatic disease will lead to acquired 
immunodeficiency syndrome.  The lymphoid tissue of the infected individual has been replaced 
by fibroid tissue.  This results in the inability of the immune system to trap the virus; therefore 
the amount of serum HIV RNA is critically elevated.  The CD4 level is below 200 cells/ml, and 
the infected individual is now susceptible to opportunistic infections.  The most frequent 
opportunistic infections include Pneumocystis jirovecii pneumonia, Mycobacterium avium 
complex, cytomegalovirus, toxoplasmosis, and candidiasis (Kirton, 2011, p.84).  The 
development of neoplasms, such as Kaposi sarcoma, non-Hodgkin lymphoma, and cervical 
cancer, is also a risk for individuals with AIDS.  Death will ultimately occur within two to five 
years of an AIDS diagnosis if left untreated (Kirton, 2011, p.84). 
Implications of Untreated HIV Infection 
The implications of untreated HIV infection are not limited to the individual.  In fact, 
adherence to ART can have profound population and economic effects. The following sections 
will further discuss the impact of ART adherence on individual health, population health, and the 
economy.  
Individual Health 
One of the most beneficial aspects of ART to the individual is a significant increase in the 
longevity of life.  Kithara et al. (2009) reported a reduction in mortality risk with the use of ART.  
They reported results of the effect of early versus late initiation of ART on survival in HIV 
infection.  This study found that initiating ART in patients with CD4 cells counts between 351 to 
500 cells/ml increased their prognosis as compared to deferring treatment.  The deferral of 
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treatment for patients with CD4 levels in this range led to a 69% increase in risk for death 
(p.1821).  These findings strongly support the significance of ART initiation. 
Population Health 
The medical treatment of an individual living with HIV has potential benefits for the 
general population.  It is thought that suppression of the individual plasma viral load has 
potential in reducing the overall transmissibility and incidence rate of HIV in the community 
(Machtinger & Bangsberg, 2006).  There is evidence of diminished incidence of mother-to-child 
and sexual transmission when HIV viral suppression is maintained (CDC, 2009; Machtinger & 
Bangsberg, 2006; McDonnell Holstad, DiIorio, Kelley, Resnicow, & Sharma, 2010).  
Additionally, increasing the ART adherence rate may reduce the development of HIV drug 
resistance, resulting in a decrease of the spread of resistant HIV strains (Machtinger & 
Bangsberg, 2006).  It is evident that the sequel of uncontrolled HIV infection extends beyond 
individual consequences. 
Economic Burden 
 From the economic perspective, ART nonadherence can create severe financial burden to 
the U. S. health care system.  The annual direct cost of nonadherence to all medications, in 
addition to HIV medications, ranges between $100 billion to $289 billion in the U. S. 
(Viswanathan et al., 2012).  Hutchinson et al. (2006) conducted an incidence-based cost-of-
illness analysis to estimate the economic burden of HIV/AIDS in the U. S.  During the time of 
the Hutchinson et al. study, the annual incidence of HIV infection was approximately 40,000 
cases. It was estimated that treatment of the 40,000 newly diagnosed individuals with HIV would 
result in a $3 billion reduction in productivity losses annually (Hutchinson et al., 2006).  
Calculating the financial cost of productivity loss for current HIV incidence rates would result in 
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greater economic burden.  The HIV incidence rates have increased to approximately 50,000 new 
cases yearly since the 2002 data reported by Hutchinson et al. (CDC, 2013). The economic 
significance of investing in ART adherence interventions becomes apparent given the indication 
that treating all newly diagnosed persons would lead to financial savings.  
ART Initiation  
 There is no curative treatment for the eradication of HIV infection.  The primary goals of 
treatment are to: 
• Reduce HIV-associated morbidity and prolong the duration and quality of survival,  
• Restore and preserve immunologic function,  
• Maximally and durably suppress plasma HIV viral load, and  
• Prevent HIV transmission (DHHS, 2014).  
The initiation of ART is based on clinical evidence and guideline recommendations.  The 
Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines for 
Adults and Adolescents (2014) provides the following recommendations for initiating ART: 
• All HIV-infected individuals to reduce the risk of disease progression.  The evidence is 
strong, originating from randomized controlled trials (RCT), for individuals with a 
pretreatment CD4 count of less than 350 cells/mm3.  Data from well designed, 
nonrandomized trials also provided strong evidence for the use of ART in individuals 
with pretreatment CD4 counts between 350 and 500 cells/mm3.  The Panel also supports 
the initiation of ART in persons with a pretreatment CD4 count greater than 500 
cells/mm3.  The evidence in support of this recommendation is based on expert opinion 
and is of moderate strength (DHHS, 2014). 
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• ART is also recommended for all HIV-infected individuals to prevent the transmission of 
HIV.  The evidence to support this recommendation for the prevention of perinatal and 
heterosexual transmission is rated as strong.  For other transmission risk groups, expert 
opinion strongly supports this recommendation (DHHS, 2014). 
• Expert opinion strongly recommends that patients initiating ART should be willing and 
able to commit to the treatment.  They should also have an understanding of the risks and 
benefits of ART, as well as, the importance of adherence with this therapy.  The patient 
and/or provider may elect to defer or postpone therapy on the basis of patient choice, 
clinical, or psychosocial factors (DHHS, 2014). 
  Based on these recommendations, all persons living with HIV at some point during the 
course of the disease will require ART to prevent immunologic deterioration.   
ART Adherence 
Medication adherence in chronic disease management is a common health care problem.  
Viswanathan et al. (2012) reported that as many as 30% of prescriptions are never filled, and 
approximately 50% of chronic disease medications are taken incorrectly.  Estimating the average 
rate of nonadherence to ART can be difficult because factors, such as, the method of assessment 
and the study population, may influence findings (Machtinger & Bangsberg, 2006).  Battaglioli-
DeNero (2007) estimated the rate of ART adherence to range between 40% and 60%, while 
Machtinger and Bangsberg (2006) reported an average rate of 70% adherence in people living 
with HIV.  These adherence rates are not sufficient to therapeutically manage this disease.  In 
fact, it is essential that all persons taking ART are adherent to greater than 95% of the prescribed 
daily doses (DiIorio et al., 2002; DiIorio et al., 2008; Krummenacher, Cavassini, Bugnon, & 
Schneider, 2011).   
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Theoretically, the benefits of ART have promising outcomes, however, without 
interventions addressing the barriers of adherence, the theoretical benefits cannot be translated 
into practice. Cooperman and Arnsten (2005) and Raper (2010) identified barriers to ART 
adherence.  These barriers included regimen complexities, poor health literacy, inadequate social 
support, substance abuse, mental illness, and nonreadiness to alter health-related behavior.  
Health care providers have the opportunity to intervene and assist people living with HIV 
with the intricacies of sustaining optimal adherence levels. Assessment of the client’s readiness 
and motivation to initiate ART is a fundamental action of the health care provider. Raper (2010) 
offered clinically important conditions that should be present to facilitate adherence. These 
included the establishment of a trusting provider-client relationship, effective communication, 
client-tailored regimens, and the identification and removal of personal barriers to adherence. 
Furthermore, it was emphasized that motivation to initiate or continue ART should be client-
driven rather than provider-driven. 
Project Proposal 
In the clinical practice setting, it is not uncommon for HIV health care providers to 
encounter patients struggling with medication adherence.  Despite cumulative efforts of HIV 
case managers, clinical pharmacists, nurses, and health care providers, a proportion of patients 
remains inconsistent with ART adherence.  As mentioned previously, this poses great risk to the 
individual, community, and economy.  This project aligns with the National HIV/AIDS Strategy 
goals of decreasing the incidence of HIV and improving health outcomes for people living with 
HIV (White House, 2010). There appears to be a gap in available evidence-based adherence 
interventions and their clinical utilization in the practice setting.  The following sections will 
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describe the proposed project intervention, implementation site, target population, and study 
objectives. 
Intervention: Motivational Interviewing 
The development and trial of various intervention methods have been discussed in the 
literature as potential mechanisms for increasing medication adherence with chronic medical 
conditions.  Direct observation therapy, cognitive-behavioral strategies, and behavioral 
approaches are some examples.  Motivational interviewing (Miller & Rollick, 2002) is a client-
focused counseling method that has been researched and utilized to assist with health behavior 
change.  It is intentionally directed toward resolving ambivalence to promote behavior change 
and has been successful with health-related problems such as substance abuse, smoking 
cessation, and treatment adherence (Lundahl & Burke, 2009).   With respect to medication 
adherence, motivational interviewing (MI) has produced positive outcomes as an intervention for 
clients struggling with hypertension, glaucoma, and osteoporosis (Cook, Bremer, Ayala, & 
Kahook, 2010; Solomon et al., 2009).  Golin et al. (2006) reported, “the individually tailored 
nature of motivational interviewing (MI), an effective theory-based, client-centered approach, 
makes it a promising strategy for addressing the complex, multidimensional features of ART 
adherence” (p.42).  Hence, the focus of this project was to introduce an evidence-based 
behavioral intervention to the multidisciplinary care team of an HIV clinic. 
Project Site 
The chosen project site was a Midwest outpatient HIV clinic.  This federally funded, 
outpatient health clinic was founded in 1990 and provides health care to approximately 900 
persons living with HIV.  This organization is staffed by the clinic supervisor, four physicians, 
one nurse practitioner, one clinical pharmacist, three registered nurses, four non-medical case 
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managers, three medical assistants, and two business office assistants.  The specific services 
provided include medical and pharmaceutical care, non-medical case management, 
transportation and financial assistance, referrals, and HIV/AIDS education. 
Prior to the project implementation, the current assessment of medication readiness was 
assessed through client self-report of medication recall.  The Treatment Assessment Readiness 
Tool (TART) had also been used inconsistently to assess client readiness to start ART 
(Treatment for Life, 2009).  This 30-item assessment tool captures HIV knowledge, previous 
history of ART use, and perceived readiness to start ART.  Previously, HIV case managers had 
administered the TART during the clinical intake process for newly diagnosed clients and for 
clients transferring their HIV care from a different medical facility.  The tool was also used prior 
to beginning ART at any point during client medical care.  However, the HIV case managers 
reported an inconsistent use of this tool due to its length, changes in care processes, and the 
limitations in client dialogue when administering the TART.  Medication adherence assessment 
was also addressed at every provider visit utilizing self-report methods of recall. 
This health clinic had established methods to address the identified barriers to ART 
adherence.  Such methods include financial drug assistance, medication regimen education, 
incorporation of medication reminder methods, and in extreme cases, direct observation therapy.  
Despite these efforts, there still remained a portion of clients who intermittently struggle with 
ART adherence.   
Target Population 
 The intended recipients of the MI intervention are people living with HIV struggling with 
ambivalence to ART.  Clients in the precontemplation, contemplation, and preparation stages of 
the Transtheoretical Model of behavior change (DiClemente et al., 1991) are most amenable to 
 24"
 
behavior change through the use of MI.  Clear identification of these clients may potentiate the 
linkage of a client-centered intervention with the intended target population in this clinic.  
During the initial phase of this implementation initiative, the target population will be the health 
care professionals engaged with clients at this clinical practice site.  
Statement of Purpose  
 This translational research initiative aims to answer the following questions: 
1. What is the influence of a two-day introductory MI course on staff MI knowledge, 
perception of MI effectiveness, perception of client behavior change, and likelihood of 
MI use? 
2. Within the context of the Promoting Action on Research Implementation in Health 
Services (PARIHS) framework, to what extent is the incorporation of a MI intervention 
into a local HIV clinic a successful implementation? 
Nature of the Project 
The project design will be a one-group pretest-posttest design to assess the within-group 
effect of introductory MI training.  The pretest-posttest design is appropriate when the project 
leader aims to assess change within groups and “when the focus of the intervention is on change 
(e.g. behaviors, attitudes)” (Polit & Beck, 2012, p.212). 
Significance to Nursing 
This project may provide valuable information regarding the effectiveness of MI training 
and the feasibility of a client-centered intervention aimed at promoting health behavior change.  
Health promotion is within the nursing paradigm.  In fact, optimization of health “in the presence 
of chronic disease or disability” is an essential public health goal (Pender, Murdaugh, & Parsons, 
2011, p. 1).  Health care providers working with people living with HIV may benefit from an 
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evidence-based intervention that provides a systematic approach to addressing medication 
adherence.  With the advent of the Doctor of Nursing Practice degree, the translation of 
evidence-based interventions into the health care setting creates a new paradigm for nursing 
research.  This implementation project aimed to contribute to this knowledge base. 
Conclusion 
This chapter provided an introduction to the health care issue of medication 
nonadherence in people living with HIV and the advantages associated with achievement of viral 
suppression. The complexities surrounding the commitment to indefinite ART treatment adds to 
the clinical importance of this issue. It is not sufficient to prescribe ART without providing 
evidence-based interventions to support adherence.  Motivational interviewing is the proposed 
intervention in this implementation project.  The PARIHS framework is an ideal process for the 
inception of a MI intervention in this local HIV clinic.  The following chapter will provide an in-
depth integrative review of MI in promoting health behavior change, treatment adherence in 
chronic disease, and ART adherence in people living with HIV.  
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CHAPTER 2 
Literature Review 
 The case for the need of effective ART adherence interventions has been presented.  The 
purpose of this chapter is to present the evidence in support of MI as effective for ART 
adherence.  First, an overview of MI will be provided to better comprehend its origins and 
process.  With this understanding, the inquiries guiding this review will be discussed.  Finally, a 
presentation of the evidence will ensue.  This thorough integrative review will support the use of 
MI as a practical, cost-effective therapy in the HIV clinical setting.   
Motivational Interviewing 
  As previously mentioned, MI is a client-focused counseling method designed to assist 
with health behavior change (Miller & Rollnick, 2002).  It is paramount that an ART adherence 
intervention is client-focused and client-driven, thus, the decision to further explore the concept 
of MI.  This section will focus on the origins and evolution of MI, as well as, discuss the guiding 
principles of this intervention.  Finally, a brief overview of the MI process will be introduced.   
MI Origin and Evolution 
 Motivational interviewing came to fruition unintentionally through the behavioral 
counseling work of William Miller in the early 1980s.  There was great focus placed on 
accurately empathizing with clients (Rogers, 1959), a skill Miller was trying to demonstrate to a 
group of young psychologists in Norway (Miller & Rose, 2009).  Through this role-play learning 
process, it was recognized that Miller had a unique, intuitive manner of eliciting behavior change 
talk from clients (Kinetic Streaming, 2012).  This launched an investigative endeavor into what 
is now known as motivational interviewing.  Since the inception of MI approximately 30 years 
ago, there has been an exponential growth of its use in research and clinical practice worldwide.  
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This counseling style is utilized in an estimated 38 languages (Miller & Rollnick, 2009) with 
greater than 200 published clinical trials (Miller & Rose, 2009).  Motivational interviewing has 
evolved into a universal, adaptable counseling approach to behavior change, such that, a theory 
has emerged from this conceptual approach (Hettema, Steele, & Miller, 2005).  The three 
hypotheses of this theory are as follows: 
1. Counselors who practice MI will elicit increased levels of change talk and decreased 
level of resistance from clients, relative to more overtly directive or confrontational 
counseling styles. 
2. The extent to which clients verbalize arguments against change (resistance) during 
MI will be inversely related to the degree of subsequent behavior change. 
3. The extent to which clients verbalize change talk (arguments for change) during MI 
will be directly related to the degree of subsequent behavior change (Hettema et al., 
2005). 
MI Definition and Principles 
The evolutional course of MI has not been limited to its rapid dissemination.  The 
defining characteristics of MI have also evolved into three categorical definitions.  According to 
Miller and Rollnick (2013), the three MI definitions are as follows:  
Layperson’s definition: Motivational interviewing is a collaborative style for 
strengthening a person’s own motivation and commitment to change. 
Practitioner’s definition: Motivational interviewing is a person-centered counseling style 
for addressing the common problem of ambivalence about change. 
Technical definition: Motivational interviewing is a collaborative, goal-oriented style of 
communication with particular attention to the language of change.  It is designed to 
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strengthen personal motivation for and commitment to a specific goal by eliciting and 
exploring the person’s own reasons for change within an atmosphere of acceptance and 
compassion (p. 29). 
Furthermore, Miller and Rollnick (2013) explained that MI incorporates a guiding 
counseling style overall, but includes directive and following styles in its approach as well.  The 
manner, in which, these styles are utilized assist the client to overcome ambivalence.  It is 
believed that “ambivalence is a normal part of preparing for change and a place where a person 
can remain stuck for some time” (p. 12).  An ambivalent person commonly utilizes both “change 
talk and sustain talk” when discussing a personal problem behavior (p. 7).  Change talk is 
described as a client’s own personal reasons to change the behavior, while sustain talk is a 
person’s argument for not changing the behavior (Miller & Rollnick).  A practitioner 
incorporating a directive style of counseling with ambivalent clients will often provoke 
arguments for not changing the behavior.  The underlying belief is that people are autonomous 
and behavior change, in an ambivalent person, will occur through intrinsic motivation evoked 
through the use of MI. 
MI Process 
 There are four overlapping and sequential processes utilized during MI, engaging, 
focusing, evoking, and planning (Miller & Rollnick, 2013).  These processes are essential to the 
overall flow of a MI conversation and lay the groundwork for resolving client ambivalence.  The 
following sections will provide a brief description of each process. 
Engaging.  While not exclusive to MI, therapeutic engagement is the required first step.  
Engagement is “the process of establishing a mutually trusting and respectful helping 
relationship” (Miller & Rollnick, 2013, p. 47).  There are many factors that can influence 
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positive or negative engagement, such as the service system, the provider’s emotional state, and 
the client’s circumstances and emotional well-being (Miller & Rollnick, 2013).  Suggestions for 
reducing negative engagement are to avoid the use of provider-driven assessment that 
encourages client passivity and the use of directive counseling. 
Focusing.  The process of focusing occurs next and can be described as developing and 
maintaining “a specific direction in the conversation about change” (Miller & Rollnick, 2013,  
p. 27).  The provider is interested in the client’s anticipated goals and hopes from attending the 
consultation.  This process is one of clarification. 
Evoking.  Once the established change goal has been identified by the client, the 
provider’s intention is to elicit “the client’s own motivation for change” and how the client might 
implement the change (Miller & Rollnick, 2013, p. 28).  It is apparent that this process differs 
from the traditional didactic approach of instructing clients what to avoid and educating them on 
how to correct their problem (Miller & Rollnick, 2013).  An important point noted by Miller and 
Rollnick (2013) is that the didactic approach is appropriate for a very small proportion of clients 
with personal change problems, particularly, those that have resolved their ambivalence and are 
ready to move forward with change.  Whether the clients have resolved ambivalence entirely on 
their own or have been expertly guided to resolve ambivalence, they have reached a level of 
readiness to change. 
Planning.  The client conversation in the planning phase changes from one of exploring 
the reasons for change to that of inquiring how to change (Miller & Rollnick, 2013).  This 
process is focused on the development of commitment to change and an action plan.  Important 
concepts during this process include maintaining patient autonomy and eliciting the client’s 
personal solutions to the behavior problem, as well as, supporting continued change talk  
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(Miller & Rollnick, 2013).  The authors observed from early research that, many times, clients 
proceeded to change entirely on their own once they experienced the focusing and evoking 
processes.  These clients had remained ambivalent about behavior change, and once this was 
resolved through the preceding three MI processes, they were able to move forward with change. 
The Integrative Literature Review: Purpose, Design, and Literature Search 
  There is a substantial amount of evidence supporting the use of MI as a client-centered 
intervention for health behavior change.  The aim of this integrative review was multifaceted.  
The primary concern was to determine if MI is an effective intervention for increasing 
medication adherence levels among adults with HIV.  The second query sought to clarify the 
optimal MI dose needed to produce a positive effect on medication adherence. Additionally, this 
review aimed to explore which professional disciplines have been utilized to deliver MI sessions.  
Finally, the last objective was to determine an appropriate method of measuring medication 
adherence in this clinical practice setting.  
This integrative review attempted to be inclusive of MI evidence from a broad to narrow 
perspective.  With this focus, the literature search was divided into three domains.  The first 
domain centered on reviewing meta-analyses and systematic reviews addressing MI as an 
intervention for health behavior change.  The second domain reviewed quantitative studies 
designed to test the effect of MI on treatment adherence in clients with chronic disease.   
The third domain focus was narrowed to research studies reporting the effect of MI on ART 
adherence in people living with HIV.  The overall goal of this review was to gather and search a 
substantial amount of evidence to address the proposed inquiries concerning MI. 
This integrative review utilized the methodology proposed by Whittemore and Knafl 
(2005) to guide the focus of the review while maintaining study boundaries.  Whittemore and 
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Knafl included five stages in their integrative review methodology: problem identification, 
literature search, data evaluation, data analysis, and presentation.  These five stages provide the 
framework for this review.      
 As previously mentioned, three search domains were incorporated into the review 
process.  Although the underlying focus was the effect of MI on medication adherence, each 
domain slightly differed in problem identification.  Whittemore and Knafl (2005) suggested that 
this initial stage also include the sampling frame of the research, thus the search parameters 
within each search domain will also be discussed.   
Search Domain 1 
There is a flourishing body of research reporting the effect of MI on behavior change.  It 
is imperative to explore this evidence when attempting to translate this research-based 
intervention into clinical practice.  Therefore, the focus of this search domain was to determine 
the effectiveness of MI with improving health behavior change within an extensive parameter of 
health problems.  To accomplish this, meta-analyses and systematic reviews were collected 
because they “yield the strongest level of evidence on which to base practice decisions” (Melnyk 
& Fineout-Overholt, 2011, p. 13).  The inclusion criteria concentrated on meta-analyses, 
systematic reviews, or studies including both meta-analytic and systematic review methods that 
focused on MI as described by Miller and Rollnick (2002).  The exclusion criteria were as 
follows: primary study population less than 18 years old, language other than English, MI 
combined with other intervention, studies focused solely on MI delivered in a group setting, 
studies with a primary focus of addiction, such as alcohol and tobacco abuse.  Meta-analyses and 
systematic reviews that included smoking cessation along with other health behaviors were 
included in this review.  Motivational interviewing was the key search term used to explore the 
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Cochrane Library and PubMed databases.  This search produced 195 articles resulting in 12 
meta-analyses and systematic reviews to be analyzed. 
Search Domain 2 
The next investigative endeavor sought to determine the effectiveness of MI on treatment 
adherence among clients with chronic medical conditions.  Because HIV is considered a chronic 
disease, it was thought that inclusion of these data would enhance the knowledge base for 
developing a MI intervention for people living with HIV.  The inclusion criteria were 
quantitative research studies, adult population, MI as described by Miller and Rollnick (2002), 
and the outcome measure of adherence.  Studies were excluded based on the following criteria: 
MI combined with another intervention, MI delivered in a group setting, language other than 
English, and studies focused solely on smoking cessation or substance abuse.  The key search 
terms were motivational interviewing, adherence, treatment adherence, and medication 
adherence.  A literature search of four databases, the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), PsychArticles, Medline, and PubMed, yielded a total of 630 
articles.  After application of the inclusion and exclusion criteria, 12 articles remained for 
analysis. 
Search Domain 3 
As described above, the identified clinical problem was suboptimal medication adherence 
among the target population of adult men and women living with HIV.  Another variable of 
interest was the intervention of MI.  The predetermined inclusion criteria were primary, English 
language research articles that included MI as an intervention, HIV-positive adults, and an 
outcome measure of medication adherence.  Studies were excluded if the target population 
included HIV-positive adults with substance abuse issues.  Exclusion was also based on the 
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delivery of the MI intervention.  Studies that delivered MI in a group setting were not included.  
This review included research articles within the time span of the years 2003 to 2014.  It was 
thought that data from this time frame would provide the most relevant research without 
narrowing the investigation significantly, resulting in an insufficient number of articles.  The 
following databases were reviewed: CINAHL, Medline, PsychArticle, PsychInfo, and Proquest 
Psychology.  An ancestry search was also conducted from a meta-analysis, which produced two 
articles that were not duplicative of research found in the database search.  Keywords significant 
to this literature search were motivational interviewing, adherence, human immunodeficiency 
syndrome, and HIV.  Nine studies were retrieved for inclusion in this review. 
The Integrative Review: Data Evaluation, Analysis, and Presentation 
 The evaluation and analysis of data are considered paramount to the rigor of integrative 
review.  Evaluation of the systematic reviews and meta-analyses followed the guidelines within 
the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement 
(Moher, Liberati, Tetzlaff, Altman, and The PRISMA Group, 2009).  Although Moher et al. 
reported that the PRISMA checklist is not designed as a quality assessment instrument, its utility 
extends beyond reporting guidelines to a framework for critically appraising systematic reviews.  
The PRISMA checklist items adopted for the first search domain are as follows: study 
objective(s), eligibility criteria, variables analyzed, databases searched, study selection, summary 
measure, synthesis of results, and summary of evidence.  The data collected from the 12 meta-
analyses, systematic reviews, and combined meta-analytic and systematic reviews have been 
aggregated in Table A1 (see Appendix A). 
The process of data evaluation and analysis for the second and third search domains 
adhered to critical appraisal recommendations of Melnyk and Fineout-Overholt (2011) for the 
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specific type of research study performed.  Utilization of a standardized format to condense data 
from multiple studies allows for comparative analysis and identification of significant themes 
(Stubbings, Chaboyer, & McMurray, 2012).  Data from the studies were extracted to create a 
summary of descriptive and objective information necessary to address the objectives of this 
review.  Tables A2 and A3 (see Appendix A) provide the study details, intervention details, and 
results.   
 Data abstraction and evaluation of the literature revealed relevant findings pertinent to the 
objectives of this review.  This author found studies with high levels of evidence contributing to 
the validity and reliability of the present review.  The presentation of the data is available in 
Tables A1, A2, and A3 (see Appendix A).  The following sections will present the available 
evidence to address the objectives of this integrative review.   
Search Domain 1: MI Effectiveness in Health Behavior Change 
This integrative review produced four meta-analyses (Burke, Arkpowitz, & Menchola, 
2003; Hettema, Steele, & Miller, 2005; Lundahl, Kuntz, Brownell, Tollefson, & Burke, 2010; 
Ren, Yang, Browning, Thomas, & Liu, 2014), four systematic reviews (Knight, McGowan, 
Dickens, & Bundy, 2006; Lundahl & Burke, 2009; Martins & Mcneil, 2009; Mulimba & Byron-
Daniels, 2014), and four studies incorporating both research methods (Armstrong et al., 2011; 
Lundahl et al., 2013; Rubak, Sandbaek, Lauritzen, & Christinsen, 2005; VanBuskirk & 
Wetherell, 2013)  to investigate the effect of MI on health behavior change.  Overall, the results 
of the meta-analyses revealed positive MI effects on influencing health behaviors.   
Meta-analyses.  Burke et al. (2003) conducted a meta-analysis of 30 randomized 
controlled trials (RCT) to examine the efficacy of adaptations of MI as proposed by Miller and 
Rollnick (2002).  The 30 RCTs consisted of health behaviors such as adherence, diet and 
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exercise, smoking and alcohol abuse, HIV risk, and eating disorders.  Burke et al. reported their 
results in subgroups of combined effect sizes according to clinical problem area and design type.  
In RCTs comparing MI with no treatment, the combined effect sizes were statistically significant 
and ranged from small to moderate effects for the problem areas of alcohol abuse, drug 
addiction, and diet/exercise (Burke et al., 2003).  Studies focused on smoking cessation and HIV-
risk behavior resulted in nonsignificant combined effect sizes.   
Furthermore, Burke et al. (2003) reported nonsignificant findings when they combined 
RCTs comparing MI to active treatment, such as skills-behavior counseling, non-directive 
reflective listening, confrontative feedback, and cognitive behavioral therapy.  These RCTs 
included the problem areas of alcohol abuse and smoking cessation. Results of a multiple 
regression analysis conducted on 23 of the 30 studies revealed that MI dose and the behavioral 
problem area accounted for 38% of the variance in outcomes.  Despite these findings, the authors 
were able to report a combined within-MI effect size of 0.82 for the 11 RCTs that used MI as the 
sole intervention across all problem areas.   
The within-treatment effect size reported above was one method Burke et al. (2003) 
utilized to determine the clinical impact of MI.  They were also able to calculate the percentage 
of improved estimates from seven studies with a total sample size of 616 clients.  Following a MI 
intervention, 51% of clients displayed an improvement in behavior outcome compared to 37% of 
clients that received no treatment or treatment as usual (Burke et al., 2003).  This finding was 
statistically significant.  Burke et al. concluded that MI appears to be effective whether 
administered as a single intervention or in addition to standard treatment.  The estimated overall 
client success rate improved from approximately 33% to 50% for those clients partaking in the 
MI intervention (Burke et al., 2003). 
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The second meta-analysis included in this review was conducted to provide “an up-to-
date summary of the evidence base for MI” (Hettema, Steele, & Miller, 2005, p. 94).  This meta-
analysis included 72 studies targeting health problems of alcohol, tobacco, and substance abuse, 
treatment adherence, eating disorders, diet and exercise, gambling, and water safety.  Hettema et 
al. (2005) reported combined effect sizes by target health problem across all follow-up points.  
The authors observed variability in effect sizes across target problems and among studies within 
each target problem.  The authors predicted this variability was attributed to discrepancies in the 
delivery of MI across studies; however, meta-regression analysis revealed that two factors 
contributed to the differences in combined effect sizes (Hettema et al., 2005).  The presence of a 
MI manual in the original studies accounted for 8.5% of the variance, while ethnicity accounted 
for 19% of the variance in the combined effect size.  Further analysis revealed that the minority 
population in the samples displayed significantly larger MI effect sizes than non-minority 
samples.  This finding suggested MI might have better outcomes in minority populations. 
Additionally, Hettema et al. (2005) separated the clinical trials comparing MI to untreated 
control groups from the trials adding MI to standard treatment or comparing MI to the standard 
treatment.  Standard treatment modalities included education, self-help manuals, stress 
management, skills training, and cognitive therapy.  The authors sought to explore the effect of 
MI as an additive component to standard treatment compared to MI as the sole intervention.  
This inquiry was based on the meta-analytic findings of Burke et al. (2003) that reported 
insignificant results when MI alone was compared to standard treatment.  The findings displayed 
a gradual decline in MI effect from approximately one month to 12-month post-intervention.  
This finding was evident in the studies that compared MI to an untreated control group and in the 
studies comparing MI to a control group receiving standard treatment (Hettema et al., 2005). The 
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group of studies comparing MI coupled with standard treatment versus standard treatment alone, 
however, displayed a persistent positive effect of MI across all follow-up periods.  The combined 
effect size for this group of studies across the five data collection periods was relatively 
consistent at approximately dc = 0.60 (Hettema et al.).  This finding is paramount as it suggests 
that an MI intervention might produce sustainable positive effects when added to current 
treatment practices. 
Overall, the meta-analysis conducted by Hettema et al. (2005) provide useful findings.  
First, the effect of MI combined with active treatment appears to endure across time.  Second, 
the synergistic effect of MI coupled with active treatment may stem from the effect of MI on 
treatment adherence and retention (Hettema et al., 2005).  Finally, MI alone may produce 
positive outcomes over time with MI booster sessions. 
Lundahl, Kuntz, Brownell, Tollefson, and Burke (2010) examined the extent to which MI 
can assist clients toward change and sought to investigate the unique effect of MI compared with 
other treatment or controls on a diversity of health-related behaviors.  Their meta-analytic study 
consisted of 119 quantitative trials.  A distinctive component to their study criteria was inclusion 
of studies utilizing MI or motivational enhancement therapy (MET), described as “a subdivision 
of MI” (Lundahl et al., 2010, p. 139).  Motivational enhancement therapy is based on the 
principles of MI, however, adds the component of feedback from standardized assessment 
measures (Lundahl et al.).  The researchers utilized MET as a potential moderator of differences 
in MI effect size because it was hypothesized that MET could affect the outcome of MI.   
The Lundahl et al. (2010) study shares similar findings to that of Burke et al. (2003) and 
Hettema et al. (2005).  First, the authors concluded the use of a MI intervention results in a small, 
yet significant, positive effect in outcomes.  Second, the authors observed a wide variability in 
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effect sizes across studies.  It was reported that 25% of the studies produced negative or neutral 
effect sizes, 50% of the studies resulted in slightly larger than small effect sizes, and 25% of the 
effect sizes were classified as larger than a medium effect (Lundahl et al., 2010).   
Moderator analyses resulted in significant findings as well.  Lundahl et al. (2010) utilized 
findings from Burke et al. (2003) and Hettema et al. (2005) to determine how to categorize 
potential moderators of MI effect size variability.  As previously mentioned, one of the potential 
moderators included was MET.  Findings indicated that MI produces a larger effect size when it 
is compared to a weak control group versus when compared to a strong control group.  
Furthermore, among the studies comparing MI against a weak control group, MET produced a 
larger effect size compared to MI.  In sum, MET might produce better results than MI alone in 
promoting behavior change (Lundahl et al.). 
 The clinical significance of the Lundahl et al. (2010) findings may have compelling 
implications for MI use in the practice setting.  First, their review reveals that MI does produce 
small, significant positive effects in promoting behavioral change.  Second, MI may promote 
behavior change in less time compared to other effective interventions.  Moreover, there may be 
an indication for the use of MET, rather than MI, in certain clinical settings.  Finally, MI appears 
to generate longstanding positive outcomes. 
Combined meta-analyses and systematic reviews.  This literature search also produced 
four studies combining meta-analytic and systematic processes to evaluate the intervention of 
MI.  Rubak, Sandbaek, Lauritzen, and Christinsen (2005) conducted this type of mixed-method 
analysis with 72 RCTs.  The meta-analysis included 19 RCTs, while all studies were 
systematically reviewed.  The RCTs were grouped based on health-related outcome before 
calculating combined effect estimates.  Significant combined effect sizes were reported for the 
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effect of MI on reducing body mass index, total blood cholesterol, systolic blood pressure, blood 
alcohol content, and standard alcohol content (Rubak et al., 2005).  There were two combined 
effect sizes failing to reach significance in demonstrating a reduction in hemoglobin A1c levels 
and the number of cigarettes smoked per day.  Despite this, Rubak et al. reported that 74% of the 
72 RCTs demonstrated significant MI effects on the target outcome.  In addition, MI appears to 
be successful when implemented in different interventional areas, such as adherence and 
behavior change, and “outperforms traditional advice giving” in the clinical setting (p. 310). 
 Armstrong et al. (2011) systematically reviewed 12 RCTs and analyzed 11 RCTs to 
investigate the effectiveness of MI on decreasing body mass.  Motivational interviewing had a 
medium effect on body mass reduction; however, this finding resulted in significant 
heterogeneity in the pooled effect size.  This study adds strength to the Hettema et al. (2005) 
finding that MI plus standard treatment results in greater outcomes than MI alone.  In this meta-
analysis, the studies incorporating MI as an additive component to the standard treatment of a 
weight loss program demonstrate the most amount of weight reduction.  This factor played a 
partial role in the significant heterogeneity in the pooled effect size. 
 The next mixed method review focused on MI effectiveness in the primary care 
population. VanBuskirk and Wetherell (2013) examined 12 RCTs incorporating health 
behaviors, such as blood pressure reduction, substance use, body weight reduction, physical 
activity, and adherence.  Seventy-five percent of the studies demonstrated a statistically 
significant MI effect on the selected outcome.  VanBuskirk and Wetherell also found MI to have 
a small, significant combined effect size with significant heterogeneity found among the studies.  
The MI deliverer accounted for 26% of the variance in outcomes across all 12 RCTs.  
VanBuskirk and Wetherell also reported meta-analytic findings for the two studies in their 
" 40"
 
sample that addressed the outcome of adherence.  Despite the small sample size in this subgroup, 
MI had a small, statistically significant effect on adherence. 
 The last study in this section also focused on MI efficacy in the medical setting (Lundahl 
et al., 2013).  The authors used an odds ratio to calculate the overall effect of MI on health 
behavior outcome, producing an odds ratio of 1.55 (n = 48), 95% CI [1.40, 1.71], z = 8.67,          
p < 0.001.  Therefore, a client participating in MI has a greater likelihood of positively altering 
health behavior than participants undertaking a comparison intervention (Lundahl et al., 2013). 
Furthermore, this study reveals that MI is successful in producing favorable outcomes with a 
variety of medical problems.  These outcomes include reductions in cholesterol, HIV viral load, 
and blood pressure.  On the contrary, MI did not have a statistically significant effect on 
lowering blood glucose, heart rate, and increasing medication adherence (Lundahl et al., 2013). 
The Lundahl et al. (2013) findings are interesting.  MI was successful in decreasing HIV 
viral load, but yet unable to demonstrate positive outcomes with medication adherence.  This 
result should be taken with caution because the three studies utilizing HIV viral load as the 
outcome measure (Golin et al., 2006; Naar-King et al., 2006; Naar-King et al., 2008) may not 
have included medication adherence as a secondary outcome in their studies.  In fact, one of the 
RCTs included in Lundahl et al.’s (2013) review reported that HIV viral load “was considered a 
proxy measure of adherence” (Naar-King et al., 2006, p.7).  This was attributed to the fact that 
HIV viral load is the main outcome of ART adherence (Naar-King et al.; Murphy et al., 2001).  
Despite the less than positive outcomes in medication adherence reported in this meta-analysis, 
MI appears to still have a positive effect on medication adherence when indirect outcomes 
dependent upon adherence, such as HIV viral load, are measured. 
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Systematic reviews.  Systematic reviews were the final type of study researched within 
this search domain.  Although unable to provide cumulated statistical findings, systematic 
reviews serve to provide an unbiased, aggregated review of the evidence adhering to strict 
procedural guidelines (Polit & Beck, 2012).  Knight, McGowan, Dickens, and Bundy (2006) 
reviewed eight studies, including four RCTs, three pilot studies, and one non-randomized 
controlled trial, to evaluate the effectiveness of MI in the physical health care setting.  The health 
domains included diabetes, asthma, hypertension, hyperlipidemia, and heart disease.  They 
concluded that MI had a positive effect on psychological, physiological, and lifestyle change 
outcomes in the majority of the eight studies (Knight et al., 2006).  The authors did express 
concern, however, with low internal content validity of the eight studies included in their review.  
Specifically, only 81% of the psychological and health behavior change outcomes, across all 
studies, were measured with a validated instrument (Knight et al., 2006). As a result, the authors 
were not able to confidently suggest the implementation of MI across health facilities based on 
the evidence gathered.  This systematic review was published seven years prior to 
systematic/meta-analytic reviews conducted by VanBuskirk and Wetherell (2013) and Lundahl 
et al. (2013).  These three studies focused on MI efficacy within the medical setting.  It appears 
that MI research has flourished since Knight et al.’s study.  The two reviews conducted in 2013 
yielded samples purely consisting of RCTs with greater rigor and larger sample sizes than the 
studies included in the Knight et al. review. 
In 2009, Lundahl and Burke compiled four meta-analyses for the purpose of 
systematically reviewing the MI evidence for use by practitioners in the clinical practice setting.  
Three of these meta-analyses (Burke et al., 2003; Hettema et al., 2005; Lundahl et al., 2010) have 
been previously mentioned in this review.  The Lundahl and Burke (2009) systematic review is 
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unique, in that, it is the only review identified by this author that specifically focuses on meta-
analytical findings of MI effectiveness.  It was reported that when MI is compared to weak 
comparison groups (no treatment, waitlist, and information only groups), the effect size ranges 
from d = 0.27 to d = 0.40 (Lundahl & Burke, 2009).  The authors converted the effect sizes to 
percentages and found that MI is 14% to 20% more effective in improving health behavior 
outcomes after two to three sessions compared to receiving no treatment or health information 
(Lundahl & Burke, 2009).  This means for every 100 persons that improve in the health behavior 
outcome without treatment, it could be estimated that 114 to 120 persons will improve in the 
health behavior outcome with MI (Lundahl & Burke, 2009).  Across these four meta-analyses, 
Lundahl and Burke reported that the overall MI effect is “as effective but not greatly more so 
than other active treatments” (p. 1236).  Examples of these active treatments included cognitive 
behavioral therapy and 12-step programs.  Interestingly, MI produces these equal effects in a 
shorter time frame compared to the active treatments.  It was estimated that MI spent 
approximately 101 to 180 minutes less than comparative treatments to produce positive 
behavioral change outcomes (Lundahl & Burke, 2009). 
Summation of the level one research evidence presented in this section reveals that MI 
has substantial potential as an effective treatment modality for behavior change.  Coupled with 
treatment as usual, MI may augment the effects of usual treatment methods (Armstrong et al., 
2011; Hettema et al., 2005).  Motivational enhancement therapy, however, appears to outperform 
MI in clinical situations where there is no active treatment in place.  While MI may produce a 
small, significant effect size, MET may potentially produce a medium effect size in this type of 
situation (Lundahl et al., 2010).  Hence, both MI and MI plus problem feedback (MET) are 
efficacious modalities in health behavior change.  Nevertheless, future studies are necessary to 
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determine the superiority of MET over classic MI in health problems beyond addiction (Lundahl 
& Burke, 2009). 
Further findings from this search domain are enlightening.  First, MI is as efficacious as 
other behavior treatment modalities in modifying behavior (Lundahl et al., 2009).  Second, MI 
requires less time to achieve intended outcomes, and these outcomes are durable across time 
(Burke et al., 2003; Hettema et al., 2005; Lundahl et al., 2009; Lundahl et al., 2010; Rubak et al., 
2005).  Finally, the potential contributors to variability in MI effect size include MI dose, MI 
deliverer, behavior outcome, ethnicity, and the utilization of a MI manual (Burke et al., 2003; 
Hettema et al., 2005; VanBuskirk & Wetherell, 2013). 
Search Domain Two: MI Effectiveness in Chronic Disease Treatment Adherence 
 There is a growing body of research aimed at exploring MI effect on treatment adherence 
among clients with chronic medical conditions.  These investigations have centered on health 
conditions, such as, major depressive disorder, schizophrenia, hypertension, chronic kidney 
disease, diabetes mellitus, obstructive sleep apnea, and osteoporosis (Barkhof, Meijer, 
deSonneville, Linzen, & deHaan, 2013; Chen, Creedy, Lin, & Wollin, 2012; Chlebowy et al., 
2014; Cook, Emiliozzi, & McCabe, 2007; Garcia-Llana, Remor, delPeso, Celadilla, & Selgas, 
2014; Interian, Lewis-Fernández, Gara, & Escobar, 2013; Lewis-Fernández et al., 2013; Ma, 
Zhou, Zhou, & Huang, 2014; Ogedegbe et al., 2008; Olsen, Smith, Oei, & Douglas, 2011; 
Russell et al., 2011; Solomon et al., 2012; Welch, Zagarins, Feinberg, & Garb, 2010).  The 
previous section described the positive effect of MI with health behavior change. The following 
review will examine the influence of MI on treatment adherence in populations living with 
chronic disease. 
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Mental health conditions.  Recent studies in the field of MI have focused on mental 
health conditions (Interian et al., 2013; Lewis-Fernández et al., 2013; Barkhof et al., 2013).  
There were two RCTs and one pilot study focusing on major depressive disorder and 
schizophrenia.  Two of these studies (Interian et al., 2013; Lewis-Fernández, 2013) reported 
statistically significant improvements in antidepressant adherence and retention in an 
antidepressant therapy program after the MI intervention.  Interian et al. (2013) reported that 
limitations to their RCT include a small sample size and the inability to capture the long-term 
effects of MI.   
The RCT utilizing a sample of patients with schizophrenia was unable to produce a 
statistically significant increase in medication adherence after six months of MI (Barkhof et al., 
2013).  In fact, the MI group and the health education comparison group displayed similar results 
on the Medication Adherence Questionnaire and the Life Chart Schedule.  A possible 
contributing factor to this finding is that the self-report measures of medication adherence may 
not have captured the true adherence level (Barkhof et al., 2013).  This supposition derived from 
findings of lower hospitalization rates in the MI group compared to the comparison group.  It 
was thought that increased adherence rates were associated with decreased relapse rates, thus, 
fewer hospitalizations (Barkhof et al., 2013).  The researchers were unclear that there was an 
actual improvement in adherence, “but that measures used in this study are not reliable or 
sensitive enough” to capture this finding (Barkhof et al., 2013, p. 1248).   
Hypertension.  The next two RCTs focused on hypertension control.  Ogedegbe et al. 
(2008) and Ma, Zhou, Zhou, and Huang (2014) evaluated the effectiveness of MI on improving 
medication adherence, systolic blood pressure (SBP), and diastolic blood pressures (DBP) in 
samples of African Americans and participants from China.  Both studies were able to 
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demonstrate positive findings in favor of MI.  Specifically, Ogedegbe et al. were able to 
demonstrate long-term effects after a 12-month MI study resulting in adherence rates of 60% in 
the MI group compared to 47% in the control group.  Furthermore, Ma et al. reported statistically 
significant improvements in adherence, SBP, and DBP after six months of an MI intervention.   
Chronic kidney disease.  Motivational interviewing research in chronic kidney disease 
includes two studies conducted in 2011 and 2013.  Russell et al. (2011) conducted a three-month 
pilot study with a convenience sample of 29 patients.  Although statistical significance was not 
achieved, 26% of the sample improved in the number of missed hemodialysis appointments after 
the MI intervention.  Russell et al. also used length of hemodiaylsis treatment to measure 
adherence.  Patients who shortened their treatment by 10 minutes or greater were categorized as 
nonadherent.  After the MI intervention, 47% of the sample improved in this area.  Russell et al. 
noted their study was limited by a small sample size.   
García-Llana, Remor, del Peso, Celadilla, and Selgas (2014) were also limited by a small 
sample size of 42 pre-dialysis patients in their pretest-posttest, quasi-experimental study to 
improve medication adherence.  A unique component of this study was the inclusion of the 
Stages of Behavior Change related to Oral Medication Compliance Assessment Scale as one of 
three adherence measurements.  Inclusion of this scale allowed the researchers to explore any 
movement of participants along the continuum of behavior change after the MI intervention.   
García-Llana et al. (2014) reported statistically significant results.  Thirty-nine percent of 
participants were in the action stage at the start of the study, while 60% of the participants were 
in the action stage six months post-intervention (García-Llana et al.).  In addition, the researchers 
found positive effects of MI on the mean change of the Survey of Adherence to Treatment score 
and improvement in medication adherence according to the Medication Adherence 
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Questionnaire.  Overall, there is promising utility of a MI program in progressing clients through 
the continuum of behavior change and with adherence to oral medications in pre-dialysis 
patients. 
Type 2 diabetes mellitus.  There are three recent RCTs testing the effectiveness of MI in 
patients with type 2 diabetes mellitus (T2DM).  These studies have focused on adherence with 
medication, physical activity, and glucose monitoring and have produced inconsistent findings 
(Chen et al., 2012; Chlebowry et al., 2014; Welch et al., 2011).   
Welch et al. (2011) conducted the first RCT with a sample size of 234 patients with 
T2DM, of which, 118 patients were allocated to the MI intervention group.  Although the MI 
group showed a statistically significant improvement in change in hemoglobin A1c (HbA1c) level 
six months post-intervention, the two control groups utilizing diabetes self-management 
education (DSME) showed a greater significant change in HbA1c level (Welch et al.).  Moreover, 
multiple regression analysis displayed a significant negative effect of MI on change in HbA1c 
level, with the MI group demonstrating a significantly lower change in HbA1c than the DSME 
group (Welch et al.). 
 Welch et al. (2011) noted their study was limited by lack of MI proficiency skills of the 
interventionists.  Proficiency criteria set forth by the Motivational Interviewing Network of 
Trainers requires a minimum score of five to be proficient in delivering MI, whereas, the four 
interventionists in this RCT scored below this level (Welch et al.).  Feedback given at study 
termination from the MI trainers revealed that the interventionists did not incorporate “complex 
reflection skills or consistently explore patient ambivalence around behavior change” (p. 59).  
Assisting clients to resolve ambivalence is the very nature of MI.  Failure to consistently address 
this ambivalence for change may have affected the outcome of this study. 
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The next RCT included a sample of 215 diabetic patients from Taiwan (Chen et al., 
2012).  The primary adherence outcome measure was HbA1c level.  The MI and control groups 
received one diabetes education session weekly and participated in a diabetes club monthly 
during the three-month study period. In addition, the MI group received one MI session two 
weeks after the baseline data collection period.  While both groups demonstrated a decrease in 
HbA1c  levels at termination, the HbA1c difference within the MI group reached statistical 
significance (Chen et al., 2012).  
Chlebowry et al. (2014) was also able to demonstrate the success of MI in a sample 62 
African Americans. There was 66.7% of the MI group adherent to physical activity compared to 
38.8% of the control group adherent at the end of 12 weeks.  On the contrary, improvements in 
medication adherence did not result in statistical significance.  In fact, the intervention and 
control group shared similar adherence rates at study termination.  Several limitations, however, 
were noted in the Chlebowry et al. (2014) study.  First, there was a high attrition rate in both the 
MI group (53.8%) and in the control group (50%), making the final sample size for data analysis 
relatively small (n = 30).  Second, this study did not report the measurement tool used for 
medication adherence, nor its reliability and validity.  This makes it difficult to determine 
whether the measurement tool used in the study adequately measured medication adherence.  
Furthermore, Chlebowry et al. noted that their findings might have been hindered by “factors 
such as patient income, medication cost, and availability of generic medications” (p. 12).  It was 
reported that approximately 85% of the study participants in the MI group had a monthly income 
of $1,000 or less (Chlebowry et al.). Prior to implementing a MI intervention for medication 
adherence, availability of the medication to the participant is an important factor that may 
influence the efficacy of the intervention. 
" 48"
 
Obstructive sleep apnea.  The next study included in this section focused on obstructive 
sleep apnea (OSA).  Olsen, Smith, Oei, and Douglas (2011) conducted a RCT with a sample of 
100 participants to test the effect of MI on continuous positive airway pressure (CPAP) 
adherence.  After the delivery of three monthly MI sessions to the experimental group, there was 
a positive influence of MI on the number of hours per night the MI group used CPAP.  Olsen et 
al. (2011) compared the MI group to the control group at months one, two, three, and twelve.  
Statistically significant results were demonstrated at the one, two, and three-month data 
collection points.  At the 12-month collection period, the MI group used CPAP for an average of 
4.21 hours per night, while the control group used CPAP for an average of 3.00 hours per night. 
There were no significant results at the 12-month collection period.  Despite this, MI still had a 
medium effect size 12 months after baseline, indicating potential long-term benefits of MI in 
assisting clients with OSA to adhere to CPAP treatment (Olsen et al.).  
Osteoporosis.  Two research studies explored the utility of MI with influencing 
medication adherence rates in clients with osteoporosis (Cook, Emiliozzi, & McCabe, 2007; 
Solomon et al., 2012).  Cook et al. conducted a quasi-experimental study with a sample of 402 
participants with osteoporosis.  Their findings demonstrated statistical significance and revealed 
that telephone-based MI sessions were effective in improving medication adherence six months 
post-intervention.  The MI group was 68.8% adherent compared to the national comparison rate 
of 40.5% (Cook et al., 2007).   They concluded that MI had an overall medium effect size on 
medication adherence in this sample of patients with osteoporosis. 
 Solomon et al. (2012) were also interested in the impact of a telephone-administered MI 
intervention on medication adherence in a sample of 2,087 clients with osteoporosis.  This large-
scale RCT was conducted over 12 months and delivered ten MI phone sessions.  The primary 
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outcome measure was the medication possession ratio (MPR), which was calculated “as the 
number of days with filled prescriptions during the observation period X 100 divided by the 
number of days in the observation period” (p. 478).  The results of the primary outcome measure 
did not reach statistical significance; however, the intervention group had a median MPR of 49% 
compared to 41% in the control group (Solomon et al.).  Subgroup analysis found a significant 
difference in medication adherence between age groups, with participants aged 65 to 74 years 
benefiting from the MI intervention.  Solomon et al. reported a median MPR of 48% in the MI 
group compared to 31% in the control group for participants in this age group.   
 Notable limitations to the Solomon et al. (2012) study may have affected their findings.  
The authors reported concern with methodology and outcome measure.  First, methodology was 
problematic due to an unintended lag time between the date the participants received their first 
prescription and the first MI session.  Solomon et al. reported a median of 113 days between 
these two time periods.  Second, the authors noted that pharmacy refill history does not ensure 
the consumption of medication by the participant.  This suggests the MPR may not be the most 
effective measure of medication adherence.  These combined factors had potential influences on 
study outcomes.   
 In summary, this review produced 12 quantitative studies focused on the effectiveness of 
MI with treatment adherence in chronic disease management.  There were eight RCTs, two 
quasi-experimental designs, and two pilot studies comprising the evidence for this search 
domain.  Across the 12 studies, the sample size ranged from 29 to 2,087 participants with a 
median sample size of 110.  Overall, 75% of the studies reported a positive MI effect on 
treatment adherence.  Based on the presented evidence, it appears that MI has the potential 
capacity to promote client adherence to treatment modalities for long-term illnesses.  Because 
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HIV is now considered a chronic, manageable disease, these data are pertinent to people living 
with HIV.  The following section will discuss the findings pertaining to the association of MI 
and the chronic disease of HIV. 
Search Domain 3: MI Effectiveness in ART adherence 
Motivational interviewing is a relatively novel intervention in the HIV setting.  MI has 
predominantly been implemented to address health behavior change in the prevention of disease 
through reduction of risky sexual behavior (Chen, Murphy, Naar-King, & Parsons, 2010; Golin 
et al., 2012; Lovejoy et al., 2011; Yeagley et al., 2012).  Literature pertaining to MI and ART 
adherence is still evolving and includes one observational study, one quasi-experiment, two 
randomized controlled pilot studies, four RCTs, and one systematic review.  The results of the 
nine studies provide ample evidence of the potential role of MI in this clinical practice setting. 
Observational study.  Krummenacher, Cavassini, Bugnon, and Schneider (2011) 
completed a four-year, retrospective, observational study for the purpose of testing an ART 
adherence intervention based on the Information-Motivation-Behavioral Skills model (Fisher, 
Amico, Fisher, & Harman, 2008) in a sample of 104 HIV positive patients in Switzerland.  Fifty-
nine percent of the sample were women, and 42% of the participants were of black ethnicity.   
The median age of the participants was 39 years.  Seventy-seven percent of the sample were 
ART-experienced.  There were 63% of participants on a twice daily ART regimen, while 36% of 
participants were taking a once daily regimen.  At baseline, the median HIV viral load was 9,210 
copies/mL and the median CD4 count was 283 cells/mm3. 
This ART adherence intervention model incorporated cognitive, motivational, behavioral, 
and affective components.  The motivational component involved semi-structured motivational 
interviews.  Results of this observational study are promising toward the inclusion of a structured 
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intervention that includes the use of MI skills.  Overall, the proportion of patients who achieved 
HIV-1 viral suppression increased during and after the intervention.  Eighty-eight percent of the 
ART treatment-naive group achieved viral suppression upon exiting the program, while the ART 
treatment-experienced groups achieved statistically significant decreases in viral load. 
Furthermore, Krummenacher et al. reported an overall adherence rate of 83% at the end of the 
study period.  
 Although an overall benefit resulted from this intervention program, careful attention 
must be made to the fact that motivational interviewing was one of four components of this 
intervention.  This makes it difficult to discern whether the change in adherence was a result of 
motivational interviewing counseling.  Nevertheless, this study adds some support for the role of 
MI in HIV adherence counseling.  
Quasi-experimental study.  Next, a quasi-experimental study conducted by Cook, 
McCabe, Emiliozzi, and Pointer (2009) included a sample of 98 men and women living with 
HIV across the United States.  The average age of the participants was 43.5 years, SD = 9.3, and 
38.8% of the sample were female.  Race and ethnicity were not collected in this study.  The 
mean number of comorbid diagnoses in this sample was 1.4, SD = 0.7, and 73% of the 
participants were taking at least two medications.  The objective of this pretest-posttest, non-
equivalent control group study was to determine the efficacy of the Script Assist program in 
increasing medication adherence.  Script Assist is an intervention program utilizing telephone-
based MI counseling.  Results at the six-month endpoint demonstrated 76% of the participants 
achieved medication adherence rates greater than or equal to 95% compared to the expected 
population adherence rate of 50% (Cook et al.).  Despite these positive findings, limitations of 
this study included a 58% attrition rate, high baseline adherence, and limitations to 
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generalizability of findings, as people living with HIV without consistent telephone access may 
not benefit from the intervention. 
 Pilot studies.  Two randomized controlled pilot studies were included in this integrative 
review.  While pilot studies are not conducted to demonstrate intervention effectiveness (Polit & 
Beck, 2012), Connelly (2008) reported that data obtained from pilot studies “may suggest the 
intervention is likely to be effective based on preliminary data” (p. 411).  DiIorio et al. conducted 
the first pilot study in 2003 as a prelude to a larger intervention trial.  There were 20 participants 
in their sample.  The characteristics of the intervention group, n = 10, are as follows: age,  
M = 46.8 years, SD = 4.8; gender, 62.5% male; race, 87.5% African American; years since HIV 
diagnosis, M = 12.13, SD = 4.19; number of medications, M = 2.63, SD = 0.74.  There were no 
significant differences in the characteristics of the control group compared to the intervention 
group, except for the mean age, M = 38.4, SD = 8.4.  In response to how often the participant 
was unable to adhere to medication in the previous 30 days, the intervention group had a 
significantly lower proportion of nonadherent individuals compared to the control group at the 
six-week study endpoint.  Despite the small sample size, these preliminary findings are 
suggestive of disparate results among a larger sample favoring the MI intervention.  
Furthermore, MI was calculated to have a medium to large effect on medication adherence 
(DiIorio et al., 2003). 
 Findings from the randomized controlled pilot study conducted by Konkle-Parker, Erlen, 
Dubbert, and May (2012) enhance support for MI in increasing medication adherence.  This 
study had a sample of 56 participants from the southern United States.  The total sample, N = 56, 
had the following characteristics: age, M = 34.6 years, SD = 8.4; gender, 62% male; race, 89% 
African American.  Greater than half of the sample had never taken ART prior to the 
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intervention, and the average HIV viral load level was approximately 50,000 copies/mL.  Guided 
by the Information-Motivation-Behavior Skills model, Konkle-Parker et al. sought to test an 
adherence intervention comprised of HIV education, a peer video, and motivational interviewing.  
The researchers utilized the Visual Analog Scale and prescription refill rate as adherence 
measures.  This study did not produce statistical significance in adherence outcomes; however, 
calculated effect sizes demonstrated that the intervention had a small effect on improving 
medication adherence.  Some factors contributing to these findings were the high percentage of 
baseline medication adherence, high attrition, and low statistical power (Konkle-Parker et al., 
2012).   
Randomized controlled trials.  This literature search resulted in four RCTs investigating 
the effect of MI on medication adherence among patients living with HIV. Golin et al. (2006) 
conducted the only RCT in this review that did not produce statistically significant findings.  The 
researchers sought to test the effectiveness of a MI adherence program against HIV education to 
enhance ART adherence.  This sample consisted of 140 patients living with HIV from North 
Carolina.  The intervention group had the following characteristics: age, M = 39.91 years,        
SD = 8.77; gender, 69.4% male; ethnicity, 76.8% African American; baseline viral load,   
M = 5,012 copies/mL, SD = 13.  The control group was similar to the intervention group in age 
and gender; however, ethnicity, 54.6% African American, and baseline viral load, M = 7,943 
copies/mL, SD = 16, differed slightly. 
The results of this study may not have demonstrated statistical significance in favor of 
MI; nevertheless, the positive effect of MI on ART adherence should not be discredited.  Mean 
adherence improved by 4.5% in the MI group compared to a 3.8% decrease in ART adherence 
experienced by the control group at week 12 (Golin et al.).  Furthermore, 29% of the MI group 
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achieved greater than 95% adherence compared to 17% of the control group.  After controlling 
for ethnicity, participants in the MI group had a 2.75% higher odds of achieving greater than 
95% adherence compared to the control group (Golin et al.).  There was no significant difference 
based on ethnicity in the percentage of participants achieving greater than 95% adherence.  The 
researchers noted that a limitation to their study was the small sample size that produced a 
relatively low powered study to detect small statistical differences (Golin et al.).  Moreover, the 
MI intervention included two MI sessions, which may not be sufficient to positively influence 
medication adherence. 
Further MI research has yielded evidence in support of MI implementation to increase 
ART adherence.  A RCT in southeastern France utilized MI with HIV education to increase ART 
adherence in a sample of 244 patients (Pradier et al., 2003).  There were no significant 
differences in baseline sociodemographic and clinical characteristics between the intervention 
and control groups.  The MI group, n = 123, had a median age of 40 years, and the control group, 
n = 121, had a median age of 38 years.  Seventy-one percent of the MI group and 75% of the 
control group were males.  At baseline, the mean HIV viral load of the MI group was 501 
copies/mL, SD = 16, and the median CD4 count was 340 cells/mm3.  The control group had a 
mean HIV viral load of 398 copies/mL, SD = 13, and the median CD4 count was 361 cells/mm3. 
Compared to the standard care group, the intervention group had a higher proportion of 
participants achieving 100% medication adherence at the study endpoint.  In fact, the researchers 
noted that adherence was significantly higher for the participants who completed three sessions 
compared to those that only completed one or two sessions (Pradier et al., 2003). The 
intervention group had a significant decrease in mean viral load from baseline to the six-month 
study endpoint; while, the control group experienced a slight increase in mean viral load in the 
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same study period.  When comparing the mean change in viral load between the intervention and 
the control group at six months, results favored the combined MI and HIV education intervention 
(Pradier et al., 2003).  On the contrary, both the control and intervention groups had similar 
proportions of patients achieving an HIV viral load less than 40 copies/mL at the end of the 
study.  A subgroup analysis of patients with HIV viral load levels above 40 copies/mL at 
baseline demonstrated a significant mean change in viral load at six months for the intervention 
group.  
Overall, the Pradier et al. (2003) findings indicate that a MI-based intervention may be 
more beneficial when delivered in greater than two sessions.  Also, when considering HIV viral 
load as a measurement outcome of adherence, it may be valuable to conduct separate analyses on 
the participants with abnormal HIV viral load levels at baseline.  This may especially be true for 
study samples with relatively high baseline proportions of participants with undetectable viral 
load levels.  It is questionable whether the participants with baseline undetectable viral loads 
were the correct target population for MI.  Motivational interviewing is for the patient 
ambivalent about taking medications.  Clients achieving undetectable HIV viral loads at baseline 
may be actively adhering to ART, as an undetectable HIV viral load is an indicator of ART 
adherence (DHHS, 2014). This study is limited by its inability to discern the true effect of MI on 
medication adherence, as this was a dual intervention.  Nevertheless, MI appears to have played 
a significant role in boosting ART adherence levels in this sample. 
The support for MI as a facilitator of ART adherence continues with findings retrieved 
from a RCT conducted in Atlanta, Georgia.  DiIorio et al. (2008) followed their pilot study 
(DiIorio et al., 2003) with a RCT to test the effect of the Get Busy Living program, a five-session 
MI-based intervention.  This study had a total sample of 213 HIV-positive participants for their 
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main analysis.  Thirty-four participants were either lost to attrition or had insufficient data for 
analysis inclusion (DiIorio et al., 2008).  The average age of the total sample was m = 41.6 years, 
SD = 7.1, and 65% of the sample was African American.  The MI group, n = 107, had a baseline 
mean HIV viral load of 11,000 copies/mL, SD = 21.9, and the control group, n = 106, had a 
baseline mean viral load of 9,200 copies/mL, SD = 19.9.  The CD4 count was similar among the 
MI group and control group, M = 250.3 cells/mm3, SD = 192.5, and M = 243.0 cells/mm3,  
SD = 183.1, respectively. 
This study produced statistically significant results.  At the 12-month data collection 
point, the MI intervention group consumed 64% of prescribed doses compared to 55% of 
medication doses consumed by the control group.  The MI group also exceeded in the percentage 
of doses taken on schedule compared to the control group (DiIorio et al., 2008).  Finally, six-
month data demonstrated a higher percentage of participants with an undetectable HIV viral load 
in the MI group compared to the control group.  The importance of this RCT extends beyond its 
statistical support for the use of MI to boost ART adherence.  The DiIorio et al. (2008) study is 
the only RCT in this review that demonstrated the potential positive long-term effects of MI in 
promoting ART adherence. 
 Maneesriwongul, Prajanket, and Saengcharnchai (2012) conducted the most recent RCT 
in Thailand.  This study included 90 HIV-positive participants who were randomly assigned to 
one of three groups, MI plus usual care, an educational video plus usual care, and usual care 
alone.  The average age of the MI group, educational video group, and usual care group was  
m = 40 years, range = 23 – 52; m = 42.3 years, range = 25 – 61; and m = 39.3 years,  range = 22- 
67, respectively.  These authors did not report standard deviations.  The majority of the 
participants in the three study groups were male.  There were no baseline HIV viral load or CD4 
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count data collected; however, 80% of the participants in each study group were on a single-pill 
ART regimen. 
The objective the Maneesriwongul et al. (2012) study was to determine the effect of the 
three intervention groups on ART adherence. The MI group and the educational video group 
both demonstrated statistically significant within-group mean differences in adherence from 
baseline to the four-week study endpoint (Maneesriwongul et al., 2012).  In addition, results of 
the between-group posttest mean adherence scale scores were significantly different for the three 
treatment groups.  However, Maneesriwongul et al. reported nonsignificant differences in 
posttest adherence scores between the MI plus usual care and the educational video plus usual 
care groups.   
This study demonstrated the superiority of MI over usual care in the increase of 
adherence levels in this population.  In fact, MI was found to be comparable to delivering an 
HIV educational video coupled with usual medical care.  A limiting factor to this study is its 
inability to evaluate the long-term effects of MI.  The authors commented that it may be more 
cost-effective to use the HIV educational video plus usual care as this intervention produced 
comparably significant results as MI (Maneesriwongul et al., 2012).  However, it is unclear if 
these findings from Thailand can be generalized to HIV populations in the United States. 
Systematic review.  The final study included in search domain three of this integrative 
review is a systematic review.  Hill and Kavookjian (2012) included five RCTs (DiIorio et al., 
2008; Golin et al., 2006; Parsons, Rosof, Punzalan, & Maria, 2005; Pradier et al., 2003; Samet et 
al., 2005) in their systematic review.  Three of these RCTs (DiIorio et al., 2008; Golin et al., 
2006; Pradier et al., 2003) were included in this integrative review.  Two studies were excluded 
based on the alcohol dependency of the study populations.  The primary research inquiry was the 
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effect of MI on patient adherence to ART.  The population of interest was HIV positive adults 
recently prescribed ART or patients already on ART with adherence issues. The targeted 
outcomes included in this review were HIV viral load, CD4 count, and ART adherence.  The 
search methods of this systematic review included 11 databases in a 20-year time span. 
Hill and Kavookjian (2012) concluded that three of the five RCTs (DiIorio et al., 2008; 
Parsons et al., 2005; Pradier et al., 2003) reported significant changes in medication adherence in 
the intervention group compared to the control group.  The two studies (Golin et al., 2006; Samet 
et al., 2005) that did not report significant findings in medication adherence after MI intervention 
cited methodological concerns.  The authors also reported the overall risk of bias in all five 
RCTs was relatively low.  Furthermore, it was concluded that current evidence could not direct 
researchers and clinicians to the MI characteristics most effective in HIV medication adherence 
(Hill & Kavookjian, 2012).  This was largely due to the discrepancies in MI dose and duration.  
Recommendations for future MI research to enhance medication adherence with this specific 
population included the incorporation of larger sample sizes with an equal distribution of 
genders, standardization of MI training and intervention fidelity, and consistency in medication 
adherence measures (Hill & Kavookjian, 2012).  Despite these limitations, the authors 
determined that MI has potential benefits in the enhancement of ART adherence; however, there 
is a need for high-quality research in people living with HIV (Hill & Kavookjian, 2012). 
A synopsis of the presented evidence reveals compelling findings regarding the use of MI 
in the HIV practice setting.  While this area of research is still progressing, greater than half of 
the studies produced statistically significant findings supporting MI use to increase ART 
adherence.   The eight primary research studies produced a sample size range of 20 to 247 
participants.  For those studies reporting effect sizes, the range displayed great variability,  
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d = 0.04 – 0.75.  This heterogeneity in effect size is similar to the meta-analytical findings 
reported by Burke et al. (2003), Hettema et al. (2005), and Lundahl et al. (2010).  In fact, these 
researchers described probable factors attributing to the variance in MI outcomes, some of which 
included MI dose and delivery.  Hill and Kavookjian (2012) also noted the lack of 
standardization in adherence measurement.  Further exploration of these moderator variables 
between MI intervention and adherence outcome may guide the implementation of this 
intervention. 
Objective Two: MI Dose 
Motivational interviewing dose has not been consistent throughout the aforementioned 
intervention studies, leaving health care providers in a quandary regarding the most beneficial 
dosage to provide in clinical practice settings.  Research has demonstrated that MI interventions 
have included as few as one MI session to as many as 10 sessions (Chen et al., 2012; Ma et al., 
2014; Solomon et al., 2012).  Specific guidance is needed as to the number of MI sessions and 
the session length required to promote ART adherence. 
Number of MI sessions.  It is proposed that MI dose is related to the behavior change 
outcome (Miller & Rollnick, 2002); however, there is no evidence-based consensus as to the 
prescriptive dosage needed to elicit medication adherence.  The findings from the meta-analysis 
by Burke et al. (2003) revealed MI has a significant dose-effect relationship.  Motivational 
interviewing intervention studies delivering a greater number of sessions resulted in “better study 
outcomes” compared to MI studies with fewer sessions (Burke et al., 2003, p. 858).  In fact, the 
authors noted that MI is intended to promote behavior change “in a small number of sessions”; 
however, the role of added sessions is to assist clients with the initiation and maintenance of the 
behavior change (Burke et al., 2003, p. 858).   Furthermore, Rubak et al. (2005) observed that 
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greater than one MI session increased the probability of the intended effect.  Two of the reviews 
considered MI dose to be a significant moderator of adherence outcome (Burke et al., 2003; 
Hettema et al., 2005).  The Lundahl and Burke (2009) systematic review of four MI meta-
analyses strongly supports this notion.  They concurred that better adherence outcomes could be 
achieved with more MI sessions; however, they were unable to provide a numerical value for the 
upper limit of the MI dose to administer.  Lundahl et al. (2010) conducted a meta-analysis of 119 
RCTs and reached a similar conclusion as Burke et al. (2003). They concluded that, “more 
treatment time was related to better outcomes for MI” (p. 153). 
It is also suggested that MI dose requirement may differ among target outcomes 
(VanBuskirk & Wetherell, 2013).  For example, target outcomes such as weight loss and 
medication adherence may require a higher MI dose compared to outcomes of reduction in 
alcohol intake and cigarette smoke exposure (VanBuskirk & Wetherell, 2013).  Of the 12 studies 
included in their review, VanBuskirk and Wetherell (2013) reported between four and eleven MI 
sessions were conducted for target behaviors associated with diet and exercise and medication 
adherence, whereas, one session was the minimum effective dose to reduce alcohol use and 
passive smoke exposure.  While not precise, this information provides some prescriptive 
guidance towards the MI dosage inquiry. 
Data retrieved from the HIV research studies (see Table A3 in Appendix A) evaluating 
the effect of MI on ART adherence may also provide practical suggestions for the number of MI 
doses needed to enhance ART adherence.  Of the nine total studies, seven studies provided data 
regarding MI dose.  The number of sessions ranged between two and eight (Golin et al., 2006; 
Konkle-Parker et al., 2012), with three sessions being the most frequently cited (Cook et al., 
2009; DiIorio et al., 2003; Maneesriwongul et al., 2012; Pradier et al., 2003).  One study 
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delivered five sessions and reported positive adherence outcomes (DiIorio et al., 2008).  Four 
studies delivered three MI sessions, and 75% of these studies reported positive statistical 
findings.  The studies delivering two and eight MI sessions (Golin et al., 2006; Konkle-Parker et 
al., 2012) were not able to demonstrate statistically significant changes in ART adherence.  This 
is an interesting finding because previously presented evidence from a meta-analysis (Burke et 
al., 2003) commented on the significant dose-effect relationship between MI and targeted 
outcomes.  Therefore, it may be expected that more intervention sessions would produce 
favorable adherence outcomes. It must be noted, however, that the study (Konkle-Parker et al., 
2012) delivering eight MI sessions utilized MI as one component of a larger intervention 
program. The fact that MI was not the sole intervention of Golin et al.’s study diminishes the 
application of study findings to this implementation project.   
In summary, evaluation of the data from the seven HIV quantitative studies in this review 
resulted in compelling findings.  According to the presented evidence, it appears that people 
living with HIV may experience treatment adherence benefits from a minimum of three MI 
sessions.  However, the only RCT (DiIorio et al., 2008) delivering five MI sessions demonstrated 
persistent ART adherence at 12 months.  Adherence persisted nine months beyond the delivery 
of the last MI session.  Considering that HIV treatment management requires > 95% of indefinite 
adherence, a greater number of MI sessions may be needed to produce lasting adherence results.  
Moreover, the number of MI sessions needed may depend on the client’s risk for nonadherence.  
This was demonstrated in the Cook et al. (2009) quasi-experimental study as participants 
screened as low-risk for nonadherence, according to the transtheoretical model of behavior 
change, were offered fewer MI sessions compared to participants at higher risk.  All participants 
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receiving the MI intervention, regardless of risk type, demonstrated an overall significant 
improvement in ART adherence after six months (Cook et al.).   
Available evidence for MI with the target population of people living with HIV at risk for 
ART nonadherence has produced the following dosage recommendations: 
1. A minimum of three sessions may be needed to produce positive ART adherence 
outcomes (Cool et al., 2009; Maneesriwongul et al., 2012; Pradier et al., 2003). 
2. The range of MI sessions that has been effective to promote ART adherence in 
people living with HIV is three to five sessions (Cool et al., 2009; DiIorio et al., 
2008; Maneesriwongul et al., 2012; Pradier et al., 2003). 
3. A greater number of sessions may be required to produce positive, long-term 
ART adherence outcomes (DiIorio et al., 2008). 
4. A greater number of sessions may be required for people living with HIV with 
higher risk for nonadherence (Cook et al, 2009). 
MI session length.  There is a substantial amount of variability in the length of time 
spent in each MI session.  Among the 12 meta-analyses and systematic reviews included in this 
integrative review, five studies reported findings pertinent to MI session length (Hettema et al., 
2005; Lundahl & Burke, 2009; Lundahl et al., 2010; Rubak et al., 2005; VanBuskirk & 
Wetherell, 2013).  Hettema et al. (2005) and Lundahl et al. (2010) reported the total average time 
spent in MI counseling was 134.4 minutes and 207 minutes, respectively.  Rubak et al. (2005) 
provided a time range between 10 minutes and 120 minutes per session, with the most frequently 
reported time of 60 minutes among the 72 RCTs in their review.   
Despite the evidence for adherence improvement with brief MI encounters of 15 to 20 
minutes duration (Rubak et al., 2005; Vasilaki, Hosier, & Cox, 2006), Lundahl et al. concluded, 
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“it is unreasonable to assume that a very short MI intervention will lead to lasting change” (p. 
153).  In fact, Lundahl and Burke (2009) systematically reviewed four meta-analyses (Burke et 
al., 2003; Hettema et al., 2005; Lundahl et al., 2010; Vasilaki, Hosier, & Cox, 2006) regarding 
MI efficacy in behavior change outcomes with an aggregate sample of 236 RCTs.  They 
concluded that, “more MI sessions will likely result in better outcomes, although the upper limit 
on dose is unknown at this juncture” (Lundahl & Burke, 2009, p. 1240).  Furthermore, Lundahl 
and Burke provided evidence for the superiority of MI over comparison treatments, such as 
cognitive behavioral therapy, in achieving positive outcomes within less treatment time.   
The total MI treatment period was an average of 101 minutes to 180 minutes shorter in duration 
compared to alternative treatments.  Despite the conclusion that more MI is superior, it appears 
that this can be achieved in less time compared to alternate successful therapies. 
Further investigation of the nine HIV-specific studies reveals less variance in the range of 
MI session lengths.  Seven studies provided data regarding session length.  Two studies (Cooke 
et al., 2009; Krummenacher et al., 2011) reported average lengths of 7.5 minutes and 35 minutes 
per session, respectively.  The remaining five studies (DiIorio et al., 2003; DiIorio et al., 2008; 
Maneesriwongul et al., 2012; Pradier et al., 2003; Konkle-Parker et al., 2012) delivered an 
overall MI session length ranging between 10 minutes and 90 minutes.  Konkle-Parker et al. 
(2012) delivered six of eight total MI sessions over brief 10-minute periods; however, this study 
was not able to achieve statistically significant adherence outcomes at the end of six months.  
Three RCTs (DiIoirio et al., 2008; Maneesriwongul et al., 2012; Pradier et al., 2003) reported 
positive ART adherence outcomes with MI session lengths ranging between 25 minutes to 60 
minutes.   
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The success of MI is apparent, whether delivered within a half or full hour session.  It is 
evident that there is no concise recommendation as to the optimal length of this intervention.  
Considering that MI is a client-centered approach to behavior change, it may explain why some 
patients respond to shorter lengths of therapy while others to longer sessions.  Clients are clearly 
unique in their barriers and motivations to behavior change.  An interesting observation 
throughout this integrative review is the lack of screening for stage of behavior change 
(Prochaska & DiClemente, 1992) within the MI intervention studies.  While all studies measured 
the outcome of adherence, very few studies measured baseline and endpoint stage of behavior 
change (Konkle-Parker et al., 2012).  It would seem paramount to include this variable in MI 
intervention studies as MI coincides well with guiding clients through the stages of behavior 
change (Miller & Rollnick, 2002; Prochaska & DiClemente, 1992).  In fact, it may be possible 
that the length of MI needed to achieve ART adherence may depend upon the client’s baseline 
stage of behavior change.  Assessment for a client’s readiness to change may be an important 
factor in determining appropriate MI dose.  Future MI intervention research may benefit from 
including a client’s stage of behavior change (Prochaska & DiClemente, 1992) as a study 
variable. 
Objective Three: Delivery of MI 
The third aim of this integrative review was to determine any differences or similarities in 
the delivery of MI across studies.  Specifically, the inquiry focused on the interventionist and the 
format of the individual MI session.  It is also imperative to determine if the findings of meta-
analytical reviews share similarities with current available evidence pertinent to people living 
with HIV"and ART adherence. 
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MI interventionist.  Motivational interviewing has been successfully versatile in its 
implementation.  Large meta-analytic and systematic reviews (Lundahl et al., 2009; Lundahl et 
al., 2010; Lundahl et al., 2013; Rubak et al., 2005) have examined whether the profession of the 
MI administrator influences behavior change outcome.  MI sessions have been led by nurses, 
mental health providers, dieticians, nurse practitioners, physicians, and health promotion 
educators with similar efficacious results.  In fact, only one meta-analytic review (VanBuskirk & 
Wetherell, 2013) concluded the type of MI interventionist negatively influenced adherence 
outcomes.  Although their meta-regression analysis resulted in this finding, the authors were not 
clear as to the clinical significance of this result.  VanBuskirk and Wetherell (2013) observed 
that many of the studies in their review did not provide specific details about the qualifications of 
the interventionist nor the description of the MI training.  Differentiating between “provider’s 
educational attainment and degree of proficiency with MI” may clarify this finding (VanBuskirk 
& Wetherell, 2013, p. 11).  Nevertheless, the majority of the evidence supports the notion that 
MI can be administered by a variety of health care providers.  
Within the HIV clinical setting, nurses have been the main MI interventionists.  Nursing 
professionals, inclusive of nurse practitioners, delivered the MI sessions in 75% of the eight 
primary studies (Cook et al., 2009; DiIorio et al., 2003; DiIoirio et al., 2008; Manessriwongul et 
al., 2012; Pradier et al., 2003; Konkle-Parker et al., 2012).  The remaining two studies utilized 
pharmacists and master-prepared health educators (Krummenacher et al., 2011; Golin et al., 
2006).  Approximately two-thirds of the studies utilizing nursing professionals reached 
statistically significant adherence outcomes (Cook et al., 2009; DiIoirio et al., 2008; 
Manessriwongul et al., 2012; Pradier et al., 2003).   
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Overall, this small sample of eight quantitative HIV studies demonstrated that positive 
ART adherence outcomes could be achieved with various health professions.  This is similar to 
the previously mentioned meta-analytic and systematic review findings.  Nevertheless, it is 
particularly compelling that nursing professionals were the most prevalent profession delivering 
MI sessions to people living with HIV.  No study commented on the rationale for the chosen MI 
interventionist, nor did the primary HIV research studies statistically evaluate the effect of the 
profession of the MI interventionist on adherence outcomes. 
The evaluation of the evidence has led to an overwhelming consensus that MI delivery is 
not specific to one profession.  High-quality MI training of the MI interventionist may have a 
greater influence on adherence outcomes. Motivational interviewing is unique in that it can be 
successfully delivered by a broad scope of health care professionals.  
MI session format.  There have been two common formats for delivering an individual 
MI session to clients.  The first is the traditional face-to-face counseling style in the office 
setting.  The second MI delivery style is via the telephone.  There have also been combined MI 
formats of in-person and telephone appointments.  The research literature addressing MI delivery 
format includes meta-analytical, systematic, and randomized controlled studies.   
MI session format has been evaluated in two combined systematic and meta-analytic 
reviews conducted by Lundahl et al. (2013) and VanBuskirk and Wetherell (2013).  Lundahl et 
al. utilized the results of 48 RCTs to evaluate the effect of MI session format on behavioral 
change outcomes.  They found no significant effect of MI session delivered in person or via 
telephone sessions on the intended outcomes.  VanBuskirk and Wetherell concluded from their 
systematic review that it is not imperative to deliver MI sessions in person to achieve positive 
outcomes.  Among the 12 RCTs in their review, 50% of the RCTs included telephone-based MI 
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sessions.  Approximately 83% of the six RCTs utilizing telephone-based MI sessions reported 
positive and statistically significant results.  The same was evident among the six RCTs 
delivering MI in-person, with only one RCT unable to achieve favorable outcomes. 
Thus far, it appears that MI session format is not a moderator of behavior change 
outcome within diverse problem areas and populations (Lundahl et al., 2013; VanBuskirk & 
Wetherell, 2013).  Lundahl et al.’s (2013) meta-analysis only included one of the eight HIV-
specific studies (Golin et al., 2006) from this integrative review. Therefore, it is important to 
explore this matter within HIV-specific quantitative studies to determine if the data reveal 
similar findings.   
The current evidence indicates that people living with HIV"are receiving MI sessions with 
similar formats as clients with other health conditions.  Approximately 63% of the HIV-specific 
RCTs in this review (Golin et al., 2006; DiIorio et al., 2003; Pradier et al., 2003; Konkle-Parker 
et al., 2012; Krummenacher et al., 2011) administered MI sessions in person, while 25% of the 
studies (Maneesriwongul et al., 2012; DiIorio et al., 2008) utilized a combined telephone and 
face-to-face approach.  Cook et al. (2009) delivered their MI intervention via telephone.  
Interestingly, 60% of the studies providing in-person MI sessions were not able to reach desired 
adherence outcomes.  It must be noted, however, that two of these unsuccessful studies were 
small, randomized pilot studies with low statistical power (DiIorio et al., 2003; Konkle-Parker et 
al., 2012).  Contrarily, all three HIV studies incorporating either, telephone-based MI or 
combined telephone and in-person MI, reached statistically significant ART adherence outcomes 
(Cook et al., 2009; Maneesriwongul et al., 2012; DiIorio et al., 2008).   
There are noteworthy similarities and differences in these findings compared to the 
broader scope of MI research in behavior change outcomes.  In comparison to the VanBuskirk 
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and Wetherell (2013) systematic review of 12 RCTs exploring MI and health behavior outcomes, 
the majority of the HIV-specific studies delivered MI sessions in person, while the proportion of 
studies with in-person and telephone-based MI sessions were equal in the VanBuskirk and 
Wetherell systematic review.  Nevertheless, both reviews provide evidence affirming the ability 
of MI to promote treatment adherence, whether delivered as a telephone-based or face-to-face 
intervention.  
In summary, motivational interviewing is not limited to the traditional in-person 
counseling style as other effective behavioral change interventions are.  This quality may be 
beneficial with non-adherent people living with HIV"struggling from lack of transportation, busy 
work schedules, or the perceived-stigma associated with coming to the HIV clinic.  This subset 
of patients may be more receptive to telephone-based MI sessions.  This aspect of MI makes it a 
beneficial, yet versatile, clinical intervention. 
Objective Four: Measurement of Medication Adherence 
The final interest in conducting this integrative review was to determine the measures 
utilized for the concept of adherence to ART.  Hill and Kavookjian (2012) observed from their 
meta-analysis that adherence measures have varied between MI intervention studies.  This 
integrative review has resulted in similar findings.   
Overall, there were three forms of indirect, primary adherence measures employed in the 
nine quantitative HIV-specific studies. The first and most prevalent was the self-report adherence 
measure.  All studies, except for that of DiIorio et al. (2008) and Krummenacher et al. (2011), 
included a self-report measure to quantify an adherence level.  Each self-report measure was 
distinct and included the Antiretroviral General Adherence Scale (DiIorio et al.; McDonnell et 
al., 2001), the Adherence to Antiretroviral Therapy Visual Analog Scale (Maneesriwongul et al., 
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2012), a linear Visual Analog Scale of the percent of adherence in the previous four weeks 
(Konkle-Parker et al., 2012), and various adherence recall questionnaires (Cook et al, 2009; 
Golin et al., 2006; Pradier et al., 2003).  All authors reported on the validation of their 
measurement tools.  The second type of adherence measure was the prescription refill rate via 
pharmacy data and was used by Konkle-Parker et al. (2012).  Finally, the third mechanism was 
the Medication Electronic Monitoring System.  This electronic system was utilized in two studies 
as the only mechanism for quantifying adherence (DiIorio et al., 2008; Krummenacher et al., 
2011). 
The majority of the HIV-specific studies also incorporated secondary forms of adherence 
measures.  Laboratory markers, such as HIV viral load and CD4 count, were commonly used as 
determinants of treatment success.  Approximately 63% of the studies utilized HIV viral load as 
a secondary adherence measure (DiIorio et al., 2008; Golin et al., 2006; Konkle-Parker et al., 
2012; Krummenacher et al., 2011; Pradier et al., 2003). 
There is not a standard ART adherence measurement tool that has been consistently 
utilized in the HIV-specific studies included in this review.  A large proportion of these studies 
have been successful in promoting adherence through MI.  However, the challenge still remains 
in making direct comparisons of ART adherence outcomes between studies.  Hill and 
Kavookjian (2013) attributed this challenge to the lack of consensus in defining and measuring 
adherence.  At this point, the MI literature does not support that the use of a precise adherence 
measure is superior to available measurement tools for people living with HIV.  It appears that 
this is a future prospect in MI and ART adherence research. 
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Conclusion 
  This integrative review brought forth practical information regarding the dynamics of 
MI as an intervention to increase ART adherence.  First, MI is an effective intervention 
appropriate for clients ambivalent about taking ART.  Despite the novelty of MI in the HIV 
clinical setting, there is sufficient evidence suggesting it is transferable across various chronic 
diseases.  Second, this review has demonstrated that there is no standard MI dose criterion 
needed to produce effective adherence results.  However, a greater number of MI sessions may 
be needed for people living with HIV"at greater risk for nonadherence and to produce long-term 
ART adherence results.  Next, it appears that MI can be delivered by a variety of health 
professions provided that appropriate MI training has been received and fidelity to intervention 
maintained.  This broadens the scope of practice for this intervention as certain HIV clinics 
utilize nurses, pharmacists, or medical case managers to address ART adherence issues with 
clients.  Finally, the literature demonstrates consistent variability in the utilization of medication 
adherence measurement tools. 
 Effective adherence intervention methods are paramount to the quality and longevity of 
life of clients with HIV"as they face the daily struggles of this chronic disease.  This integrative 
review sought to examine the current evidence base for the implementation of MI into a HIV 
clinical practice setting.  The following chapter will introduce the theoretical foundations guiding 
this practice initiative. 
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CHAPTER 3 
 
Conceptual Framework 
 
This chapter focuses on the underlying theoretical frameworks supporting the 
implementation of MI into the HIV clinical practice setting. The Information-Motivation-
Behavioral (IMB) Skills model of ART adherence was one of two chosen frameworks to 
comprehend the role of MI in medication adherence (Fisher & Fisher, 2000).  The 
Transtheoretical Model (TTM) of behavior change also supported the use of this behavioral 
intervention (Prochaska & DiClemente, 1984).  Finally, the revised Promoting Action on 
Research Implementation in Health Services (PARIHS) framework was the chosen method for 
the process of implementing this evidence-based intervention (Kitson, Harvey, & McCormack, 
1998; Rycroft-Malone, 2004; Stetler, Damschroder, Helfrich, & Hagedorn, 2011). The following 
sections describe the basic components and postulates of each conceptual framework. 
Information-Motivation-Behavioral Model of ART Adherence 
The IMB model of ART adherence was derived from the general IMB model of health 
behavior, however, focuses specifically on the determinants of health behavior related to ART 
adherence (Fisher & Fisher, 2000).  The IMB model of ART adherence is a conceptual model 
utilized “to understand, predict, and promote adherence” to HIV medication (Fisher, Fisher, 
Amico, & Harman, 2006, p. 463).  The major concepts include adherence information, adherence 
motivation, adherence behavioral skills, and adherence behavior.  The relationships between the 
concepts and their elements are presented in Figure 1.  This model postulates that people living 
with HIV are more likely to adhere to ART “to the extent that HIV-positive individuals are well-
informed, motivated to act, and possess the behavioral skills required to act effectively” (Fisher 
et al., 2006, p. 463).   
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Motivational interviewing addresses the concept of adherence motivation.  The IMB 
model of ART adherence asserts that personal adherence motivation and social motivation 
contribute to an individual’s motivation towards ART adherence (Fisher et al., 2006).  
Specifically, the MI intervention is aimed at eliciting an individual’s personal motivation for 
adherence behavior.  There were current interventions in place at the project site that addressed 
the IMB model concepts of adherence information and behavioral skills.  Thus, the addition of 
an intervention aimed toward the missing component of adherence motivation would contribute 
to the success of achieving the intended health outcomes of the IMB model. 
 
Figure 1.  The information-motivation-behavioral skills model of ART adherence (2006).  From “An 
Information-Motivation-Behavioral Skills Model of Adherence to Antiretroviral Therapy” by J. D. Fisher, 
W. A. Fisher, K. R. Amico, & J. J. Harman, 2006, Health Psychology, 4, 462-473.  Copyright 2006 and 
reprinted with permission from Jeffrey D. Fisher, PhD from the University of Connecticut (see Appendix 
B). 
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Transtheoretical Model of Behavior Change 
The TTM of behavior change is a prime conceptual model upon which to focus a MI 
intervention (Prochaska & DiClemente, 1984).  The TTM was developed “to integrate principles 
and processes of change from across leading theories of psychotherapy and behavior change” 
(Prochaska, 2008, p. 845).  The aim of this model is to direct the timing and type of intervention 
utilized to assist clients with achieving healthy behavior changes (Wright, Velicer, & Prochaska, 
2008).   
There are 15 constructs forming the TTM.  These include the stage of change, two 
decisional balance constructs, two self-efficacy constructs, five experiential change processes, 
and five behavioral processes (Wright et al., 2008).  The core concept of the TTM is stage of 
behavior change.  This stage is a developing process across five behavior stages that occur over 
time (Prochaska, 2008).  The five stages include precontemplation, contemplation, preparation, 
action, and maintenance.  It is postulated that people do not change habitual behavior in a 
sudden, decisive manner, but rather, progress “in a linear or cyclical fashion” through the five 
behavior stages (Prochaska, 2008; Wright et al., 2008). The movement between stages may 
include relapses to previous stages.  According to the TTM, the experiential and behavioral 
constructs are independent variables that facilitate the behavior change; while, the decisional 
balance and self-efficacy constructs are considered the outcome measures (Velicer et al., 2000).  
The stage and process constructs encompassing the TTM are displayed in Figure 2.       
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 Figure 2.  Stages and processes of change.  Adapted from “Prochaska’s stage model of  
 change” retrieved from  https://pc3coachingtoolkit.pbworks.com/w/page/54072360/Prochaska's Stage 
Model of Change 
 
Interconnections Between the IMB Skills Model, the TTM, and MI 
The utility of the IMB skills model of ART adherence within this implementation project 
will provide the fundamental framework to understand the concept of ART adherence and its 
relationship to motivation.  The TTM fits within the IMB skills model by providing an 
understanding of the mechanism of behavior change.  Specifically, the TTM will be applied to 
the relationship between the IMB constructs of adherence motivation and adherence behavior.  
Motivational interviewing will function within this model as a type of behavioral process 
intervention as described by the TTM (Prochaska, 2008).  Hence, the role of MI is to facilitate 
the transition along the behavior change continuum with the intention to promote increased 
adherence behavior leading to the health outcome of HIV viral suppression.  A depiction of the 
interconnections of the IMB, TTM, and MI is displayed in Figure 2. 
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Figure 3.  A depiction of the interconnections between the IMB skills model of ART 
adherence, the TTM stages of behavior change, and motivational interviewing.  Adapted from 
Fisher, Fisher, Amico, and Harman (2006), Prochaska and DiClemente (1984), and Miller and 
Rollnick (2002). 
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Promoting Action on Research Implementation in 
  Health Services Framework 
 The information presented thus far has provided evidence in support of the use of MI to 
promote ART adherence, as well as, the conceptual models with which to understand the 
behavioral components of adhering to ART.  However, evidence alone does not support the 
transition of interventions into routine clinical practice (Kitson, Harvey, & McCormack, 1998.)  
To support the success of implementing a MI intervention into the clinical practice setting of this 
HIV clinic, the revised PARIHS framework (Kitson et al., 1998; Rycroft-Malone, 2004; Stetler, 
Damschroder, Helfrich, & Hagedorn, 2011) will serve as the guiding framework.   
The revised PARIHS framework consists of three main interacting elements that are 
proposed to influence successful implementation of evidence-based practices into the clinical 
setting.  These elements include evidence, context, and facilitation.  It is furthered hypothesized 
that the PARIHS framework is best utilized in two stages (Kitson et al., 2008).  In the first stage, 
evidence and context can be used as preliminary diagnostic and evaluative measures.  The results 
of these measures would then guide the development of the facilitation method in the second 
stage (Kitson et al., 2008).  Knowledge of the conceptual definitions of each core element will 
enhance the understanding of the propositions of the PARIHS framework. 
The concept of evidence extends beyond research evidence in the PARIHS framework.  
To fully understand the evidence for a practice initiative, evidence must include the combination 
of research, clinical expertise, patient experience, and local data (Rycroft-Malone et al., 2004).   
Successful implementation is more likely to occur when the sub-elements of evidence, research, 
clinical expertise, patient experience, and local data are high on the evidence continuum 
(Rycroft-Malone, 2004).  In the revised version of the framework, the characteristics of the 
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targeted evidence-based intervention was added as a subelement of the evidence construct 
(Stetler et al., 2011). 
Context is the second element of the PARIHS framework and is defined as “the 
environment or setting in which people receive healthcare services, or in the context of getting 
research into practice, the environment or setting in which the proposed change is to be 
implemented” (Rycroft-Malone, 2004, p. 299).  There are three contextual factors, or 
subelements, that contribute to successful implementation.  These factors include culture, 
leadership, and evaluation.  It is proposed that an environment with a strong context (culture, 
leadership, and evaluation) will foster successful implementation of evidence-based practice 
change versus low contextual environments (Rycroft-Malone, 2004). 
The final core element of the PARIHS framework is facilitation.  Facilitation “refers to 
the process of enabling (making easier) the implementation of evidence into practice” (Rycroft-
Malone, 2004, p. 300).  The facilitator is postulated to play an integral role in promoting 
successful implementation by affecting the context of the practice environment and by 
collaborating with the health care workers within the environment.  Facilitation is organized into 
the subelements of purpose, role, skills, and attributes.  Similar to evidence and context, 
facilitation is measured on a low to high continuum, with successful implementation more likely 
to occur in the presence of high facilitation.  Figure 4 displays the core elements and subelements 
of the PARIHS framework, while Figure 5 depicts the influence of evidence, context, and 
facilitation toward successful implementation. 
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     Figure 4.  Elements of the PARIHS framework.  Adapted from “The PARIHS framework:  
    A framework for guiding the implementation of evidence-based practice”, by J. Rycroft-   
    Malone, 2004, Journal of Nursing Care Quality,19, p. 301-302.  Copyright 2004 by Lippincott 
    Williams & Wilkins, Inc. 
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Figure 5.  The role of evidence, context, and facilitation in achieving successful implementation.  A three-
dimensional depiction of the positive and negative influences of evidence,  
context, and facilitation toward successful implementation.  Adapted from “Enabling the implementation 
of evidence-based practice: A conceptual framework” by A. Kitson, G. Harvey, and B. McCormack, 
1998, Quality in Health Care, 7, p. 153.   
 
The PARIHS framework is not steadfast and has undergone constructive revisions since 
its inception.  Stetler, Damschroder, Helfrich, and Hagedorn (2011) proposed the most recent 
refinement of the PARIHS framework and provided a tangible guide for evidence-based practice 
implementation.  The objective of the revised PARIHS framework is binary.  First, Stetler et al. 
sought to guide users in application of the best method to operationalize the framework within 
the Quality Enhancement Research Initiative action-oriented approach.  Second, the aim was to 
concentrate on the identified obstacles to utilization of the framework in the practice setting.  
Overall, the revisions added clarity to conceptual and operational definitions in the PARIHS 
framework, as well as, incorporated new elements and subelements to the original framework.   
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Figure 6.  The revised PARIHS framework.  Adapted from “A Guide for applying a revised version of 
the PARIHS framework for implementation,” by C. Stetler, L. Damschroder, C. Helfrich, and H. 
Hagedorn, 2011, Implementation Science, 6, p. 6.  Copyright 2011 by BioMed Central Ltd. 
 
Conclusion 
The utility of the IMB skills model, the TTM of behavior change, and the revised 
PARIHS framework played a specific role in this MI implementation project.  The IMB skills 
model provided the foundation for the importance of adherence motivation in achieving the long-
term outcome of ART adherence and HIV viral suppression.  The TTM aided in identifying a 
client’s stage of behavior change for the purpose of targeting the intervention towards the 
behavior stages most amenable to MI.  Finally, the revised PARIHS framework was intended to 
guide the inception of this evidence-based intervention into the clinical practice environment.  
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CHAPTER 4 
Methods 
Thus far, supporting evidence has demonstrated the extent and implications of ART 
nonadherence in people living with HIV.  Motivational interviewing was introduced as a 
mechanism for eliciting a client’s intrinsic motivation for adherence behavior.  The conceptual 
frameworks supporting the intervention included the IMB skills model of ART adherence and 
the TTM of behavior change.  The focus of this chapter is to introduce the refined project 
inquiry, intended target population, and development of the evidence-based practice (EBP) team.  
The methodological presentation of this EBP initiative utilized the elements of the revised 
PARIHS framework as an implementation guide.   
EBP Project Goals 
 The original research inquiries presented in Chapter 1 focused on the effectiveness and 
feasibility of an MI intervention in a local HIV clinic.  These inquiries were refined as results of 
the integrative review provided ample evidence of the effectiveness of MI in promoting behavior 
change and medication adherence.  While this organization addressed two main components of 
adherence behavior according to the IMB Skills model, findings from the organizational 
assessment revealed a need for an intervention aimed at client motivation.  Organizational 
assessment findings also affirmed that senior leadership and clinicians found value in a MI 
intervention and were interested in the effect of MI training on staff perceptions and knowledge 
of MI.  This EBP project aimed to provide the foundation for a quality improvement (QI) 
initiative to implement MI by providing MI training to the multidisciplinary care team.  
Specifically, this project evaluated the influence of an introductory MI training course on MI 
knowledge, perceived MI effectiveness, perception of client behavior change, and likelihood of 
" 83"
 
MI use among care team members.  While the long-term patient outcome goal of this MI 
intervention was improvement in HIV viral suppression, multiple steps were needed in this QI 
initiative.  In order to produce the intended patient outcomes, this QI initiative first addressed the 
future MI interventionists within the practice environment.  
Target Population 
 The intended population for the MI introductory training was the multidisciplinary care 
team at the project site.  There were 17 staff members inclusive of the site manager, physicians, 
nurse practitioners, pharmacist, registered nurses, case managers, and medical assistants.  This 
multidisciplinary care team was the ideal target population on whom to focus an intervention to 
promote ART adherence, as they are the key stakeholders in adopting the principles and spirit of 
MI.   
EBP Team Development 
 Prior to addressing the elements of the revised PARIHS framework, it was paramount to 
establish the team within the organization that would foster the development and integration of 
MI into the practice setting.  This organization had an established QI team led by the nurse 
practitioner and an HIV case manager.  The remaining members of the QI team represented each 
of the disciplines in the clinical setting.  The intended approach for integration of this EBP 
intervention into this organization was to structure it as a QI initiative and to utilize the existing 
QI members as the EBP team.  This approach fostered an interdisciplinary and collaborative EBP 
team.  
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Revised PARIHS Framework: Evidence and Characteristics of Motivational Interviewing 
 The first step in the transition of MI into practice was assessing the evidence for the EBP 
initiative.  Evidence is not limited to research outcomes.  Forms of evidence also included 
clinical and patient experience, local practice data, and characteristics of the intervention (Stetler 
et al., 2011).   
Research and Published Guidelines 
 Chapter two provided a thorough investigation of the published literature in support of 
MI with medication adherence promotion.  There was also support for the use of MI to enhance 
ART adherence provided by the DHHS (2014) in “Guidelines for the use of antiretroviral agents 
in HIV-1 infected adults and adolescents.” A well-supported evidence base for MI, coupled with 
practice guidelines recommending MI as a behavioral adherence intervention, provided a strong 
foundation for this EBP initiative. 
Clinical Experience and Perceptions 
 Clinical experience is essential to the knowledge base in support of the need for MI in 
this practice setting.  The conceptual definition of clinical experience is knowledge that is 
expressed and embedded in practice (Stetler et al., 2011).  Clinical experience can originate from 
the experience of others or one’s personal experience.  Evidence derived from clinical experience 
is concerned with the strength and nature of the motivation for or against the implementation of 
MI, as well as, the extent to which there is consensus among the key stakeholders regarding this 
intervention (Stetler et al., 2011).  This form of evidence was gathered during a group discussion 
after the initial presentation of this EBP initiative to the organization.  There were 12 essential 
staff members present during the presentation and were comprised of the following professional 
disciplines: physicians, nurse practitioner, pharmacist, nurses, medical assistants, and case 
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managers.  Although the site manager was unavailable for this group discussion, the medical 
director of the clinic represented senior leadership.   
There were key themes identified from the group discussion pertaining to clinical experience.  
The first theme was a multidisciplinary recognition of the problem of ART adherence.  The 
second emerging theme was the recognition of insufficient proficiency in delivering behavioral 
interventions. Professional disciplines involved in direct patient care verbalized a generalized 
sense of inadequacy when it came to assisting clients with behavior change.  Finally, the need for 
an intervention directed at client motivation emerged as the third theme as the professional staff 
realized their approach to treatment adherence lacked this important concept.  
Patient Experiences, Needs, Preferences and Local Practice Information 
 Given that MI is a client-centered intervention, inclusion of the patient population in the 
formation of the evidence base for this intervention was essential.  Organizational patient data 
contributed to local practice information while describing the extent of patient needs.  The ART 
adherence data of clients in this outpatient  HIV clinic was above the national reported average.  
The CDC (2012) estimated that approximately 36 of 100 persons living with HIV"in the U. S. are 
taking ART, and only 28% of persons living with HIV in the U. S. have achieved viral 
suppression.  According to a CAREWare data report of viral load suppression within the period 
of September 1, 2013 to September 30, 2014, a total of 941 patients were actively in medical 
care at the project site.  The estimated adherence rate within this time period was approximately 
86%.  CAREWare is a free data collection system offered by the Health Resources and Services 
Administration (HRSA) that allows HIV service providers receiving Ryan White CARE Act 
funds to collect client-level data (GAO, 2009).  The data in the following figure was retrieved 
from the CAREWare report. 
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HIV viral suppression is one of the HIV/AIDS Bureau performance measures, and the 
outcome value of 200 copies/ml is the criterion set forth by HRSA (2013).  The decision of 
HRSA to adopt a higher value than reported in the literature resides in the fact that there are 
multiple viral assays with differing detection limits, and the viral suppression value of 200 
copies/ml is inclusive of these various limits (HRSA, 2013).  As noted in Figure 7, the 
CAREWare client data report also utilizes an HIV serum level of 200 copies/ml or less as the 
HIV viral suppression goal.  According the the Infectious Disease Society of America (IDSA; 
2013), “HIV viral suppression is defined as a viral load persistently below the level of 
detection of the assay; however the DHHS guidelines define virologic failure as a 
Number of Patients 
Prescribed ART  
Yes  
(n = 810) 
Viral Load < 200 copies/
mL  
(n = 689) 
Viral Load > 200 copies/
mL  
(n = 71) 
No  
(n = 131) 
Figure 7.  Client-level data of the project site.  Flow chart of the number of patients not 
prescribed ART and the number of patients prescribed ART that have not achieved viral 
suppression at the outpatient HIV clinic.  This data represents the time period between 
September 1, 2013 and September 30, 2014.  The values in the black boxes represent the 
existing gap in HIV viral suppression.  It must be noted that the discrepancy between the total 
number of patients prescribed ART, n = 810, and the sum of n =689 and n = 71 may be due to 
lab values that were not captured through the manual input of data into CAREWare. 
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confirmed viral load > 200 copies/ml” (p. 15).  Within the EBP project site, the HIV viral 
assay can detect HIV serum levels as low as 40 copies/ml or less, and is thus, the preferred 
criterion for HIV viral suppression in this practice.   
The current data report revealed that there were approximately 200 clients that were 
either not taking ART or had not achieved consistent viral suppression while taking ART.  Given 
that the CAREWare report utilizes the less than 200 copies/ml criterion for HIV viral 
suppression, the number of clients who have not achieved viral suppression may be greater 
according to the IDSA guidelines. Despite this possible discrepancy, there were approximately 
20% of the patient population who had yet to achieve HIV viral suppression at this outpatient 
HIV clinic. 
Characteristics of Motivational Interviewing Intervention 
 The revised PARIHS framework includes the characteristics of the EBP intervention as a 
critical subelement of the evidence construct of the framework.  The conceptual definition of this 
subelement is described as the “attributes or designated features of an EBP that may influence 
the likelihood of its adoption” (Stetler et al., 2011, Additional file 1).  There are seven key 
attributes that should be evaluated by the EBP team before implementation of the targeted 
intervention with their patient population.  These attributes include the relative advantage, 
observability, compatibility, complexity, trialability, design quality, and cost.   
Consideration of these specific attributes of MI assisted with the adoption of this intervention.  
This project focused on the attributes of trialability, observability, and costs of MI. 
Trialability.  Within the revised PARIHS framework, trialability refers to “the ability to 
test the EBP on a small scale in the organization, and to be able to reverse course (undo 
implementation) if warranted” (Stetler et al., 2011, Additional File 4).  Given this context, this 
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MI implementation project examined the feasibility of incorporating MI into a local HIV clinic 
by determining the influence of introductory MI training on staff knowledge, perception, and 
likelihood of MI use.  Specifically, implementation feasibility studies are concerned with “the 
extent, likelihood, and manner in which an intervention can be fully implemented as planned and 
proposed, often in an uncontrolled design” (Bowen et al., 2009, p. 453).  The following 
components will outline the methodology of the MI feasibility project. 
Project design, sample, and eligibility criteria. The chosen project design was a one-
group pretest-posttest design.  Baseline data were collected immediately prior to the introductory 
MI training and a post-test was completed after the two-day training.   
The total available target population for this sample was the 17 care team members of the 
organizational site.  The desired number of team members to participate in the MI training was at 
least 10 to 15.  Inclusion and exclusion criteria were as follows: 
Inclusion criteria. 
• Participant was employed at the project site. 
• Participant was voluntarily willing to participate in the MI training sessions and complete 
the MI Survey and demographic form. 
• Participant was able to speak and read English. 
Exclusion criteria. 
• Participant was functioning in a business office position at the project site.  
• Participant was not available at the time the MI survey was distributed for completion. 
Recruitment methods.  The process for recruiting participants began with informing 
prospective participants of the project plan.  A 45-minute presentation was held during the staff 
lunch hour.  This presentation informed the staff of the background and significance of ART 
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nonadherence, theoretical support for this behavioral intervention, and the proposed QI initiative 
of MI implementation.  Information regarding the introductory MI training was also provided.  
The clinical site supervisor approved staff to receive their hourly wage for attendance at this 
meeting.  Further efforts at recruitment included the delivery of weekly reminders of the 
impending MI training.  This was accomplished through announcements during morning huddle, 
email notifications, and information posted on the clinic communication board. 
Human participant considerations.  This QI project did not undergo review by the 
Human Research Review Committee of Grand Valley State University, as it was not deemed a 
research study.  This QI project was not intended to produce generalizable knowledge.  The 
intention was to gather information regarding the care team members of the project site to guide 
the QI team in the uptake of MI. There were no foreseen clinical risks to the participants in this 
feasibility project.   
Informed consent process.  The primary project investigator obtained informed consent 
for participation in the project.  Participants were given ample time for questions.  Participants 
were given an implied consent letter prior on the first day of the MI training sessions.  This letter 
informed participants that completion of the MI survey indicated participant willingness and 
consent to participate.   
The participants were also informed of the right to withdraw from completing the MI survey 
without penalty.  The contact information of the primary project investigator was given to the 
participants.  The project investigator had completed CITI training. 
Data management and storage.  The MI Survey and demographic forms were kept 
secured at the Kirkhof College of Nursing research office.  Each participant was assigned a non-
identifiable number that was stored in an electronic enrollment form on an encrypted flash drive. 
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The flash drive of participant and survey data was also securely stored at the Kirkhof College of 
Nursing research office.  
Data collection instruments.  There were two self-report questionnaires administered to 
participants prior to the start of the MI training on the first day of the two-day training.  These 
questionnaires included the Motivational Interviewing Survey (see Appendix C) and a brief 
demographic form (see Appendix D). 
 The Motivational Interviewing Survey is a 13-item questionnaire intended to gather 
information regarding participant “knowledge of motivational interviewing, perceptions of the 
effectiveness of motivational interviewing, the likelihood of utilizing MI strategies,” and 
participant perceptions of clients and behavior change (Willits, Albright, Broidy, & Lyons, 2009, 
p. 1).  This questionnaire was developed and utilized in a study conducted by Willits et al. (2009) 
to compare pre- and post- MI knowledge and perceptions after a three-day MI training session.  
Permission for use of the Motivational Interviewing Survey is available in Appendix E. 
 The demographic variables of interest included gender, job role, length of employment at 
the organization, and previous history of MI use.  Collection of these data did not identify a 
particular participant; however, the data allowed the identification of any variation in MI 
variables within the demographic variables.  
Description of intervention.  All 17 care team members were invited to attend a two-day 
introductory training in MI by a trainer from the Motivational Interviewing Network of Trainers.  
The credentials of the MI trainer include a Master of Arts degree, licensure in professional 
counseling, and certification in advanced alcohol and drug counseling. The MI training was 
delivered during two, eight-hour sessions on November 14, 2014 and November 21, 2014.  The 
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MI training included didactic instruction and opportunities for practicing MI skills.  The 
following modules were included in the training: 
• Day 1: 
! Module 1:  Defining MI and the Role of MI Practice 
! Module 2:  Why Do People Change? How Can MI Help? The Spirit and 
Principles of MI 
! Module 3:  Conversational Potholes: Responding to Sustain Talk and Discord 
• Day 2: 
! Module 4:  Client-Centered Interviewing Skills: OARS 
! Module 5: The “Zip Code” of Behavior Change:  Recognizing Change Talk 
! Module 6:  Eliciting and Strengthening Change Talk   
! Conclusion: Integration Efforts/Issues 
Statistical analyses.  This project utilized IBM© SPSS© Statistics 20 to analyze data.  
Descriptive statistical data were calculated to describe participant characteristics, while 
inferential statistical analyses informed of differences in pretest-posttest within-group data.  The 
MI Survey responses were reported as ordinal data as follows: 1 = strongly disagree, 2 = 
disagree, 3 = undecided, 4 = agree, 5 = strongly agree.  The negatively scored items were reverse 
scored.  The Wilcoxon signed-rank test for matched pairs was used to assess the magnitude of 
the differences in the pretest-posttest data, while Kendall’s tau rank correlation coefficient was 
used to explore the relationship between the demographic and MI variables  (Field, 2009; Triola 
& Triola, 2006).   
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Project time frame.  The following table provides a timeline of the completed project 
procedures. 
Table 4     
Project Procedures Timeline  
Procedure  October 30, 2014 November 14, 2014   November 21, 2014 
 
Presentation of  
White Paper for   X 
Participation 
 
Review Inclusion/ 
Exclusion Criteria     X 
 
Participation Letter     X 
 
Motivational Interviewing 
Survey       X    X 
 
Motivational Interviewing 
Training Session      X    X 
 
Observability.  Observability as a characteristic of the EBP intervention is concerned 
with the extent to which results or usefulness of MI will be easily available to the users (Stetler et 
al., 2011, Additional file 1).  It was anticipated the outcomes resulting from the data collection 
tools would provide valuable information to the organization.  First, data would be available to 
determine the effect of a 2-day MI training on MI knowledge, perceived MI effectiveness, 
likelihood of MI use, and perception of client behavior change.  Second, these data would 
provide insight into the overall staff perceptions and understanding of this behavioral 
intervention, as well as, future educational needs.  An early step of incorporating an EBP 
intervention into clinical practice was to promote acceptability and receptivity of the practice 
innovation through staff education.  
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Costs.  The costs associated with this EBP project initiative included the cost of MI 
training.  The fee for the MI trainer was $900.00 for an eight-hour group training day or $120.00 
per hour for MI coaching or supervision.  The total expense for the two-day MI training was 
$1,800.00.  The project site was funded a $10,000.00 grant for staff and patient education.  This 
grant funded the cost of the MI training.  
Contextual Readiness for Targeted Evidence-based Practice Implementation 
 After evaluation of the evidence for the EBP intervention, the revised PARIHS 
framework recommends formal evaluation of the context in which the proposed practice change 
is to occur.  The framework provides four quantitative measurement instruments to assess the 
context of an organization.  The Organizational Readiness to Change Assessment (ORCA) tool 
was the chosen method to assess the MI implementation and was completed by the project leader 
(Helfrich, Li, Sharp, & Sales, 2008).  The ORCA tool is a 74-item questionnaire based on the 
PARIHS framework.  Specifically, the context section of the ORCA tool, consisting of 23 items, 
was the portion of the assessment utilized for this step of the EBP project.  The context section 
has a reliability of ∝ = 0.85 and addresses the elements of culture, leadership, measurement, 
readiness for change, and resources of the organization (Helfrich et al., 2008). A copy of the 
ORCA tool and permission for its use is available in Appendices F and G, respectively. 
Findings from the context assessment of the organization resulted in an overall score of 
3.6.  The scoring of the ORCA context assessment section ranges from 1 to 5, with 5 indicating 
higher readiness to change and 1 indicating lower readiness to change.  The scores for each 
subsection of the context assessment are provided in Table 5. Overall, the context assessment 
score indicated the contextual environment of the project site was relatively ready for a practice 
change.  
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Table 5    
ORCA: Context Assessment Scores 
 
 
Variable               Score 
 
Leadership Culture    3.7 
Staff Culture     4.0 
Leadership Practice    3.5 
Evaluation/Accountability   3.5 
Opinion Leader Culture    4.0 
Slack Resources    2.8 
Overall Context Score    3.6 
Note.  The ORCA score ranges from 1 to 5.  A score of 1 indicates lower readiness to change, and a score 
of 5 indicates higher readiness to change. 
 
Facilitation 
 The element of facilitation in the revised PARIHS framework is “a deliberate process of 
interactive problem solving and support that occurs in the context of a recognized need for 
improvement and a supportive interpersonal relationship” (Stetler et al., 2011, Additional file 3).  
Facilitation involves the coordination and application of the necessary skills, role, and purpose to 
foster the uptake of the implementation.   
Formative evaluation of the evidence and context allows for diagnostic assessment of the type 
and extent of facilitation required for this EBP implementation.  The ORCA tool contains a 39-
item facilitation section that measures the capacity for internal facilitation within the 
organization.  The facilitation subscale has a reliability of ∝ = 0.95, and the results are available 
in Table 6.  There was an overall high capacity for internal facilitation within the project site as 
evidenced by an overall ORCA facilitation subscale score of 4.0 (the scoring is similar to the 
ORCA context subscale). 
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Table 6    
ORCA: Facilitation Assessment Scores 
 
 
Variable                Score 
 
Leadership Roles in Planning    4.0 
Project Champion Role     4.8 
Leadership Roles in Support    4.0 
Implementation Team Roles    3.8 
Implementation Plan     3.8 
Communication      4.3 
Assessment      4.0 
Project Resources     3.8 
Evaluation      3.8 
Overall Facilitation Subscale    4.0     
Note.  The ORCA score ranges from 1 to 5.  A score of 1 indicates lower readiness to change, and a score 
of 5 indicates higher readiness to change. 
 
Successful Implementation 
The concept of successful implementation within the PARIHS framework involves the 
implementation plan and its realization, EBP innovation uptake, and achievement of patient 
and/or organizational outcomes (Stetler et al., 2011).  For the purpose of this project, the three 
subelements of the implementation plan and its realization, EBP innovation uptake, and 
organizational outcome were utilized as indicators of successful implementation.   
According to the elements of the PARIHS framework, successful implementation of this EBP 
project was indicated by:  
• The proportion of staff who completed the two-day introductory MI training 
(Implementation Plan and its Realization). 
• The proportion of staff demonstrating a positive change in MI Survey score after the two-
day MI training course (EBP Innovation Uptake and Organizational Outcome). 
 These indicators of successful implementation were intended to contribute to the formulation of 
sustainable recommendations for the uptake of MI use in this practice setting.  
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Conclusion 
 This chapter has provided a detailed description of the EBP implementation project 
utilizing the PARIHS framework.  Embedded within the evidence construct of this framework, a 
feasibility project plan was developed to address the trialability of MI in the context of the HIV 
clinical setting.  It was anticipated that valuable implementation information would derive from 
understanding MI knowledge, perceived MI effectiveness, likelihood of MI use, and perceptions 
of client behavior change of the multidisciplinary care team.  Furthermore, the measures of 
successful implementation were anticipated to contribute to the evaluation of the effectiveness of 
the MI introductory training. The following chapter will provide the results of the participant 
characteristics, MI Survey, and successful implementation measures.   
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CHAPTER 5 
Results 
The purpose of this MI implementation feasibility project was to lay the foundation for 
the uptake of MI as an intervention to promote medication adherence in people living with HIV.  
This chapter describes the findings of an educational intervention conducted with a 
multidisciplinary care team in a Midwest HIV outpatient medical setting.  The objectives of the 
intervention were to improve MI knowledge, perceived MI effectiveness, the likelihood of MI 
use, and perceptions of client behavior change.  The success of the implementation project was 
measured according to the parameters defined within the PARIHS framework. This chapter will 
report the participant characteristics, MI Survey scale results, MI Survey item results, and the 
findings of the measures of successful implementation.   
Participants 
The target population of this implementation project was the multidisciplinary care team 
of an outpatient medical setting that serves clients with HIV.  The professional disciplines 
comprising the care team included physicians, a nurse practitioner, a pharmacist, registered 
nurses, medical assistants, case managers, and the clinic supervisor.  There were 17 eligible staff 
members to participate in the two-day MI introductory training course.  Eleven staff members 
who volunteered were available to attend the first MI session.  Of the 11 participants attending 
the first MI session, seven participants completed the second MI session.  The six staff members 
unavailable to attend the MI training course and the four participants who did not complete 
session two were unable due to illness, scheduled vacation time, and patient care responsibilities.  
Overall, seven of the 17 staff members completed the two-day MI introductory training course.   
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Data were collected from the participants utilizing a demographic form created by the 
investigator.  To maintain participant anonymity, the variables of interest were gender, job role, 
length of employment, and previous MI use.  Table 7 provides a description of participant 
characteristics at the pretest and posttest data collection periods. 
Table 7 
 
Participant Characteristics 
 
              Pretesta               Posttestb 
 
Variable      % (n)    % (n) 
 
Gender 
 Male     45.5 (5)    57.1 (4)  
 
Job Role 
 Clinician    54.5 (6)    42.9 (3) 
 Non-Clinician    45.5 (5)    57.1 (4) 
 
Employment Length  
in Years 
 0-3      45.5 (5)    28.6 (2)    
 4-6      9.1 (1)    14.3 (1) 
 7-9      0 (0)    0 (0) 
 > 9      45.5 (5)    57.1 (4) 
 
Previous MI Use 
 Yes      9.1 (1)    14.3 (1)    
 No     81.8 (9)    71.4 (5) 
 Unanswered    9.1 (1)    14.3 (1) 
Note. Clinician roles may include nurse practitioner, physician, pharmacist, registered nurse, and medical 
assistant.  Non-clinical roles may include case managers and administrators. 
a N = 11; b n = 7. 
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Motivational Interviewing Survey 
The MI Survey is a 13-item Likert-type scale intended to capture MI knowledge, 
perception of MI effectiveness, likelihood of MI use, and perception of client behavior change 
(Willits et al., 2009).  The score of the MI Survey ranges from 13 to 65.  The results of reliability 
testing of the MI Survey were not available in the original study conducted by Willits et al. 
(2009).  This project leader requested reliability scale results from the original researchers 
without success (see Appendix H).  The MI Survey posttest results of the seven participants 
completing the intervention of this implementation project demonstrated good reliability, 
Cronbach’s α = .75.  The two subscales, helper-related attitude (6 items) and perception of client 
behavior change (7 items), had lower reliability, Cronbach’s α = .50 and α = .51, respectively.  
Overall, the MI Survey and its two subscales demonstrated adequate internal consistency for the 
purpose of this project.   
Motivational Interviewing Survey: Scale Analyses 
The statistical analyses of MI survey results were conducted on data collected on the first 
day of the MI sessions, prior to the start of MI session one and immediately following the 
termination of MI session two.  Wilcoxon signed-rank analysis was conducted to test the 
difference between the median MI Survey score at baseline and follow-up. The purpose of the 
analyses was to measure the effectiveness of the MI training.  The result of the Wilcoxon signed-
rank test reached statistical significance. The baseline median MI Survey score, N = 11,  
Mdn = 39.00, was lower than the median MI Survey score at follow-up, n = 7, Mdn = 52.00,  
Z = -2.375, p = .018.   
A Pearson’s product moment correlation coefficient was utilized to calculate the effect 
size as recommended by Field (2009).  There is a strong inverse relationship between the median 
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pretest score and posttest score, r = - .63.  Specifically, the lower the median MI Survey score at 
baseline the greater the likelihood of having a higher median MI Survey score after completion 
of the intervention.  This suggests that participants with decreased MI knowledge, perceived MI 
effectiveness, perceptions of client behavior change, and likelihood of MI use were more apt to 
improve in these areas after attending the two-day MI training.   
 Relationship between participant characteristics and MI Survey scale scores. 
 The investigator was also interested in the association between participant characteristics 
and MI Survey scores at baseline and termination.  Kendall’s tau coefficient was utilized as the 
test statistic based on the small sample size and the large number of tied ranks of pretest and 
posttest MI Survey scores (Field, 2009).  The findings resulted in a significant positive 
relationship between gender and MI Survey posttest results.  The median posttest score for 
males, n = 4, Mdn = 50, was lower than the median posttest score for the female participants,  
n = 3, Mdn = 56, τ = .82, p = .028.  It appears that female participants were more likely than 
male participants to have a higher MI Survey score after completion of the MI introductory 
sessions.  Furthermore, a relationship between job role and MI Survey pretest scores approached 
significance.  Participants employed in a clinician role had a lower median MI Survey score,  
n = 6, Mdn = 38, than participants employed in a non-clinician role, n = 5, Mdn = 44, τ = - .54,  
p = .052.  No significant correlations were found between gender, employment length, previous 
MI use and pretest scores nor between job role, employment length, previous MI use and posttest 
scores (see Table 8). 
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Table 8 
Correlation between Participant Characteristics and MI Survey Score 
 
              Pretest      Posttest 
Variable   τ   p    τ  p 
 
Gender   .230a  .406    .816c  .028*  
  
Job Role         -.537a  .052               -.136c  .714 
 
Employment Length (yrs)          .142a  .597    .378c  .289 
 
Previous MI Use         .156b  .596    .129d  .756 
Note.  τ = Kendall’s tau rank correlation coefficient. aN = 11.  bn = 10.  cn = 7.  dn = 6.  * p < .05.  There 
was one participant who did not provide a response to the variable “previous MI use,” resulting in a 
sample size of 10 for this variable.  Pairwise deletion of the missing data was utilized in this correlational 
analysis. 
 
Motivational Interviewing Survey: Item Analyses 
 The Wilcoxon signed-rank test was also performed to explore the median difference 
between response scores of each survey item.  There were no significant differences in 
participant responses to eight items, while the remaining five survey items demonstrated 
statistical significance.  The following sections will further describe participant responses to the 
individual MI Survey items and provide results of significant correlations between participant 
characteristics and MI Survey item responses.  Tables 9 and 10 provide descriptive statistics for 
the pre and post MI Survey item responses.   
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Table 9 
 
Descriptive Statistics for Pretest Item Responses of the MI Survey 
 
 
    Itema       M  SD  Median 
 
Item 1       2.36  1.027  2.00  
Item 2       2.18    .874  2.00 
Item 3       1.82    .603  2.00 
Item 4       1.82    .603  2.00 
Item 5       4.45    .522  4.00 
Item 6       2.64  1.120  3.00 
Item 7       2.91  1.044  3.00 
Item 8       4.45    .522  4.00 
Item 9       4.27    .467  4.00 
Item 10       4.18    .751  4.00 
Item 11       4.00    .447  4.00 
Item 12       3.00  1.183  2.00 
Item 13       3.00  1.183  3.00 
All Items                41.00  4.626            39.00 
Note.  aN = 11.   
 
Table 10 
 
Descriptive Statistics for Posttest Item Responses of the MI Survey 
 
 
    Itema       M  SD  Median 
 
Item 1       4.57    .535  5.00  
Item 2       3.86    .378  4.00 
Item 3       2.14    .900  2.00 
Item 4       2.43  1.134  2.00 
Item 5       4.86    .378  5.00 
Item 6       4.14    .378  4.00 
Item 7       3.86    .690  4.00 
Item 8       5.00    .000  5.00 
Item 9       4.43    .535  4.00 
Item 10       4.86    .378  5.00 
Item 11       4.86    .378  5.00 
Item 12       4.57    .535  5.00 
Item 13       4.00  1.414  5.00 
All Items                53.57  4.467            52.00 
Note.  an = 7. 
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Item 1: I understand the basic ideas and principles of motivational interviewing.  At 
the start of the first MI training session, approximately 64% of the participants did not have a 
foundational understanding of MI, while only 18.2% of participants had a firm understanding of 
MI principles.  Figure 8 indicates that there was a large shift in MI knowledge post-intervention 
based on the responses to item 1.  All respondents either agreed or strongly agreed that they had 
a basic understanding of MI after completing the MI training.  This finding was confirmed by 
Wilcoxon signed-rank analysis (see Table 11).  There were no significant correlations between 
participant characteristics and pre and post responses to item 1.       
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 "Figure 8.  Percentage of responses to MI Survey item 1 at baseline and intervention termination.  Percentage of pretest responses (n = 11) are as follows: 18.2% strongly 
disagree, 45.5% disagree, 18.2% undecided, and 18.2% agree.  Percentage of posttest 
responses (n = 7) are as follows: 42.9% agree, 57.1% strongly agree. "
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Table 11 
Wilcoxon Signed-Rank Test of Change in Item 1 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 1 – Pretest  
Item 1 
 Negative Ranks  0a       .00         .00   
 Positive Ranks  7b     4.00     28.00       -2.388d  .017*  
 Ties  0c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
  
 Item 2: I feel proficient and able to use motivational interviewing in my practice.  
There was a small percentage of participants who felt proficient in utilizing MI within their 
practice setting at baseline.  However, Figure 9 demonstrates a major shift in responses post-
intervention for the agree category with approximately 86% of participants feeling MI proficient.  
While an estimated 73% of respondents either disagreed or strongly disagreed to MI proficiency 
at baseline, post-intervention responses indicated that no participants confirmed a lack of 
perceived MI proficiency at termination.  These findings were statistically significant according 
to Wilcoxon signed-rank analysis (see Table 12).  Furthermore, bivariate correlational analysis 
revealed a significant negative correlation between participant job role and responses to item 2 at 
baseline.  Participants in a clinical job role were more likely to respond that they were not 
proficient in MI prior to the training sessions, n = 5, Mdn = 2, compared to participants in a non-
clinical role, n = 6, Mdn = 3, τ = -.65, p = .028.  There was also a positive correlation between 
job role and the change in posttest and pretest responses to item 2 of the MI Survey.   
Participants in a clinical job role were more likely to have a higher median difference, n =  5, 
Mdn = 3, in response score from baseline compared to non-clinical participants, n = 6, Mdn = 1, 
τ = .75, p = .046.  
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Table 12 
Wilcoxon Signed-Rank Test of Change in Item 2 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 2 – Pretest  
Item 2 
 Negative Ranks  0a       .00         .00   
 Positive Ranks  6b     3.50     21.00       -2.220d  .026*  
 Ties  1c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
 
 Item 3: Lack of motivation for change is a significant frustration for my clients.  
Prior to the MI training sessions, most participants perceived their clients to be frustrated from a 
lack of motivation for change.  Post-intervention results indicated that an estimated 86% of 
participants agreed to some degree with item 3, while the remainder of the sample did not agree 
with this statement.  Wilcoxon signed-rank analysis confirmed the lack of change in participants’ 
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Figure 9.  Percentage of responses to MI Survey item 2 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 18.2% strongly disagree, 54.5% disagree, 
18.2% undecided, 9.1% agree.  Percentage of posttest responses (n = 7) are as follows: 14.3% 
undecided, 85.7% agree."
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responses from baseline (see Table 13).  There were no significant relationships between 
participants’ characteristics and pre and post responses to item 3. 
 
 
Table 13 
Wilcoxon Signed-Rank Test of Change in Item 3 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 3 – Pretest  
Item 3 
 Negative Ranks  1a      1.50       1.50   
 Positive Ranks  2b      2.25       4.50       -.816d  .414  
 Ties  4c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05. 
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Figure 10.  Percentage of responses to MI Survey item 3 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 63.6% agree, 27.3% 
strongly agree.  Percentage of posttest responses (n = 7) are as follows: 14.3% disagree, 71.4% 
agree, 14.3% strongly agree.""
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 Item 4: My clients’ lack of motivation for change is a significant frustration in my  
work.  The majority of participants were frustrated with their clients’ lack of motivation for 
change at baseline.  Figure 11 indicates a slight decrease in responses to the strongly agree and 
agree categories from pretest to posttest data collection periods.  Approximately 29% of the 
sample did not perceive their clients’ lack of motivation for change to be a significant frustration 
in their work after attending the MI training sessions, whereas prior to the MI sessions, this 
percentage was zero.  Table 14 reveals there were no significant changes in responses from 
baseline to post-intervention.  Despite this, participant length of employment had a negative 
correlation with the response to item 4 at baseline. Participants who worked three years or less, 
 n = 4, Mdn = 2, tended to agree with item 4, whereas participants who had been employed in 
their current position for greater than nine years were in strong agreement with this item, n = 5,  
Mdn = 1, τ = -.64, p = .031.  It appeared that the longer a participant was employed, the more 
likely the participant strongly perceived a client’s lack of motivation to be a frustrating aspect to 
their work. 
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Table 14 
Wilcoxon Signed-Rank Test of Change in Item 4 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 4 – Pretest  
Item 4 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  2b    1.50     3.00       -1.342d  .180  
 Ties  5c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
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Figure 11.  Percentage of responses to MI Survey item 4 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 63.6% agree, 27.3% 
strongly agree.  Percentage of posttest responses (n = 7) are as follows: 28.6% disagree, 57.1% agree,"14.3%"strongly"agree.""
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 Item 5: I believe a client’s own level of motivation for change is important.  
Participant responses to item 5 were similar before and after the MI training sessions.  All 
participant responses were either, agree or strongly agree, to this statement.  There was an 
increase, however, in the proportion of participants who strongly agreed to item 5 following the 
MI training compared to the proportion who strongly agreed prior to the training.  This finding 
failed to reach statistical significance according to Wilcoxon signed-rank analysis  
(see Table 15).   
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Figure 12.  Percentage of responses to MI Survey item 5 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 45.5% strongly agree, 54.5% agree.  
Percentage of posttest responses (n = 7) are as follows: 85.7% strongly agree, 14.3% agree.
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Table 15 
Wilcoxon Signed-Rank Test of Change in Item 5 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 5 – Pretest  
Item 5 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  2b    1.50     3.00       -1.414d  .157  
 Ties  5c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
 
 Item 6: If a client is not initially motivated, I do not think that I will be able to 
increase his or her motivation.  Responses to item 6 varied at baseline.  Approximately half of 
the participants believed that they were unable to influence client motivation, while the 
remaining respondents were either undecided or disagreed with this statement.  Figure 13 
indicates a shift in participant responses after the MI training, with all participants in 
disagreement to some degree with item 6, indicating that they believed they could increase client 
motivation.  This finding approached statistical significance (see Table 16).  There were no 
significant correlations between participant characteristics and pre and post responses to item 6. 
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Table 16 
Wilcoxon Signed-Rank Test of Change in Item 6 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 6 – Pretest  
Item 6 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  4b    2.50   10.00         -1.841d   .066  
 Ties  3c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
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Figure 13.  Percentage of responses to MI Survey item 6 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 27.3% disagree, 27.3% undecided, 27.3% 
agree, 18.2% strongly agree.  Percentage of posttest responses (n = 7) are as follows: 85.7% 
disagree, 14.3% strongly disagree."
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 Item 7: There is limited administrative support for integrating MI into my work.  
Participant responses regarding administrative support for integrating MI into their work also 
varied at baseline.  Approximately 36% of participants did not perceive there to be limitations in 
administrative support for MI integration prior to completing the MI training.  This proportion 
was similar to the proportion of participants who did perceive limitations in administrative 
support at baseline.  After the completion of MI session two, however, the proportion of 
participants who perceived administrative support limitation as a barrier to MI integration 
declined to zero and shifted to the undecided, disagree, and strongly disagree response 
categories.  This finding approached significance with Wilcoxon signed-rank analysis (see Table 
17). 
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Figure 14.  Percentage of responses to MI Survey item 7 at baseline and intervention 
termination.  Percentage of pretest responses (n = 11) are as follows:  36.4% disagree, 27.3% 
undecided, 27.3% agree, 9.1% strongly agree.  Percentage of posttest responses (n = 7) are 
as follows: 28.6% undecided, 57.1% disagree, 14.3% strongly disagree.
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Table 17 
Wilcoxon Signed-Rank Test of Change in Item 7 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 7 – Pretest  
Item 7 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  4b    2.50   10.00         -1.857d  .063  
 Ties  3c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
 
 
 Item 8: Motivational interviewing is applicable to my work.  All participants 
perceived MI to be applicable to their work at baseline.  The proportion of participants who 
agreed to item 8 was slightly higher than the proportion of participants who strongly agreed to 
this statement.  After completion of the MI training, all participant responses were in the strongly 
agree category.  This difference in responses, however, failed to reach statistical significance. 
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Figure 15.  Percentage of responses to MI Survey item 8 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 54.5% agree, 45.5% strongly agree.  
Percentage of posttest responses (n = 7) are as follows: 100% strongly agree."
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Table 18 
Wilcoxon Signed-Rank Test of Change in Item 8 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 8 – Pretest  
Item 8 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  3b    2.00     6.00       -1.732d  .083  
 Ties  4c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks. * p < 0.05 
  
 
 Item 9:  I am a skillful good listener in working with clients.  All participants believed 
themselves to be skillful listeners prior to attendance of the MI training sessions.  There was an 
increase from baseline, however, in the percentage of respondents who strongly agreed to item 9 
at the end of the training sessions.  This difference was not statistically significant.  
 
 
 
0
10
20
30
40
50
60
70
80
Strongly 
Disagree
Disagree Undecided Agree Strongly AgreeP
er
ce
nt
ag
e 
of
 R
es
po
nd
en
ts
Responses to "I am a Skillful Good Listener when Working with Clients" 
Pretest
Posttest
Figure 16.  Percentage of responses to MI Survey item 9 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 72.7% agree, 27.3% strongly agree.  
Percentage of posttest responses (n = 7) are as follows: 57.1% agree, 42.9% strongly agree.""""
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Table 19 
Wilcoxon Signed-Rank Test of Change in Item 9 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 9 – Pretest  
Item 9 
 Negative Ranks  1a      1.50       1.50   
 Positive Ranks  1b      1.50       1.50       0.000d  1.000  
 Ties  5c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dThe sum of negative ranks equals the sum of positive ranks.  * p < 0.05 
 
 
 Item 10: I will use motivational interviewing in my work.  The distribution of baseline 
responses to item 10 varied slightly.  While most participants anticipated using MI in their work, 
there was a small proportion of individuals who were undecided about MI use at baseline.  
Figure 17 indicates a large increase in the percentage of respondents who strongly agreed they 
would use MI in their work after the completion of the MI training sessions.  Approximately 
36% of respondents strongly agreed to MI use in their work at baseline compared to 86% of 
participants who strongly agreed they would use MI post-intervention. Wilcoxon signed-rank 
analysis confirmed this significant finding.  There were no significant relationships between 
participant characteristics and pre and post responses to item 10. 
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Table 20 
Wilcoxon Signed-Rank Test of Change in Item 10 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 10 – Pretest  
Item 10 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  4b    2.50    10.00           -2.000d  .046*  
 Ties  3c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks.  * p < 0.05 
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Figure 17.  Percentage of responses to MI Survey item 10 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 18.2% undecided, 45.5% agree, 36.4% 
strongly agree.  Percentage of posttest responses (n = 7) are as follows: 14.3% agree, 85.7% strongly 
agree."
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 Item 11: I think that the most effective way to motivate clients or patients to change 
is by drawing on their own internal motivations.  A large percentage of participants agreed to 
item 11 at baseline.  Despite this prior belief that a client’s internal motivation is essential for 
behavior change, there was still improvement observed in participants’ responses post-
intervention.  In fact, there was a large shift from baseline to post-intervention in the proportion 
of participants who strongly agreed to item 11.  Table 21 demonstrates the significance of this 
difference in responses.       
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
Strongly 
Disagree
Disagree Undecided Agree Strongly Agree
Pe
rc
en
ta
ge
 o
f R
es
po
nd
en
ts
Responses to "I Think That the Most Effective Way of Motivating Clients to 
Change is by Drawing on Their Own Internal Motivations"
Prestest
Posttest
Figure 18.  Percentage of responses to MI Survey item 11 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 9.1% undecided, 81.8% agree, 9.1% strongly 
agree.  Percentage of posttest responses (n = 7) are as follows: 14.3% agree, 85.7% strongly agree."""
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Table 21 
Wilcoxon Signed-Rank Test of Change in Item 11 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 11 – Pretest  
Item 11 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  5b    3.00   15.00            -2.121d  .034*  
 Ties  2c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks.  * p < 0.05 
  
 
Item 12: Some clients need to be coerced or pressured to change.  At baseline, 
slightly greater than half of the participants believed coercion and pressure were needed for 
behavior change, while the remainder of the sample disagreed or strongly disagreed with item 
12.  There was a significant shift in responses after completion of the MI training sessions as 
evident in Figure 19 and Table 22.  No participants believed coercion and pressure were needed 
for client behavior change post-intervention.  Bivariate correlational analysis revealed a positive 
relationship between gender and responses to item 12 at baseline.  Male participants were more 
likely to agree with this statement, n = 4, Mdn = 2, compared to female participants, n = 3, Mdn 
= 4, τ = .78, p = .011.  Furthermore, the relationship between gender and responses to item 12 
post-intervention approached significance.  While both genders agreed to item 12 post-
intervention, males were more likely to have responses in the disagree category, n = 4, Mdn = 4, 
while females were more likely to strongly disagree to this item, n = 3, Mdn = 5, τ = .75, p = .06. 
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Table 22 
Wilcoxon Signed-Rank Test of Change in Item 12 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 12 – Pretest  
Item 12 
 Negative Ranks  0a      .00       .00   
 Positive Ranks  6b    3.50   21.00         -2.232d  .026*  
 Ties  1c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks.  * p < 0.05 
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Figure 19.  Percentage of responses to MI Survey item 12 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 54.5% agree, 36.4% disagree, 9.1% strongly 
disagree.  Percentage of posttest responses (n = 7) are as follows: 42.9% disagree, 57.1% strongly 
disagree."
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 Item 13: Some clients will never change regardless of how I interact with them.  The 
responses to item 13 were distributed across all response categories at baseline.  There was a 
large increase in respondents who strongly disagreed with the belief that some clients will never 
change their behavior from the pre- and post-data collection periods.  This finding, however, did 
not reach statistical significance (see Table 23).  There were no significant correlations between 
participant characteristics and pre and post responses to item 13; however, the relationship 
between gender and the difference in pre and post responses approached significance.  Males 
were more likely to have a lower median difference in pre and post responses to item 13, n = 4, 
Mdn = 0.5, compared to females, n =3, Mdn = 2, τ = .68, p = .067. 
 
 
 
 
 
0
10
20
30
40
50
60
Strongly 
Disagree
Disagree Undecided Agree Strongly Agree
Pe
rc
en
ta
ge
 o
f R
es
po
nd
en
ts
Responses to "Some Clients Will Never Change Regardless 
of How I Interact with Them" 
Pretest
Posttest
Figure 20.  Percentage of responses to MI Survey item 13 at baseline and intervention termination.  
Percentage of pretest responses (n = 11) are as follows: 9.1% strongly disagree, 27.3% disagree, 
27.3% undecided, 27.3% agree, 9.1% strongly agree.  Percentage of posttest responses (n = 7) are 
as follows: 57.1% strongly disagree, 14.3% disagree, 28.6% agree.
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Table 23 
Wilcoxon Signed-Rank Test of Change in Item 13 Responses 
 
   n Mean Rank Sum of Ranks          Z                  p 
Posttest Item 13 – Pretest  
Item 13 
 Negative Ranks  1a      2.50       2.50   
 Positive Ranks  5b      3.70     18.50         -1.725d  .084  
 Ties  1c 
 Total  7 
Note.  aPosttest Score < Pretest Score.  bPosttest Score > Pretest Score.  cPosttest Score = Pretest Score.  
dBased on negative ranks.  * p < 0.05 
 
Successful Implementation 
 The indicators of successful implementation of MI within the parameters of this project 
were identified in chapter four.  The PARIHS framework was utilized as a guide in identifying 
the measures required to determine the success of this MI implementation project.  As previously 
identified, there were two main indicators of successful implementation.  The first indicator was 
the proportion of staff who completed the MI introductory training, while the second indicator 
focused on the proportion of staff who demonstrated a positive change in the overall MI Survey 
score.  The following sections will provide the results of these inquiries. 
Indicator One 
 The first indicator of successful implementation focused on the completion of the MI 
training sessions.  Approximately 65% of the 17 eligible staff members volunteered and were 
available to attend the first MI session.  Of the 11 participants attending the first MI session, 64% 
of participants completed the second MI session.  Overall, 41% of the 17 eligible staff members 
completed the two-day MI introductory training course.   
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Indicator Two 
 The second indicator of successful implementation was measured utilizing the sample of 
seven participants who completed both MI training sessions.  As indicated in Figure 21, 100% of 
the sample demonstrated an improvement in the post MI Survey score from baseline.   
 
Conclusion 
 This chapter provided a thorough presentation of the findings pertaining to participant 
characteristics, total MI Survey score, MI Survey item scores, and successful implementation 
indicators.  These findings contributed to the understanding of the MI knowledge and 
perceptions of the multidisciplinary care team within this outpatient HIV medical setting.  The 
next chapter will further explore the implications and significance of these findings. 
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Figure 21.  Pre and post MI Survey scores for the participants who completed both MI 
training sessions, n = 7.  The possible MI Survey score range is 13 to 65.  Each participant 
is represented by an alphabetical letter to ensure anonymity, as the MI surveys were coded 
numerically."
" 123"
 
CHAPTER 6 
Discussion 
 This implementation project was designed to promote the uptake of MI as an intervention 
to increase medication adherence behavior in people living with HIV.  One of the first indicators 
of successful uptake of an evidence-based intervention is a change in knowledge and perception 
of the intervention by the individuals intended to actualize it in clinical practice (Stetler et al., 
2011).  This chapter serves several purposes.  First, it will discuss the implications and practical 
significance of the findings from the MI Survey.  Second, the success of the MI implementation 
project will be analyzed within the context of the revised PARIHS framework. Next, the policy 
implications and limitations of this proposed practice change will be explored.  Finally, this 
chapter will explicate the various roles enacted by the doctoral student to conduct this project, as 
well as, provide recommendations for the full implementation of MI in this setting to improve 
antiretroviral medication adherence. 
Implications and Significance 
 The findings of this project revealed important aspects about the anticipated users of MI 
in this clinical practice environment.  The two-day MI introductory training course had a 
profound impact on the care team, such that, all team members had an overall improvement in 
MI knowledge, perception of MI effectiveness and behavior change, and the likelihood of 
utilizing MI in daily patient care interactions.  Specifically, regarding the concept of MI 
effectiveness, most care team members believed a client’s internal level of motivation to be 
important and the most effective manner in eliciting behavior change prior to attending the MI 
sessions.  This suggests that the care team had an a priori intuitiveness about the role of internal 
motivation in behavior change.  Furthermore, there was a collective perception that MI was an 
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effective modality for improving client motivation for health behavior change.  The beliefs that 
internal motivation and MI are catalysts for behavior change are crucial aspects to the uptake of 
this intervention in this clinical setting.   
 The perspective of the care team on client behavior change also provides insight to the 
culture of the practice environment.  Prior to the MI training, there was a large portion of the care 
team who perceived coercion and pressure to be necessary tactics to provoke client health 
behavior change.  This suggests these care team members may have utilized these unsuccessful 
strategies during previous client interactions.  Strategic efforts guided by pressure and coercion 
may lead to client resistance towards change (Miller & Rollnick, 2002).  These beliefs in 
coercion and pressure tactics, however, were abandoned after completion of the MI training.  
This finding is paramount because it signifies the potential adoption of a new practice approach 
to provider-client interactions.   
 Nevertheless, there is still opportunity for improvement in staff perceptions of client 
behavior change.  There still remained a portion of the care team who believed some ambivalent 
clients would never change their health behavior through interactions grounded in MI principles.  
This suggests further education in MI may be a necessary component for the uptake of this 
intervention in this practice setting. 
 There are substantial implications that can be understood about the likelihood of the care 
team utilizing MI in their daily work.  First, there is evidence that further MI training is 
warranted.  Although a large portion of the care team felt proficient in applying their new MI 
skills with their clients after the MI sessions, there was a small portion of the team who did not 
feel proficient, based on the MI Survey results.  Moreover, at the end of the MI training course, 
all participants of this project verbalized a desire to attend the advanced MI training course to 
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enhance their skills.  This demonstrates a sense of commitment and investment in MI by the 
multidisciplinary care team at this facility.   
 The second implication associated with the likelihood of MI use is based on the finding 
that the majority of the care team expressed a sense of frustration with clients' lack of motivation 
before and after the MI training.  The training had little effect in altering the frustration felt by 
the care team.  Specifically, care team members employed for a greater length of time had 
stronger feelings of frustration compared to care team members employed for less time in their 
current roles. It is apparent that frustration with client lack of motivation exists within this 
clinical setting, and this frustration was not amenable to an introductory MI training course for 
most care team members.  Willit et al. (2009) also found similar results for item four of the MI 
Survey in their multisite sample of 405 participants employed in correctional education facilities. 
The majority of the participants agreed that a client’s lack of motivation for change was a 
significant frustration in their work prior to and after a three-day MI training course.  Perhaps, 
the HIV care team’s frustration with client lack of motivation will dissipate as the care team 
becomes more MI proficient and confident in their ability to assist clients along the behavior 
change continuum.  This perceived frustration might also be a driving factor for utilization of MI 
in this setting.  
 The final conclusions that can be drawn regarding the likelihood of MI use in this 
practice setting provide strong support for future MI use.  Prior to the MI training, all participants 
believed MI to be applicable to their daily work and that they were good skillful listeners.  After 
the MI introductory sessions, these beliefs remained consistent with pre-training beliefs.  The MI 
sessions, however, seemed to solidify participants’ beliefs about MI applicability.  All care team 
members were in strong agreement that MI was applicable to their client interactions after 
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training completion.  Listening skills and perceived value in the intervention are prerequisites for 
adoption of MI in this clinical setting (Stetler et al., 2011). Moreover, the care team perceived 
they had the support from administration to implement MI into their work.  This is an essential 
finding because leadership support is a component of contextual readiness within the revised 
PARHIS framework (Stetler et al., 2011).  Most importantly, all care team members agreed to 
use MI in their daily work after the introductory MI sessions.  This receptivity to MI use is, yet, 
another indicator of contextual readiness for the practice change.  
 There have been some reports by the care team of their attempts in MI utilization during 
their client interactions after attending the MI introductory training.  In fact, a clinician member 
of the HIV care team reported the ability and awareness of identifying ambivalence during client 
interactions after attending the MI training sessions.  The clinician also reported a personal 
increase in the use of reflective listening skills with clients.  It was noted that one particular 
client benefited from this MI interaction as he moved along the behavior change continuum from 
contemplating to preparing to restart his antiretroviral medications during the time frame of one 
routine appointment.  This suggests that MI is feasible to incorporate into client conversations.  
Reports from other HIV care team members, also, support the likelihood of MI utilization. The 
majority of the feedback centered on the new awareness and ability to identify ambivalence to 
behavior change.  The ability to identify client ambivalence and reflective listening are necessary 
skills in assisting clients with health behavior change. 
 This section summarized important information regarding the anticipated users of MI in 
this outpatient HIV setting.  First, the care team’s beliefs regarding the importance of internal 
motivation in eliciting behavior change coincide with MI principles.  Second, there appears to be 
“buy-in” of the intervention by leadership and the care team.  Moreover, there is an opportunity 
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for future MI education within this clinical setting, and most importantly, HIV care team 
members have begun utilizing their new MI skills during client interactions. 
Project Analysis 
 The revised PARIHS framework was utilized in the analysis of this MI implementation 
project.  The three sub-elements of successful implementation included the implementation plan 
and its realization, the evidence-based practice innovation uptake, and organizational outcomes 
achievement.  Each of these sub-elements was utilized to gain a better understanding of the 
overall success of this MI implementation project. 
Implementation Plan and Its Realization 
 According to Stetler et al. (2011), the evaluation of successful implementation with 
respect to the implementation plan and its realization incorporates “the degree to which 
implementation strategies are both fielded in the intended form/format and related adoption 
activities reach the targeted audience” (Additional File 4).  For this reason, the first indicator of 
successful implementation was the proportion of staff who completed the MI training.  As 
indicated in the results section, 41% of the eligible care team members completed the two MI 
sessions.  However, there was still a large portion of the care team that the intervention did not 
reach. 
 Careful analysis of the influential factors that may have affected the degree of MI training 
completion in this setting revealed important information for implementation replication.  First, 
the facilitator role within this project may have needed to incorporate a better communication 
method with the physicians.  Many of the physicians did not seem to be aware of the scheduled 
MI training until the week prior despite email notifications, announcements made during 
morning huddle, a flyer posted on the communication board, and a presentation of the proposed 
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MI implementation project by the facilitator.  Second, individual conversations with the 
physicians revealed they were interested in learning MI, but they felt that an eight-hour training 
would be difficult to attend with their patient care responsibilities.  Although the training was 
scheduled on the least busy clinic day and many physicians did not routinely have clinic 
scheduled on this day, they still had inpatient care responsibilities.  One of the physicians 
inquired about the possibility of attending a MI webinar course that could be completed when 
schedules were less busy. Considering that MI is a provider-level change within this 
organization, it is imperative that all health care providers have access to the educational sessions 
of a new intervention.   
Evidence-Based Practice Innovation Uptake 
 Formative evaluation of MI uptake within the parameters of this project focused on the 
prerequisite basis for intervention adoption.  The concepts considered necessary for intervention 
adoption within the revised PARIHS framework included awareness, knowledge, attitude, and/or 
skill (Stetler et al., 2011).  Specifically, this project focused on MI knowledge, awareness 
(perception of MI and behavior change), and staff attitude as indicated by the likelihood for MI 
use.  These indicators of MI uptake revealed an overall improvement in MI knowledge and 
perception, client behavior change perception, and attitude about MI use in the seven participants 
who completed the MI introductory sessions.  Moreover, some of the participants had already 
incorporated the use of MI skills in their client interactions, despite the fact that the clinical site 
was merely in the preliminary planning stages of incorporating this QI initiative.   
All participants who completed the entire MI training experienced an overall positive 
improvement in the indicators of intervention uptake.  Based on this fact, it is likely those care 
team members unable to attend the MI training course would also experience an improvement in 
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these prerequisites for MI adoption if able to attend the MI sessions.  In addition, MI knowledge 
did improve after training; however, the staff requested further MI training for skill 
advancement.  At the time of the writing of this chapter, arrangements were in place to offer the 
two-day advanced MI training course to the HIV care team. 
Organizational Outcomes Achievement 
 The final element contributing to the evaluation of successful implementation was 
organizational outcomes achievement.  Outcomes achievement as defined in the revised PARIHS 
framework refers to “the impact or outcome expected to follow adoption or use of the targeted 
EBP recommendation” (Stetler et al., 2011, Additional File 4).  Within the scope of this project, 
the expected impact of the MI training focused on staff outcome.  The intended impact of the MI 
training, as previously identified, was to improve staff knowledge, perception, and likelihood for 
MI utilization.  All HIV care team members who completed the MI introductory training 
demonstrated an overall improvement in these areas. 
Summary 
 Analysis of the three sub-elements of successful implementation allowed for the 
identification of the successful aspects of the project, as well as, the areas in need of 
improvement.  Although the implementation plan was not effective in reaching all eligible care 
team members, the overall success of the MI training was impactful for the participants who did 
complete the sessions.   
When considering the results of the contextual assessment of the organization (see Table 9) 
completed prior to the project implementation, it is not surprising there was preliminary uptake 
of MI in this clinical setting.  The contextual environment of the clinic demonstrated a strong 
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sense of readiness for practice change, a well-established system of quality improvement, and the 
financial resources to fund staff education. 
Policy Implications 
 This project was designed to lay the foundation for the uptake of MI in an outpatient HIV 
clinic.  Although the actual implementation of this first phase of MI utilization did not involve 
organizational policy changes, full MI implementation within this practice site may need to 
consider these implications.  Considerations for organizational policy may be necessary if full 
MI implementation with ambivalent clients does improve ART adherence in this practice setting.  
For example, the organization would need to determine to what extent health care delivery at the 
provider level would incorporate MI principles and how this would be monitored.  In the event 
that MI is successful with improving patient outcomes, organizational policy may need to 
incorporate MI as a standard of care to ensure uniformity and quality in utilization across health 
care providers.  Furthermore, there is potential for MI dissemination within other outpatient 
health care facilities within the larger parent organization.  Written policy regarding the MI 
education of health care staff may be required to ensure consistency and quality of MI training.  
A process and budgetary system would, also, need to be in place to ensure new employees are 
properly trained as well.  
Limitations 
 There were various limitations to this MI implementation project. First, the actions taken 
by the facilitator to endorse and communicate the date of the MI training failed to reach potential 
key players – the physicians.   It may be that the physicians are more responsive to face-to-face 
communicative interactions.  The MI announcements made during morning huddle were not 
inclusive of all physicians.  This is because some physicians were already attending to patients in 
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the hospital during the morning huddle, which was located in the outpatient clinic.  To 
accommodate for their absence, the MI training information was sent via email and posted on the 
communication board located in the HIV outpatient clinic.  However, these methods did not 
seem to enhance communication.  A second facilitative factor associated with poor physician 
attendance of the MI training was the failure to consider the difficulty for the physicians in this 
practice to commit to an eight-hour training day.  Perhaps an alternative training method or 
schedule, such as a webinar or half-day sessions, would have increased physician attendance.  
Nevertheless, collaboration between the coordinator and physicians is essential in identifying the 
best approach to MI training format and scheduling. 
 The MI Survey scale also created a limitation to this project.  The scale was not tested for 
internal consistency reliability by its original authors, and the scale did not demonstrate optimal 
internal reliability with the data obtained from the participants of this project.  While the MI 
Survey did demonstrate adequate reliability, the results with this sample suggested the MI 
Survey might have items that did not well represent the concepts of interest. 
 The small sample of participants also limited the statistical analyses of this project.  This 
project was not intended to produce generalizable knowledge; however, a larger sample size may 
have provided useful information about the multidisciplinary care team.   
Data obtained from more participants would better represent the care team, with respect to the 
change in MI knowledge, perceived MI effectiveness, perception of client behavior change, and 
likelihood of MI use, following the MI training. This should be taken into consideration when 
developing a quality improvement MI initiative based on findings from the MI Survey.  
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Roles of the Doctor of Nursing Practice Student 
 The enactment of three roles was necessary for the completion of this evidence-based 
practice initiative.  These roles included that of scholar, leader, and innovator.  The doctorally-
prepared practice scholar demonstrates an advanced knowledge base and critical inquiry into the 
gaps in health care delivery (Dreher & Glasgow, 2011).  The basis for this implementation 
project derived from clinical experience in this HIV outpatient setting.  Antiretroviral therapy 
nonadherence was a health care issue with substantial consequences, and many times, with 
unsuccessful adherence strategies.  Enactment of the practice-scholar role involved a critical 
review of this evidence-based intervention, an application of findings to this practice 
environment, and utilization of theoretical frameworks to foster the success of the translation of 
knowledge into practice (AACN, 2006).  Introduction of a new practice change also required the 
roles of leader and innovator.  As a leader, the doctorally-prepared advanced practice nurse must 
understand the complexities of the health care environment and promote interprofessional 
collaboration to address population health care needs (Montgomery & Porter-O’Grady, 2010). 
Recommendations 
 The final recommendations, derived from the integrative review, organizational 
assessment, and project analysis, are intended to promote future sustainability of MI in this 
outpatient HIV clinic.  The scope of this MI implementation project was to lay the foundation for 
the actual uptake of MI as an ART adherence intervention in this clinical practice setting.   
There are indications of MI feasibility in this clinical environment as evidenced by the high 
likelihood of MI use, reported staff accounts of utilizing MI skills, and the financial support to 
fund staff education.  These recommendations address the education, implementation, and 
evaluation of MI and may be used as a guide for the QI team to proceed with utilizing this 
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intervention to promote ART adherence with clients.  The recommendations for further MI 
education are as follows: 
• Motivational interviewing education of the care team should proceed with advanced  
training in MI skills. The cost of this advanced training is $1,750, which is within the 
allotted funding limit for staff education. 
• Alternative MI training formats should be considered for the physicians of this practice.  
 A combination of webinars and a half-day group format with a MINT trainer may be a 
  better alternative for the schedule demands of the physicians.  There is a five-session 
  (one hour/session) MI webinar available at  
 http://www.healthsciences.org/MI-Health-Coaching-Webinar-Series.  The cost is $250 
  per person or $200 per person for groups of five or more participants.  The MINT trainer  
 involved in this implementation project is currently in the process of developing a  
 webinar series for MI training as well.  It may be of value to have the physicians  
 participate in the webinar offered by the same MI trainer who worked with the other care  
 team members.   
• The care team members of this clinic should have access to individual MI coaching as  
 needed for skill enhancement and reflection with an MI expert.  The cost of MI coaching  
 is approximately $100-$120/hour. 
• This organization should purchase resources for the care team to further foster MI use in  
 this setting.  The MINT trainer recommended the following books: 
o Motivational Interviewing in Health Care: Helping Patients Change Behavior by 
Stephen Rollnick, William R. Miller, and Christopher C. Butler (The cost is 
$27.20 through Guilford Press) 
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o Building Motivational Interviewing Skills: A Practitioner’s Workbook by David 
B. Rosengren (The cost is $40.80 through Guilford Press) 
The recommendations for MI implementation are as follows: 
• A process needs to be established for the identification of clients in need of MI for ART  
adherence.  CAREWare data reports should be utilized to establish this target population. 
The Stage of Change questionnaire (Willey et al., 2000) should be incorporated as a 
mechanism for identifying clients in the precontemplation, contemplation, and 
preparation stages of behavior change.  These will be the clients most amenable to this 
intervention. 
• There needs to be a documentation process established for the MI client interactions that  
 fosters continuity of care between the different professional disciplines of the care team. 
   The ideal process would include utilization of the electronic health record to document  
  (1) MI processes and skills incorporated during the MI interaction, (2) the client’s  
 stage of change, and (3) the action plan.  Access to this information in the electronic  
 health record will allow, for example, the clinician to continue with the MI interaction  
 that was previously started by the HIV case manager or pharmacist. 
• Motivational interviewing conversations should be delivered in a manner that 
fits the needs of the client.  This intervention has been shown to be effective with face-to-
face and telephone interactions, as well as, a combination of the two methods (Lundahl et 
al., 2013; VanBuskirk & Wetherell, 2013). 
• The actual number of MI interactions will depend on client needs.  However, more MI  
 interactions are more likely to produce sustainable client outcomes (Burke et al, 2003;  
 Hettema et al., 2005; Lundahl & Burke, 2009). 
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The recommendations for MI evaluation are as follows: 
• The clients’ stage of change should be utilized as a process indicator. The Stage of  
 Change questionnaire will indicate client progression on the behavior change continuum. 
• Outcome indicators for MI evaluation should include HIV viral load and a medication  
 adherence self-report measure that is not time-consuming in this busy practice. 
Conclusion 
 This evidence-based practice project introduced a client-centered adherence intervention 
to the multidisciplinary care team of an outpatient HIV clinic.  These health care 
professionals have experienced the clinical difficulties associated with clients’ lack of 
motivation for ART adherence.  Based on the IMB Skills Model of ART adherence, it was 
apparent that the lacking variable needed to achieve adherence behavior and viral 
suppression was adherence motivation.  The organizational assessment revealed a readiness 
for practice change, and the PARIHS framework functioned as the implementation and 
evaluation guide for MI uptake in this setting. The two-day introductory MI training was an 
effective method for improving MI knowledge, perception of MI effectiveness, perception of 
client behavior change, and likelihood of MI use in this HIV care team.  Motivational 
interviewing is a feasible adherence intervention with potential for sustainability.  Given the 
strict adherence requirements of ART and the implications of untreated HIV infection, this 
HIV clinic should proceed with the implementation of MI with clients ambivalent about 
taking ART.  
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Appendix A 
 
Integrative Literature Review Tables 
 
Table A1   Search Domain 1: Meta-analyses and Systematic Reviews of Motivational Interviewing 
Note.!AMI- adaptations of motivational interviewing; !BESD- binomial effect size display; C- combined meta-analysis and systematic review;!CABS- coronary artery bypass surgery; 
CG- comparison/control group;!CR – cardiac rehabilitation; DBP- diastolic blood pressure; DUK- Diabetes United Kingdom; EASD- European Association for the Study of Diabetes;  
IDF- International Diabetes Federation; M – metal-analysis; MISC- Motivational Interviewing Skill Code; MITI- Motivational Interviewing Treatment Integrity; S-systematic review; SBP- 
systolic blood pressure; SD- significant difference; SMD- standardized mean difference; WMD- weighted mean difference 
 
Citation 
Review Type 
 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
total N 
Summary 
Measure 
Results Findings 
Armstrong, 
Mottershead, 
Ronksley, 
Sigal, 
Campbell, & 
Hemmelgran 
(2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M S 
 
 
C 
 
X 
Systematically 
review RCTs 
that investigated 
MI effectiveness 
in ↓ body mass 
• Age ≥ 18y 
• BMI ≥ 25 
• MI interven-
tion 
• CG 
• Outcome of 
body mass 
(weight or 
BMI) 
• RCT 
 
 
• Weight in kg 
• BMI 
 
*The authors 
use ‘body mass’ 
to refer to both 
weight and/or 
BMI 
MEDLINE, 
EMBASE, 
PsychINFO, 
CINAHL,  
CENTRAL, 
and an 
ancestry 
search of 
relevant 
articles 
 N = 12 for 
qualitative 
synthesis 
 
N = 11 for 
meta-analysis 
 
(n = 1448 total 
subjects,  
n = 801 in IG,  
n = 651 in CG) 
Pooled 
effect 
estimate 
 
Random-
effects 
Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of MI on ↓  
in body mass: 
 
SMD = -0.51 
(95% CI, -1.04, 
0.01: p = .053) 
with significant 
heterogeneity 
I2 = 95.0% 
p < 0.001 
Studies with wt. 
loss as 1°  or 2°  
outcome: 
1°: SMD = -.83 
(95% CI -1.91, 
0.25) 
2°: SMD = -.13 
(95% CI -.29, 
0.21) 
Effect of MI on 
↓  in weight and 
BMI 
Weight: 
WMD = -1.47kg 
95% CI -2.05,  
-0.88; p < .01 
I2 = 54.7% 
BMI: 
WMD = -0.25kg 
95% CI -0.50, 
0.01; p = .058;  
I2  = 24.5% 
 
 
• MI had a 
medium ES 
on ↓ BMI, 
however 
there was 
significant 
heterogen-
eity in this 
pooled ES. 
• The factors 
contributing 
to increased 
wt. loss 
included MI 
tx duration > 
6 mo., use 
of an 
attention 
control, and 
MI tx fidelity. 
• MI as an 
adjunct to 
wt. loss 
program 
resulted in 
the most wt. 
loss 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
& 
Characteristics 
Summary 
Measure 
 
Results Findings 
Burke, 
Arkpowitz, & 
Menchola 
(2003) 
 
M 
 
X 
 
S 
 
 
C 1. present the 
basic 
characteristi
cs of RCTs 
of AMIs 
2. evaluate the 
evidence for 
the efficacy 
of AMIs  
3. examine 
evidence of 
sustained 
efficacy of 
AMIs 
4. explore the 
evidence of 
clinical 
impact of 
AMIs 
5. to identify 
moderator 
variables 
across 
studies 
 
 
• The 
interven-
tion had to 
include 
Miller & 
Rollnick’s 
MI 
principles 
• MI 
delivered 
on an 
individual 
face-to-face 
basis 
• The study 
design met 
the criteria 
for a RCT 
 
   Multiple 
 
Ancestry 
search of 3 
prior MI meta-
analyses, the 
MI website, 
psychInfo, and 
electronic 
message to all 
MINT for 
published and 
unpublished 
research 
 
Keywords:  
Motivational 
interviewing 
 
No search time 
period specified 
 
n = 30 
 
Alcohol: 15 
Smoking: 2 
Drugs: 5 
HIV-risk: 2 
Diet: 4 
Adherence: 1 
Eating Disorder: 
1 
 
• n of each RCT 
ranged 22-952 
with m = 206 
 
• 19 RCTs used 
control groups, 
4 used active 
treatments, and 
5 used both. 
 
• Dose of AMI 
ranged 15-240 
min. with a m = 
99 min. 
 
• Individual 
ES 
• Combined 
ES 
• Multiple 
regression 
 
Results 
 
Individual ES 
(within-AMI) 
11 RCTs had 
at least 1 
significant ES 
in favor of 
AMI ranging 
from 0.22 – 
1.94 with a 
95% CI 
 
Combined 
within-AMI 
ES = .82 
 
Combined ES 
In RCTs 
comparing AMIs 
with no 
treatment, the 
combined ES 
ranged from 
0.25 – 0.56 with 
a 95% CI in 
favor of AMIs. 
 
The RCTs 
comparing AMIs 
with active 
treatment did not 
produce a 
statistically 
significant 
combined ES. 
Multiple 
Regression 
n = 23 
Dose ß= .39 
Problem area ß= 
.35, R2= .38 
p < .05 
AMI dose and 
problem area 
accounted for 
38% of the 
variance in 
outcomes. 
The effects of 
AMI seem to 
persist over 
time. 
 
The % of 
people 
displaying an 
improvement 
in the problem 
area after AMI 
was significant  
(51% vs. 37%; 
df =1, 
X2  = 10.95, p < 
.01). 
AMI alone or in 
combination 
with UC 
appeared to 
improve 
success rates 
from ~ 33% to 
50% overall. 
AMI appeared 
to produce the 
same effects 
as other 
treatments  
but in < time 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
& 
Characteristics 
Summary 
Measure 
 
Results Findings 
Hettema, 
Steele, & 
Miller (2005) 
 
 
 
M 
 
X 
 
S 
 
 
C Provide an up-
to-date 
summary of the 
evidence base 
for MI 
• Group or 
individual 
interven-
tion with MI 
compo-nent 
• @ least one 
post-
treatment 
outcome 
measure 
• @ least 1 
control or 
compari-
son group 
with no MI 
• a procedure 
to provide 
equivalent 
groups 
 
IV = MI 
DV = various 
outcome 
measures  
(health 
behavior, 
addiction, 
adherence) 
 
Other study 
variables 
analyzed: 
Type, goal, 
format, setting, 
intervention 
agent, treatment 
components, 
sample 
characteristics 
PsychInfo, 
hand-search 
bibliographies 
from MI 
website, 
previous 
reviews 
n = 72 
N = 14,267 
 
Target 
Problems: 
alcohol (31) 
smoking (6) 
HIV (5) 
Drugs (14) 
Adherence (5) 
Gambling (1) 
Intimate 
relationships(1) 
Water safety (4) 
Eating disorder 
(1) 
Diet/exercise (4) 
• m = 198.16 
sample size 
per study 
• Age m = 34 
• Male 54.77% 
• MI dose:       
r = 15-720 min.            
m = 2.24hrs 
• CG dose:     
r = 0-28hrs 
m = 2.89hrs         
Combined 
ES reported 
by target 
problem 
across all 
follow-up 
points and @ 
follow-up 
points ≤ 3 mo 
Combined ES 
for individual 
studies ranged 
from -0.19 to 
3.25 (m = .43, 
SD = .62) across 
all study points. 
 
58% of the 
studies showed 
a significant 
effect favoring 
MI (p < .05) 
ALL STUDIES 
(95% CI) 
0-1 month 
dc= 0.77 
(0.35, 1.19) 
>1-3 months 
dc= 0.39 
(0.27, 0.50) 
>3-6 months 
dc= 0.30 
(0.16, 0.43) 
>6-12 months 
dc= 0.11 
(0.06, 0.17) 
MI + UC vs. UC 
 
 
The effects of 
MI appear to 
persist or ↑over 
time when MI 
added to an 
active Tx. 
 
Synergistic 
effect of MI + 
active Tx 
seems to stem 
from the effect 
of MI on Tx 
adherence and 
retention. 
 
MI alone may 
have ↑effects 
with booster 
sessions. 
 
MI used as a 
prelude to 
active Tx 
appears to 
endure across 
time. 
 
Variation in MI 
delivery 
appears to 
have impact 
on outcome. 
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Table A1 (continued) 
 
 
Citation 
Review Type 
 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
total N 
Summary 
Measure 
Results Findings 
Knight, 
McGowan, 
Dickens, & 
Bundy (2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M S 
 
X 
C Evaluate 
effectiveness 
of MI in 
physical 
healthcare 
settings  
• Population 
suffering 
from or at 
risk for a 
physical 
illness 
• Studies 
using MI to 
promote 
behavior 
change 
• RCTs and 
non-RCTs 
Multiple 
variables 
including: 
psychological-
cognitive (15 
studies 
psychological-
emotional, 
 life-style 
change, and 
physiological 
(2002-2004) 
Amed, 
CINAHL, 
EMBASE, 
MEDLINE, 
Psychinfo, ISI 
Web of 
Science, and 
SIGLE 
 
Cochrane 
Library, NRR, 
DAI, HTA, and 
CHI 
 
 
8 total: 4 
RCTs, 3 pilot 
studies, 1 non-
random 
controlled trial 
 
DM (3) 
asthma (1) 
HTN (1) 
Lipids (1) 
CABS (1) 
CR (1)  
Avg. of 7.5 
outcomes 
measured 
per study 
ranging 
from 
psycho- 
logical, 
lifestyle 
change, 
and physio-
logical. 
 
17 of 21 
total 
measures 
were 
validated. 
MI had a positive 
effect on 
psychological, 
physiological, and 
life-style change 
outcomes in the 
majority of the 8 
studies.  
MI was 
delivered by 
various health 
care 
disciplines. 
 
The # of MI 
sessions 
ranged from 1-
6 among the 8 
studies. 
 
Authors 
concerned with 
low  internal 
content validity 
of RCTs and 
other studies, 
suggesting 
that the 
evidence does 
not support  
general 
MI implemen- 
tation across 
health 
facilities. 
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Table A1 (continued) 
 
 
Citation 
Review Type 
 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
total N 
Summary 
Measure 
Results Findings 
Lundahl & 
Burke (2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M S 
 
X 
C To review the 
research 
support for MI 
to allow 
practitioners to 
make informed 
decisions 
about the utility 
of MI in 
practice. 
Meta-analysis 
of MI effective-
ness 
• MI effective-ness 
• MI Dose 
• MI Durability 
• MET effect 
• MI format 
• Utilization of a MI 
manual 
 
Not reported 4 meta-
analyses: 
1. Hettema et 
al. (2005) 
2. Burke et al. 
(2003) 
3. Vasiliki et 
al. (2006) 
4. Lundahl et 
al. (2009) 
 
N/A N/A • 14%-20% of 
people treated 
with 1 to 2 MI 
sessions can 
expect to do better 
than clients not 
receiving MI 
treatment. 
• Overall, evidence 
suggests that MI 
is as effective as 
other active 
treatments. 
• MI appears to be 
effective in shorter 
duration (by 2-3 
sessions) 
compared to other 
treatments. 
• MI effects are 
durable up to 1 
year post-tx. 
• MI dose appears 
to be correlated 
with outcomes. 
• MI appears to be 
a versatile 
treatment that can 
be used in 
different formats 
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Table A1 (continued) 
Citation Review 
Type 
Objective Eligibility Criteria Variables 
Analyzed 
Databases 
Searched 
# of 
Studies 
 
Summary 
Measure 
 
Results Findings 
Lundahl, 
Kuntz, 
Brownell, 
Tollefson, & 
Burke 
(2010) 
 
 
 
 
 
 
M 
 
X 
 
S 
 
 
C 1. Examine the 
degree to 
which MI 
can help 
clients 
change 
2. Investigate 
the unique 
effect of MI 
compared 
with other 
Tx or 
controls 
 
• 1984-present 
• comparison with 
waitlist or control 
group 
• MI vs. TAU 
• MI + TAU vs. 
TAU 
• MET 
• Comparison 
group included 
dissemination of 
material 
 
***Studies from  
ProjectMATCH 
were excluded to 
avoid sampling 
bias 
   IVs 
MI or MET 
 
DVs 
ETOH use 
Marijuana use 
Tobacco use 
Drug use 
 
↑ in physically 
healthy 
behavior 
 
↓ in risk-taking 
behavior, 
depression, 
and anxiety 
• Bibliography of MI 
research compiled 
by Dr. Miller 
• Ancestry search of 
other meta-analyses 
• PsychInfo, 
PsychArticle 
Psychology & 
Behavior, Medline, 
CINAHL, ERIC, 
Business Source 
Premier, PubMed 
Academic Search 
Premier, Social 
Services Abstracts, 
Sociology Abstracts 
n = 119 Hedge’s g 
(nonbiased 
ES) 
g = 0.22 
(CI, .17-.27) 
z = 8.75 
p < .001 
ES 
Distribution 
25%: g = 0 
50%: g = 0.22 
75%: g = 0.50 
ES Variability 
ES contained 
significant 
heterogeneity 
Qw = 228.71 
P > .001 
Moderator 
Analyses 
MI vs. weak CG 
show ↑ ES 
compared to MI 
vs. strong CG 
Qb = 13.58 
P < .001 
 
MET (g = 0.32) 
produced positive 
change compared 
to MI (g = 0.19) in 
studies comparing 
MI vs. weak CG 
Qb = 4.97(1) 
P < .03 
Findings 
- MI produces 
small, significant 
positive effects in 
various outcome 
domains. 
 
 
• MI is likely to 
produce 
significant 
positive 
results 
toward 
behavior 
change in 
less amount 
of time 
compared to 
other EIs  
• The effects 
of MI appear 
to be durable 
across time, 
demonstrat-
ing 
significance 
up to 1-2 yrs. 
post-tx 
• When 
compared to 
weak CG, MI 
had a 
significant 
positive 
relationship 
between 
dose and 
effect. 
• MET 
produces 
better results 
than MI 
alone in 
promoting 
behavior 
change. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of 
Studies 
 
Summary 
Measure 
 
Results 
(cont.) 
Findings 
(cont.) 
Lundahl et 
al. (2013) 
 
 
 
M 
 
 
 
S 
 
 
C 
 
X 
1. Clarify the 
general 
efficacy of MI 
in medical 
setting 
2. Determine 
whether MI 
effects in 
medical 
setting are 
moderated by 
type of 
medical 
problem, MI 
delivery, 
patient 
characteristic, 
or study 
design 
3. Provide future 
research 
guidance 
 
• MI or MET 
• RCT with 
control group 
• Conducted in 
medical 
setting 
•    Multiple 
medical 
outcomes  
• Delivery site 
• Provider 
type 
• MI durability 
1983-2000 
PubMed, 
MedLine, 
CINAHL, Health 
Source, 
PsychArticles, 
PsychINFO, 
Scopus, Social 
Work Abstracts, 
Web of 
Knowledge, MI 
bibliography 
from MINT 
n = 48  
N = 9, 618 
participants  
Odds Ratio 
expressed as the 
BESD 
 
Results 
 
ES Analysis 
• OR = 1.55 
95 % CI  
[1.40, 1.71] 
z = 8.67 
p < 0.001 
Heterogeneity 
Test 
Qw = 521.68 
P < 0.001 
I2 = 90.42 
 
Moderator 
Analysis 
* 95% CI 
1. Measurement 
Methods: 
Biophysical 
Indicators:  
OR = 1.18, 
[1.09,1.28] 
Medical Records: 
OR = 1.48,  
[1.24, 1.78] 
Self-Report: 
OR = 1.69 
[1.55,1.84] 
Qb = 33.28 
P < 0.001 
 
2. Medical 
Outcome: 
Qb = 130.02 
P < 0.001 
 
3. MI Dose: 
Total MI minutes 
approached 
significance at  
P = 0.06 as a 
continuous 
moderator of MI 
effect 
• 63% of studies 
comparing MI vs. 
comparison were 
statistically 
positive for MI 
effect 
• According to the 
BESD, 56% of 
participants 
improved with MI 
and 44% of 
participants 
improved with 
comparison 
intervention. 
 
Findings 
• The omnibus OR 
suggested a 55% 
increased chance 
that MI will 
produce a positive 
effect on the 
intended outcome. 
 
• MI has 
produced 
positive 
outcomes in a 
variety of 
medical 
outcomes. 
• MI was not 
able to 
produce 
statistically 
significant 
results in 
decreasing 
blood glucose, 
heart rate, and 
medication 
adherence 
• This study 
demonstrated 
that MI and 
MET are 
equally 
effective in 
producing 
intended 
outcomes. 
• MI can be 
delivered by a 
variety of 
professions, 
regardless of 
training time or 
supervision, 
and in 
numerous 
types of 
medical 
facilities. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility 
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of Studies 
 
Summary 
Measure 
 
Results Findings 
Martin & 
McNeil 
(2009) 
 
 
 
M 
 
 
 
S 
 
X 
 
C 
 
 
Evaluate 
empirical studies 
testing 
effectiveness 
and clinical utility 
of MI in 3 health 
areas: 
• Diabetes 
• Diet & exercise 
Oral health 
Not 
explicated 
• MI effect 
• MI training 
• Tx fidelity 
• MI dose 
• MI delivery 
 
 
 
 
Not explicated 
 
n = 37 
• 24 diet & 
exercise 
• 9 diabetes 
4 oral health 
N/A MI Training 
Ongoing practice 
and feedback may 
be needed to 
maintain MI 
proficiency. 
Tx Fidelity 
Many of the studies 
failed to assess tx 
fidelity or did not 
report this 
assessment.  There 
are two validated MI 
tx integrity tools: 
1) MISC 2.1 
2) MITI 3.0 
MI Dose 
Although it is 
proposed that MI 
dose is related to 
behavior change, the 
authors reported that 
many studies failed 
to report length of MI 
sessions. 
MI Delivery 
The authors reported 
that MI session 
content is rarely 
provided in studies. 
 
• This system-atic 
review lacked 
explicit 
description of 
eligibility criteria 
and the 
methodology. 
• This makes it 
difficult to 
ascertain 
whether a 
rigorous, 
systematic 
approach was 
utilized and 
whether the 
articles included 
in the review 
accurately 
address the 
study 
objectives. 
• Despite this, the 
authors 
concluded that 
MI has a clear 
indication for a 
variety of health 
behavioral 
problems. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility Criteria Variables 
Analyzed 
Databases 
Searched 
# of 
Studies 
 
Summary 
Measure 
 
Results Findings 
Mulimba & 
Byron-
Daniel 
(2013) 
 
 
 
 
M 
 
 
 
S 
 
X 
 
C 
 
 
Evaluate 
effectiveness of 
MI in improving 
health behaviors 
in diabetic 
patients by 
assessing: 
1. lifestyle and 
nonpharma-
cological self-
management 
techniques 
2. the quality of 
the research 
• adults 16 yrs. and 
over with T1DM or 
T2DM 
• MI intervention or 
variant 
• Comparison group 
with no 
intervention or 
non-MI 
intervention 
• Outcome of 
improvement in 
health behavior 
including 1 or > of 
following: 
Weight 
management, 
physical activity, 
healthy eating, 
smoking 
cessation, 
medicine 
adherence, alcohol 
reduction, and 
glucose, blood 
pressure, and 
cholesterol 
monitoring 
• RCTs and non-
RCTs 
 
MI dose, 
MI 
Training 
& quality 
control, 
partici-
pant 
uptake, 
follow-up, 
and 
outcome 
Cochrane Central 
Register of 
Controlled Trials, 
Medline, Embase, 
Science Direct, 
CINAHL, 
Dissertation 
Abstracts 
International, NHS 
Evidence in Health 
and Social Care, 
Google, 
www.motivationalint
erviewing.org, and 
ancestry search of 
similar reviews 
n = 8 
 
6 RCTs, 
1 cohort 
study, 
1 experi- 
mental 
design 
EPHPPQA 
tool to 
assess 
internal and 
external 
validity of 
each study to 
rate method-
ologic rigor. 
Summary of 
Studies 
 
• 4 of 6 RCTs were 
methodologically 
strong studies. 
• 3 of 6 RCTs 
outlined methods 
for randomization 
• 2 of 6 RCTs 
reported a 
calculation of 
sample size 
requirement 
based on power. 
• No studies 
discussed an 
upper age limit 
for their study 
participants. 
• 1 study included 
only female 
participants. 
 
• 2 of 7 studies 
found significant 
MI effects for 
lowering BG. 
• 2 of 5 studies 
found significant 
MI effect for 
improving 
dietary intake. 
• 1 of 5 studies 
had a significant 
MI effect on 
weight loss. 
• 1 of 2 studies 
reported a 
significant MI 
effect on 
smoking 
cessation for 
patients with 
diabetes. 
• 4 of 8 studies 
found a positive 
MI effect on 
DSM. 
• Concluded not 
enough 
evidence to 
support MI use 
in this 
population. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility Criteria Variables 
Analyzed 
Databases 
Searched 
# of 
Studie
s 
 
Summary 
Measure 
 
Results Findings 
Ren, Yang, 
Browning, 
Thomas, & 
Liu (2014) 
 
 
 
 
 
M 
 
X 
 
S 
 
 
 
C 
 
 
• Evaluate 
effects of MI 
on BP control 
in high cardiac 
risk population 
• RCT 
• Adult ≥ 18  
yrs. with ≥ 1 
cardiac risk factor 
• MI delivered in 1° 
care setting 
• MI was the 1° 
intervention 
• Outcome 
measured included 
∆ in BP reported 
as mean 
difference pre- and 
postinterven-tion 
or as intervention 
effect with 95% CI 
IV = MI 
DVs = SBP, 
DBP 
Ovid Medline, 
Embase, 
PsychINFO, 
Scopus, Cochrane 
Library, CINAHL 
plus, and Web of 
Science 
n = 7 Combined 
WMD 
SBP 
* 95% CI 
After Intervention 
-2.61 mmHg 
[-3.96, -1.27] 
Z = 3.81 
P = 0.001 
 
Postintervention 
Follow-up 
-1.64 mm HG 
[-2.75, -0.53] 
Z = 2.90 
P = 0.004 
 
DBP 
*95% CI 
After Intervention 
-0.90 mm Hg 
[-1.75, -0.06] 
Z = 2.10 
P = 0.04 
 
Postintervention  
Follow-up 
-0.58 mm Hg 
[-1.25, 0.09] 
Z = 1.70 
P 0.09 
MI is an effective 
approach in 
controlling SBP, 
however the 
authors 
concluded that 
more research is 
needed to 
confirm the effect 
on DBP. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility  
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of  
Studies 
 
Summary 
Measure 
 
Results Findings 
Rubak, 
Sandbaek, 
Lauritzen, & 
Christinsen 
(2005) 
 
 
 
 
M 
 
 
 
S 
 
 
 
C 
 
X 
 
 
Evaluate 
effective-ness 
of MI in 
different areas 
of disease 
RCT, 
MI vs. 
traditional 
advice, 
MI based on 
Miller & 
Rollnick 
Intervention 
characteristics, 
study design, 
area of 
intervention, and 
outcome 
measure 
16 databases, 
conference 
proceedings 
b/w 1997-2004 
from the ADA, 
DUK, EASD, 
and the IDF 
 
Systematic 
n = 72  
 
Meta-
analysis 
n = 19 
 
Combined 
ES estimate 
with 95% CI 
Systematic 
• 74% (53/72) RCTs 
demonstrated an MI 
effect 
• 94% of 72 RCTs 
used individual 
interviews 
• Median duration of 
MI was 60 min. 
(Range 10-120 min.) 
• 32 RCTs delivered 
MI for 60 min.  81% 
of these RCTs were 
effective. 
• 11 RCTs delivered 
MI for 20 min.  64% 
of these were 
effective. 
Meta-analysis 
(* 95% CI) 
HbA1c (n=243) 
ES = 0.43 
p = 0.155  
(-0.16-1.01) 
CHOL (n=1358) 
ES = 0.27 
p = 0.0001 
(0.20-0.34) 
SBP (n=316) 
ES = 4.22 
p = 0.038 
(0.23-8.99) 
• The likelihood 
of an effect 
from MI 
increased with 
the # of 
encounters. 
• MI can be 
effective in 
brief 
encounters of 
only 15 
minutes. 
• MI is effective 
in different 
areas of 
intervention, 
such as 
adherence and 
behavior 
change. 
• MI is equally 
effective when 
delivered by 
different 
disciplines. 
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Table A1 (continued) 
 
 
Citation 
Review 
Type 
Objective Eligibility  
Criteria 
Variables 
Analyzed 
Databases 
Searched 
# of  
Studies 
 
Summary 
Measure 
 
Results Findings 
VanBuskirk & 
Wetherell 
(2013) 
 
 
M 
 
 
 
S 
 
 
 
C 
 
X 
 
 
Determine if 
MI is effective 
in improving 
behavioral 
modification in 
patients 
seeking tx for 
health 
conditions in 
the 1° care 
setting 
• RCT 
• MI as the 1º 
tx arm or MI 
as dual-
focused tx 
• Articles in 
English 
• Control could 
be TAU, 
waitlist, or 
other 
intervention 
Intervention 
characteristics, 
interventionist, 
study design, 
area of 
intervention, and 
outcome 
measure 
MEDLINE, 
PsychInfo, 
Cochrane 
library Review, 
EBSCO Host, 
Society of 
Behavioral 
Medicine, MINT 
n = 12 Total 
combined 
ES and 
combined 
ES for 
subgroups 
based on 
outcome 
group 
Systematic Review 
• 75% of studies 
showed significant MI 
effect 
• 67% of studies used 3 
or < MI sessions 
• 58% of studies used 
telephone to deliver 
MI 
Meta-Analysis 
(* 95 % CI) 
ALL STUDIES: 
ES = 0. 18 
[. 03, . 33] 
p = .02 
Q = 75. 32 
P < .01 
Adherence: 
ES = 0.19 
[.01, .37] 
p = .04 
Q = 1.20 
p > .05 
* Remaining 4 outcome 
subgroups did not have 
significant ES but 
ranged b/w .07 and .47 
Moderator Analysis: 
MI Deliver: 
ß = .26 [.08, .44] 
p = .004 
• Total clinical 
contact was 
not a 
significant 
moderator of 
MI effect size. 
• Telephone-
delivered MI 
sessions 
appear to be 
effective in 
achieving 
outcome. 
• It is possible 
that the 
qualification of 
the MI 
deliverer may 
affect 
achieving the 
target 
outcome. 
• MI appears to 
be effective for 
a variety of 
behavioral 
outcomes with 
primary care 
population. 
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Table A2     Search Domain 2: Motivational Interviewing and Chronic Disease 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments Chronic Dx, Group sizes, 
& 
characteristic
s 
Conceptual 
Framework 
& 
Study Design 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Barkhof, 
Meijer, de 
Sonneville, 
Linszen, & 
de Haan 
(2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: T2DM 
 
Sample Size 
I = C = 111 
Age 
m = 58.92 ± 
10.22 
Gender 
Female 
50.2% 
Male 49.8% 
Baseline 
HbA1c 
m = 8.71± 
2.00 
 
No frame-
work 
 
RCT 
 
Pretest-
posttest 
design 
 
Subjects 
recruited b/w 
7/9/08-
11/8/08 from 
DM clinic in 
Taiwan 
Research 
with nursing 
background 
MI vs. UC 
 
IV= MI 
 
1° DV = 
HbA1c 
 
Measures 
 1° HbAlc 
45-60 
min. 
 
final data 
collected 
@ 3 mo. 
post-
interven-
tion 
 
1 2 weeks 
after 
baseline 
data 
collected 
Baseline HbA1c 
m = 8.97± 2.17 
 
 
3 mo. HbA1c 
m = 8.16± 1.73 
 
t = 5.38 
p < 0.01 
 
 
Baseline 
HbA1c 
m = 8.53± 1.82 
 
3 mo. HbA1c 
m = 8.48± 1.78 
 
t = 0.57 
p = 0.56 
 
MI did improve 
significantly 
HbA1c levels 
in individuals 
with a baseline 
value greater 
than 7.62 
compared to 
usual care. 
 
Although this 
study did have 
a large sample 
size, it was 
limited by the 
short 3-month 
duration of the 
study period. 
Note.  HBM – health belief model; CKD – chronic kidney disease; CPAP – continuous positive airway pressure; DSME – diabetes self-management education; LCP- licensed clinical 
psychologist; MA – medication adherence; MEMS- medication event monitoring system; MGLT- Morisky- Green- Levine Test; MPR – medication possession ratio; OSA – obstructive 
sleep apnea; SAT- Survey of Adherence to Treatment; SMTS-Self-reported Medication Taking Scale; SOC – stage of change; TAQPH- Treatment Adherence Questionnaire of 
Patients with Hypertension; T2DM – type 2 diabetes mellitus; TTM – transtheoretical model of change 
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Table A2 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
Who 
intervened? 
 
 
Intervention 
& Measure(s) 
 
Length of 
Time 
 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Cook, 
Emiliozzi, 
and 
McCabe 
(2007) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: 
osteoporosis 
 
n = 402 
 
participants 
from 57 
HCPs that 
prescribe  
risedoronate 
sodium 
across the  
U. S. 
 
Age 
 m =66.9 
SD = 12.5 
Gender 
94% female 
 
no race or 
ethnicity data 
collected 
No 
Conceptual 
Framework 
 
Quasi- 
Experimental 
design 
 
Consecutive 
sampling 
method b/w 
6/2003 – 
9/2004 
RN Telephone MI 
counseling 
(ScriptAssist) 
 
IV = MI 
DV = MA 
 
Measures 
1˚= refill hx 
2˚= interview 
w/ 2 
questions 
Minutes per 
phone call: 
m = 15.3 
3-5 
based on 
low to 
moderate 
risk 
Q 4 mo. 
for a 
range of 
0-14 mo. 
Intent-to-treat 
analysis: 
3 month data 
I = 76.7% 
X2 = 7.32 
P = .007 
6 month data 
I =68.8% 
X2 = 6.75 
P = .009 
 
Moderate ES 
of 0.19 across 
both time 
periods 
2° Outcome: 
3 month data 
I = 81.8% 
X2 = 31.3 
P < .001 
6 month data 
I = 69.8 
X2 = 196.1 
P < .001 
Comparison 
data from 
NBDO 
 
C = 67.5% 
 
 
 
C = 40.5% 
 
 
 
 
 
 
 
 
 
C = 67.5% 
 
 
 
C = 40.5% 
Telephone-
based MI 
counseling 
was effective 
in increasing 
MA compared 
to population 
baseline 
adherence 
rates for 
osteoporosis. 
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Table A2 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Chen, 
Creedy, Lin, 
& Wollin 
(2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: T2DM 
 
Sample Size 
I = 104 
C = 111 
Age 
m = 58.92 ± 
10.22 
Gender 
Female 
50.2% 
Male 49.8% 
Baseline 
HbA1c 
m = 8.71± 
2.00 
 
No frame-
work 
 
RCT 
 
Pretest-
posttest 
design 
 
Subjects 
recruited b/w 
7/9/08-
11/8/08 from 
DM clinic in 
Taiwan 
Research with 
nursing 
background 
MI vs. UC 
 
IV= MI 
 
1° DV = 
HbA1c 
 
Measures 
 1° HbAlc 
45-60 min. 
 
final data 
collected @ 
3 mo. post-
intervention 
 
1 2 weeks 
after 
baseline 
data 
collected 
Baseline 
HbA1c 
m = 8.97± 2.17 
 
 
3 mo. HbA1c 
m = 8.16± 1.73 
 
t = 5.38 
p < 0.01 
 
 
Baseline 
HbA1c 
m = 8.53± 1.82 
 
3 mo. HbA1c 
m = 8.48± 1.78 
 
t = 0.57 
p = 0.56 
 
MI did improve 
significantly 
HbA1c levels in 
individuals with 
a baseline 
value greater 
than 7.62 
compared to 
usual care. 
 
Although this 
study did have 
a large sample 
size, it was 
limited by the 
short 3-month 
duration of the 
study period. 
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Table A2 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristic
s 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
session
s 
 
 
Timing 
 
Intervention group Control/ 
comparison 
group 
García-
Llana, 
Remor, del 
Peso, 
Celadilla, & 
Selgas 
(2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: CKD 
 
Sample Size 
n = 42  
Age 
m = 64 ± 
15.87 
Gender 
Female 40% 
Male 60% 
 
TTM 
 
Pretest-
posttest 
design 
 
Non-random 
sample of 
subjects from 
clinic in Spain 
Health psycho-
logist 
Individual 
Intervention 
Program 
utilizing MI 
 
IV= MI 
intervention 
program 
 
Multiple 
DVs 
adherence 
QOL 
Clinical 
markers 
 
Adherence 
Measures 
• SAT 
• MGLT 
• SOC 
 
90 
min./sessio
n with 45 
min. of MI in 
each 
session  
 
 
6 Monthly 
sessions 
x 6 
months 
Within-group ∆ 
 
Adherence 
Measure Results 
 
SAT score: (Pre) 
m = 27. 12 
SD = 2.74 
(Post) 
m = 31.45 
SD = 2.05 
Mean ∆ = -4.33 
t = - 10.29 
p < 0.001 
MGL score: (Pre) 
29 % nonadherent 
(Post) 
16% nonadherent 
X2 = 3.36 
P < 0.001 
SOC score: (Pre) 
39% in Action 
stage 
(Post) 
60% in Action 
stage 
X2 = 1.79 
P < 0.001 
 
No 
comparison 
group 
• Limitations to 
the study 
include lack of 
randomization 
and a control 
group. 
• This study 
incorporated a 
theoretical 
framework, the 
TTM, and 
utilized the 
Stages of 
Change tool to 
measure the 
clients’ 
progress 
through 
behavioral 
change. 
Overall, there is 
promising utility 
of a MI program 
in progressing 
clients through 
the change 
continuum and 
with adherence 
to oral 
medications. 
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Table A2 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Intervention & 
Measure(s) 
What did 
they do 
and What 
measures 
used? 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Interian, 
Lewis-
Fernandez, 
Gara, & 
Esbobar 
(2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: 
depression 
 
Sample Size 
I = 26 
C = 24 
 
- Latino men 
and women, 
- English 
and/or 
Spanish-
speaking 
RCT with 
block 
randomization 
of sample 
- 1 LCP & 
3 psychology 
doctoral 
students 
 
*Tx fidelity 
assessed by 
the MITI code 
META 
Vs. UC 
 
IV= MI 
DV= MA 
 
Measures 
1˚=MEMS  
2˚=SMTS 
5 month 
study period 
Three 60 
minute 
sessions 
Two 
sessions 
b/w 
baseline 
and 5 
wks. and 
session 3 
b/w wk 5 
and 5 
mo. 
Unadjusted 
mean at wk. 5 
m = 72.9% 
F(1, 48) = 
10.51 
p = .002 
(ES) d = 0.92 
 
Unadjusted 
mean at 5 mo. 
m = 61.5% 
F(1,48) = 9.4 
p = .004 
(ES) d = 0.87 
 
Adjusted mean 
at wk. 5 
m = 71.94 
95% CI (58.51-
85.37) 
p = .003 
 
Adjusted mean 
at 5 mo. 
m = 59.81% 
95% CI (46.70-
72.91) 
p = .008 
 
Unadjusted 
mean at wk. 5 
m = 40.8% 
 
 
 
 
Unadjusted 
mean at 5 mo. 
m = 31.7% 
 
 
 
Adjusted mean 
at wk. 5 
m = 41.72 
95% CI (27.75-
55.73) 
 
 
Adjusted mean 
at 5 mo. 
m = 33.57% 
 
Although a 
small sample 
size, this study 
produced 
statistically 
significant 
results in 
support of MI in 
increasing MA 
prior to and 
after adjusting 
for baseline 
adherence and 
having attended 
at least one 
therapy session 
during the study 
period. 
 
Study does not 
capture long-
term effects of 
MI. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, & 
characteristics 
Conceptua
l 
Framework 
& 
Study 
Design 
 
Who 
intervened? 
 
Intervention 
 &  
Measure(s) 
 
Length of 
Time 
 
# of 
sess-
ions 
 
 
Timing 
 
Intervention group 
(no comparison group) 
 
Lewis-
Fernández 
et al. 
(2013) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: 
Depression 
 
Sample Size 
n = 50 
 
Age 
m = 39.8 ± 
12.2 years 
 
Gender 
Female 52% 
Male 48% 
 
No frame-
work but 
used MI 
principles 
to guide 
develop-
ment of 
motiva-
tional 
pharmaco
-therapy 
 
Open-trial, 
pre-post 
pilot Study 
 
 
Psychiatrist MI sessions 
 
IV= MI 
 
1° DV = 
treatment 
retention 
 
Measures 
• Continuous 
measure of 
retention 
defined as # 
of days in tx 
• Dichotomous 
measure of 
retention 
defined as: 
1. premature 
termination 
2.  missing 2 
consecutive 
appts 
3.  off meds ≥ 
7 days 
Other 
measures 
included HDS, 
SDS, and QOL 
Session 1 
avg. was 
36.7 
minutes 
 
Session 2, 
4, and 8 
avg. was 
24.3 
minutes 
 
 
4 @ wk 0, 
1, 4, and 
8 
 
 
data 
collected 
@ 
baseline 
and 12 
wks. 
post-
interven-
tion 
 
12 wks results 
• Non-retention proportion 
was 10/50 (20%) 
• Days in MI 
pharmacotherapy: 
m = 74.2 
SD = 23 
88.3%, 95% CI 
[80.98, 95.9] 
(Total possible days was 84) 
• Non-retention was not 
significantly r/t age (p = 
0.23), gender (p = 0.49), or 
education level (p = 0.64) 
• 80 % of participants ended 
the study on their 1st 
antidepressant prescribed at 
the start of study 
HAMD17  
Baseline: 
m = 23.6 
SD = 3.5 
Week 12: 
m = 7.7  
SD = 7.0 
Change: 
m = - 15.9 
t = 14.2 
p < 0.001* 
 • It must be noted 
that the 
continuous 
measure of 
antidepressant 
retention is NOT a 
measure of 
medication 
adherence, but 
rather, the number 
of days retained in 
the program. 
• Inclusion of MI 
and 
pharmacotherapy 
for depression in a 
low-income, low-
acculturated 
Latino sample 
resulted in a low 
non-retention 
proportion. 
 
Limitations of this 
study include lack of 
randomization, a 
control group, and 
small sample size. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
Character-
istics 
Concep-
tual 
Frame-
work 
& 
Study 
Design 
 
Who 
inter-
vened? 
 
Intervention 
& 
Measure(s) 
 
Length 
of Time 
 
# of 
sess-
ions 
 
 
 
Timing 
 
 
Intervention group Control/ comparison group 
Ma, Zhou, 
Zhou, & 
Huang 
(2014) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: HTN 
 
Sample 
Size 
I =  60 
Age 
m = 59.17 
± 11.42 
Female 
48.3% 
Male 51.7% 
 
C = 60 
Age 
m = 58.35 
± 10.63 
Female 
53.5% 
Male 46.7% 
SCT 
 
RCT 
 
Subjects 
recruited 
from 2 
health 
centers 
in China 
Nurses 
trained in 
MI 
MI vs. UC 
 
IV= MI 
 
1° DV = 
Treatment 
adherence 
 
Measures 
TAQPH 
SBP 
DBP 
30-40 
min. 
 
24-week 
study 
period 
 
8 Not 
indicated 
Within-group 
Differences 
TAQPH score @ 
baseline: 
m = 75.91 
@ 6 months: 
m = 80.94 
p = 0. 019* 
 
SBP @ baseline: 
m = 153.17 
@ 6 months: 
m = 141.81 
p = 0. 019* 
 
DBP @ baseline: 
m = 89.01 
@ 6 months: 
m = 82.55 
p = 0.036* 
Between-group 
Differences 
TAQPH score @ 6 
months: 
m = 80.94 
p = 0.032* 
 
SBP @ 6 months: 
m = 141.81 
p = 0.011* 
DBP @ 6 months: 
m = 82.55, p = 0. 027* 
Within-group 
Differences 
TAQPH score @ baseline: 
m = 76.40  
@ 6 months: 
m = 78.22  
p = 0. 363 
 
SBP @ baseline: 
m = 150.28 
@ 6 months: 
m = 146.73 
p = 0.054 
 
DBP @ baseline: 
m = 88.65 
@ 6 months: 
m = 85.13 
p = 0.079 
Between-group 
Differences 
TAQPH score @ 6 
months: 
m = 78.22 
p = 0.032* 
 
SBP @ 6 months: 
m = 146.73 
p = 0.011* 
DBP @ 6 months: 
m = 85.13 
p = 0.027* 
• The clients 
in the MI 
group were 
able to 
demonstrat
e a 
positive MI 
effect in 
improving 
medication 
adherence 
and 
decreasing 
both SBP 
and DBP. 
Limitations 
to this study 
include small 
sample size, 
attrition, and 
use of self-
reported 
adherence 
measure 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Ogedegbe 
et al. (2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: HTN 
 
Sample Size 
I =  95 
C =  95 
 
AA recruited 
from 2 
community-
based clinics 
in New York; 
Age  
m = 54 
Gender 
88% female 
Baseline BP 
m = 144/86 
RCT Trained RAs MI vs. UC 
 
IV= MI 
DV= MA 
 
Measures 
1˚=MEMS 
2˚= BP 
12 months 4 Q 3 mo. 1° Outcome: 
Completer 
Analysis 
I = 60% 
p = .0054 
95% CI (-.02-
27%) 
Intent-to-treat 
Analysis 
Within group 
difference pre-
post: 
1.1% 
t = 0.24 
df =159 
p = .810 
2º Outcome: 
• SBP (within-
subject ∆) 
-7.7± 19.8 
mmHg (t = 
3.04, df = 60,  
p = 0.003) 
• DBP (within-
subject ∆) 
-4.25±10.6 
mmHg (t = 
3.13, p = .003) 
1° Outcome: 
Completer 
Analysis 
C = 47% 
 
 
 
Intent-to-treat 
Analysis 
Within group 
difference pre-
post: 
-12.9% 
t = -2.89 
df = 159 
p = 0.004 
2º Outcome: 
• SBP (within-
subject ∆) 
-9.7±22.2 
mmHg (t = -
3.14, df = 51, p 
= .003) 
• DBP 
(within-subject 
∆) 
-4.60±14.1 
mmHg 
(t = 2.36,  
p = .022) 
MI prevented the 
decline in 
adherence rates 
over time 
compared to UC 
when delivered 
every 3 months 
in the clinical 
setting. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Olsen, 
Smith, Oei, 
& Douglas 
(2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: OSA 
 
Sample Size 
I = 50 
Age 
m = 55.14 
Gender 
19 female 
31 male 
 
C = 50 
Age 
m = 57.74 
Gender 
12 female 
38 male 
 
 
 
HBM 
 
RCT 
 
Consecutive 
sampling b/w 
5/2007 –
12/2008 
RN MI 
sessions 
 
IV= MI 
 
DV = 
adherence 
to CPAP 
treatment 
 
 
Measures 
# of hours 
per night 
CPAP was 
used 
Sessions 1 
& 2 were 30 
min. 
 
Session 3 
was 20 min. 
3 every 4 
weeks 
1 month data 
I = 4.85 hr 
p = .003 
d = .59 
2 month data 
I = 4.73 hr 
p = .005 
d = .56 
3 month data 
I = 4.63 hr 
p = .005 
d = .55 
12 month data 
I = 4.21 
p = .061 
d = .38 
1 month data 
C = 3.25 hr 
 
 
2 month data 
C = 3.22 
 
 
3 month data 
C = 3.16 
 
 
12 month data 
C = 3.00 
Participants 
who received 
the MI 
intervention 
were more 
likely to 
adhere to 
CPAP for a 
greater 
number of 
hours per 
night.   
 
Although there 
was an 
insignificant 
difference in 
mean hours of 
CPAP use 
between the I 
and C groups 
at 12 months, 
there was a 
moderate 
effect size in 
favor of the I 
group. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention & 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Russell et 
al. (2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: CKD 
 
n = 29 
 
convenience 
sample of 
patients from 
HD clinic in 
central U. S. 
 
Age 
m = 66.41 
SD = 13.9 
 
Gender/Race 
53% female 
68% White 
 
 
No 
conceptual 
framework 
 
Pilot Study 
with pre-post 
test quasi-
experimental 
design 
All staff: 
nurses, 
technicians, 
dieticians, 
social 
workers 
MI session 
during dialysis 
treatment 
 IV = MI 
DV = non-
adherence to 
dialysis 
treatment 
 
Measures 
1. missed 
appts. 
2. Shortened 
treatment 
3. IDWG 
4. Serum 
phosphate 
5. Serum 
albumin 
3 months Not 
specified 
Not 
Specified 
Pre-Post 
Results: 
 
Missed Appts. 
26% improved 
68% Ø change 
 
Shortened 
Treatment 
47% improved 
27% Ø change 
p < .05 
IDWG 
11% improved 
68% Ø change 
 
Serum 
Phosphate 
32% improved 
47% Ø change 
 
Serum Albumin 
21% improved 
73% Ø change 
The only 
statistically 
significant 
change was in 
shortened 
treatment. 
None Although only 1 
of 5 measures 
had a 
significant 
improvement 
post –
intervention, 
missed 
treatments also 
favored 
improvement 
after the MI 
intervention. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Solomon et 
al.  (2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: 
Osteoporosis 
 
Sample Size 
I =  1046 
C =  1041 
 
-low income 
older adults 
on Medicare 
in 
Pennsylvania 
-convenience 
sample 
Age 
 m=77.8 
SD = 6.4 
Gender/Race 
98% female 
90% White 
RCT with no 
conceptual 
framework 
Health 
educators (no 
indication of 
educational 
background) 
MI vs. UC 
Delivered 
via 
telephone 
 
IV=MI 
DV= MA 
 
Measures 
1˚=MPR 
 
12 months 10 Not 
indicated 
median MPR = 
49% 
(IQR 7-88%) 
Kruskal-Wallis 
test 
p = .07 
 
 
median MPR= 
41% 
(IQR 2-86%) 
Kruskal-Wallis 
test 
p = .07 
-MI did not 
statistically 
improve MPR 
compared to 
UC. However, 
there was an 
8% increase in 
MPR between 
the I & C 
groups.  The 
power analysis 
for sample size 
was calculated 
to detect an 
absolute 
difference of 
10%. 
- This is a 
telephone-
based 
intervention that 
was conducted 
by health 
educators that 
received a ½ 
day of MI 
training.  This 
questions 
intervention 
fidelity. 
 
 
! 159!
 
   Table A2 (Continued) 
 !!
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
Chronic Dx, 
Group sizes, & 
characteristics 
Conceptual 
Framework 
& 
Study 
Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Welch, 
Zagarins, 
Feinberg, 
& Garb 
(2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: T2DM 
 
Sample Size 
n = 234 
I = 118 
C = 116 
Age 
m = 55.7 ± 
10.2 yrs. 
Gender 
Female 59% 
Male 41% 
Baseline 
HbA1c 
m = 8.9 ±  
1.2% 
RCT  4 certified 
diabetic 
educators   
4 experi-
mental 
groups: 
1. MI Alone 
2. MI with   
report 
3. DSME 
4. DSME 
with report 
 
IV= MI 
 
1° DV = 
HbA1c 
 
Measures 
 1° HbAlc 
Session 1: 
60 min. 
Session 2-
4: 
30 min. 
 
 data 
collected @ 
baseline & 
6 mo. post-
interven-
tion 
 
4 
 
m = 3.3 
0, 1, 3, 
& 6 
months 
HbA1c ∆ @  
6 months 
 
Group 1: 
m = -0.41% 
p < 0.01 
 
Group 2: 
m = -0.32% 
P < 0.14 
 
Group 1 & 2: 
m = -0.37 ± 
1.35% 
p = 0.01 
 
Multiple 
Regression 
ß ± SE: 
0.41 ± 0.19 
t = 2.10 
p = 0.037 
*sig. negative 
effect of MI on 
HgbA1c ∆ 
 
HbA1c ∆ @  
6 months 
 
Group 3: 
m = -0.59% 
p < 0.01 
 
Group 4: 
m = -0.95% 
p < 0.01 
 
Group 1 & 2: 
m = -0.78 ± 
1.29% 
p < 0.01 
• This study was 
unable to support 
the clinical use of 
MI in lowering 
HgbA1c level in 
patients with 
T2DM. 
• The two groups 
that did not use MI 
showed a 
significantly greater 
improvement in 
HgbA1c than the 
two groups that 
used MI. 
• The CDEs did not 
reach proficiency 
on all MI skills 
according to the 
MINT. 
• The CDEs failed to 
use comprehensive 
reflection skills or to 
consistently 
address 
ambivalence. 
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Table A3      Search Domain 3: Motivational Interviewing and ART Adherence 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes, 
& 
characteristics 
Conceptual 
Framework 
& 
Study Design 
Who 
intervened 
 
Intervention & 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
Cook, 
McCabe, 
Emiliozzi, 
& Pointer 
(2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dx: HIV 
 
n = 98 
 
Age 
m = 43.5 
SD = 9.3 
Range = 23-
73 
Gender 
38.8% 
female 
 
• 78.6% at-
risk for 
non-
adherence 
• 21.4% at 
low risk for 
non-
adherence 
58% lost to 
attrition by 6 
mo. f/u 
Prochaska’s 
TTM 
  
Quasi-
experiment 
with  
pre-post test 
design and 
non-
equivalent 
control group 
RN Telephone MI 
counseling 
(ScriptAssist) 
 
* median of 
3.6 phone 
calls per 
completed call 
 
IV = MI 
DV = MA 
 
 
Measures 
Self-report 
capturing tx 
persistence 
and 
adherence 
percentage 
 
 
 
 
Length of 
phone call 
m = 7.5 
min. (SD = 
11.7 min.) 
Median of 
3 per 
patient 
Low Risk 
1 follow-
up call 
@ 6 
months 
 
High 
Risk 
4 follow-
up calls 
≥ 95% MA  
 
After 6  
months 
 
IG = 76% 
z = 3.12 
p = .001 
ES = .25 
≥ 95% MA  
 
after 6 
months 
 
 
CG = 50% 
 
 
* Comparison 
data was 
obtained 
from the 
expected 
population 
rates based 
on the 
literature 
A greater 
percent of 
patients had 
> 95% 
medication 
adherence 
than 
expected for 
this 
population 
after 6 
months of 
treatment. 
 
The primary 
measure 
provides 
subjective 
data, which 
limits the 
objectivity of 
the data 
collected 
  Note. AATVAS – Adherence to Antiretroviral Therapy Visual Analog Scale; AGAS – Antiretroviral General Adherence Scale; HAKLQ – HIV/AIDS Knowledge Level Questionnaire;  
  HBRAQ- Health Belief Regarding ART Questionnaire; LW-IMB-AAQ – Life Windows Information Motivation Behavioral Skills ART Adherence Questionnaire 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes, & 
characteristics 
Conceptual 
Framework 
& 
Study Design 
Who 
intervened? 
 
Intervention & 
Measure(s) 
Length of 
Time 
 
# of 
sessions 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
DiIorio et 
al. (2003) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(IG) n=10  
(CG) n=10 
 
Adult HIV+ 
 
 Age 
 range = 26-
53  
 
Gender 
53.9% male 
 
Ethnicity 
87.5% AA 
Randomized 
controlled 
pilot study 
RN MI counseling 
sessions 
 
Measure 
 
1. AGAS 
2. # of 
missed 
doses in 
last 2 wks 
3. # of 
missed 
doses in 
last 30 
days 
20-90 min 
sessions, 
total study 
period=8wk 
3 Q 2 
weeks 
(self-report) 
baseline to f/u 
1. AGAS 
m=26.50, 
t=-1.27, p=.224, 
no SD but 
ES=.59 
 
2. Missed med 
in last 2 weeks, 
m = .06,  
t = 1.42,  
p =.198, no SD 
but ES = .67 
 
3. Missed med 
in last 30 days, 
m = .13,  
t = 1.42,  
p = .198, no SD 
but ES = .75 
 
4. 12.5% in past 
30 days unable 
to take meds, 
χ2= 5.13,  
p = .024 
(self-report) 
baseline to f/u 
1. AGAS 
m=23.44 
 
 
 
 
2. Missed med 
in last 2  
weeks, m = .18 
 
 
 
3. Missed med 
in last 30 days, 
m = .35 
 
 
 
4. 66.7% in 
past 30 days 
unable to take 
meds,  
χ2 = 5.13, 
 p = .024.  
MI has 
potential to 
increase 
med 
adherence.   
 
Outcome 
measured 
by self-
report.   
 
More 
objective 
measures 
may be 
needed. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes, & 
characteristics 
Conceptual 
Framework 
& 
Study 
Design 
 
Who 
intervened? 
 
Intervention & 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention 
group 
Control/ 
comparison 
group 
DiIorio et 
al. (2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated 
(I) n = 125 
(C) n = 122 
 
Analyzed 
(I) n = 107 
(C) n = 106 
 
HIV + adult 
men & 
women 
 
Age 
m = 41  
 
Gender 
65% male 
 
Ethnicity 
89% AA 
RCT 
 
RN MI counseling 
sessions; 1st 
session in-
person, session 
2-5 in-person or 
telephone;  
 
Get Busy Living 
program 
 
Measure 
1. MEMS 
2. VL 
3. CD4 
 
 
 
 
 
40-45 
min/session, 
total 
intervention 
period=12wk
s, total study 
period=12 
mo. 
 
 
5 Did not 
specify 
how 
often MI 
given 
 
 
Baseline to 
12mo. f/u 
 
MEMS data: 
(GE x TE) 
 
1. % DT:  
m = 64% 
95% CI  
[57, 70] 
p =  0.023 
 
2. % DTS: 
m = 41% 
95% CI  
[34, 47] 
p = 0.005 
 
VL data @ 6 
mo.: 
 
% 
undetectable 
58% 
95% CI  
(41, 76) 
p < 0.001 
 
*No SD in CD4 
outcome 
 
Baseline to 
12mo. f/u 
 
MEMS data: 
(GE x TE) 
 
1. % DT:  
m = 55% 
95% CI 
[49,62] 
 
2. %DTS: 
m = 24%  
95% CI 
[18, 31] 
 
VL data @ 6 
mo.: 
 
% 
undetectable 
47% 
95% CI  
(31, 64) 
 
Overall, 
results 
provide 
support for 
MI as 
intervention 
to increase 
HAART 
adherence.   
 
This study 
captured the 
potential of 
MI in 
producing 
long-term 
adherence 
outcomes. 
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Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes, & 
characteristics 
Conceptual 
Framework 
& 
Study 
Design 
 
Who 
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length 
of Time 
 
# of 
sessions 
 
 
Timing 
 
Intervention group Control/ 
comparison 
group 
Golin et al. 
(2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allocated 
(I) n = 74 
(C) n = 66 
 
Analyzed 
(I) n = 59 
(C) n = 58 
 
HIV+ adult male 
& females 
 
Mean Age 
I = 39.91 
C = 40.46 
 
Gender 
I = 69.4% male 
C = 63.1% male 
 
Ethnicity 
I = 76.8% AA 
  14.5% White 
C = 54.6% AA 
   30.3% White 
SCT 
 
 
RCT 
Master level 
health 
educator (did 
not specify 
type of 
profession) 
MI sessions; 
program 
called PACT 
 
Measures 
1.  CAS 
2. VL 
 
12wks 2 @ wk 
4 & 8 
wks 4 - 12 data 
CAS: 
• mean adherence 
improved by 4.5% 
(p = .10) 
 
• 29% achieved 
>95% adherence  
(p = .13)  
 
Post-hoc: 
After controlling for 
ethnicity, 2.75x 
higher odds of 
>95% adherence 
p = .045  
95% CI 
[1.023, 7.398] 
 
Baseline to 12wks 
Viral Load: 
52% undetectable 
wks 4 - 12 data 
CAS: 
• mean 
adherence 
decreased by 
3.83% 
 (p = .10) 
 
• 17% 
achieved 
>95% 
adherence  
(p = .13) 
 
Baseline to 
12wks 
Viral Load: 
44% 
undetectable 
Two MI 
sessions 
may not be 
sufficient to 
produce a 
sustained 
result in 
HAART 
adherence. 
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Table A3 (Continued) 
 
 
Author  
& Year 
 
Study Design 
& Objective 
 
Eligibility 
Criteria 
 
Variables 
Analyzed 
Databases 
Searched 
&  
Keywords 
# of 
studies  
 
 
Results 
 
Concerns 
 
Comments 
Hill & 
Kavookjian 
(2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic 
Review  
 
Objectives: 
1. Determine the 
effect of MI on 
ART 
adherence. 
2. Determine 
which 
character-
istics of 
intervention 
are most and 
least effective. 
3. Determine 
existing gaps 
in literature for 
research and 
practice 
implications. 
Inclusion: 
• MI 
intervention 
• HIV + adults 
on HAART 
• RCTs or 
rigorous 
non-RCTs 
• Target 
outcomes of 
VL, CD4, 
and 
adherence 
• English 
studies b/w 
1990-
November 
2010 
Study 
design, 
sample, 
MI dose, 
adherence 
measure, 
outcome 
 
 
• Medline 
• Academic 
Search Premier 
• CINAHL 
• Psych Articles 
• PsychINFO 
• ISI Web of 
Science 
• EBSCO 
• Cochrane 
Database of 
Systematic 
Reviews 
• Cochrane 
Controlled 
Trials Register 
• International 
Pharmaceutical 
Abstracts 
• Miller & 
Rollnick 
reference list 
Keywords: 
Adherence, 
compliance, HIV, 
AIDS, 
Motivational 
interviewing, 
medication, 
HAART, ART 
5 RCTs 
 
4 studies 
from US, 
1 study 
from 
France 
• 3/5 studies used 
MI in-person 
• Intervention period 
varied between 2-6 
months 
• Frequency of MI 
sessions varied 
between 2 and 8 
sessions 
• Overall risk of bias 
was low among 
the 5 studies 
• 3/5 studies 
reported significant 
adherence 
changes post-
intervention 
• The 2 studies 
without significant 
findings reported 
concerns with 
methodology 
• Most studies had 
disproportionate 
number of males 
vs. females 
• Small sample 
sizes 
• Variation in length 
of MI training 
• Lack of standard 
MI training 
method 
• Variation in 
adherence 
measures among 
studies  
• Gaps in literature 
pertaining to MI 
effect on QOL 
and economic 
outcomes 
The results of this 
systematic review 
indicate that MI is a 
promising intervention 
for HAART adherence.  
There needs to be 
further research, 
however, with larger, 
diverse samples of 
patients to increase 
the generaliz-ability of 
the outcomes.   
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Table A3 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes & 
Characteristic 
Conceptual 
Framework 
& 
Study 
Design 
Who 
intervened? 
 
 
Intervention 
& 
Measure(s) 
 
Length 
of Time 
 
# of  
sessions 
 
 
Timing 
 
Intervention group Control/ 
comparison 
group 
Konkle-
Parker, 
Erlen, 
Dubbert, 
& May 
(2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(I) n = 33 
 
(C) n = 23 
 
HIV + adult  
 
Age 
m = 34.6  
 
Gender 
62% male 
38% female 
 
Ethnicity 
89% AA 
 
 
 
 
 
 
 
 
 
IMB Model 
 
Random-
ized 
controlled 
pilot study 
Nurse 
practitioner 
 
 
HIV 
education, 
Video, 
MI, 
Feedback, 
cognitive 
skills 
training, 
adherence 
devices, 
 
1º 
Measures 
VAS 
Refill rate 
 
2º 
Measures 
VL 
IMB Scale 
 
30-60 
min. 
 
 
Avg. < 
10 min. 
 
 
2 
 
 
6 
@ wks. 
1 & 2 
 
@ wks. 
3,4,6, 
10,16, 
24 
 
 
1º Measures 
 
1. VAS 
m = 13.45,  
SD = 9.99 
p > 0.05, d = 0.22 
2. Refill rate 
m = 0.93,  
SD = 0. 23 
p > 0.05, d = .04 
3. 90% adherent 
by VAS 
n = 21, 86% 
p > 0.05, OR = 1.08 
 
2º Measures 
1. VL 
m = - 3.86, SD = 
2.15 
t = 2.416, p < 0.022 
d = 0.27 
2. VL < 400 
n = 20, 80% 
OR = 1.45, p > 0.05 
3. IMB Scale-
motivation 
m = 3.43, SD = 
6.78 
p > 0.05, d = 0.18 
1º Measures 
 
1. VAS 
m = 11.69 
SD = 9.99 
2. Refill rate 
m = 0.92 
SD = 0.27 
3. 90% 
adherent 
by VAS 
n = 15 
87% 
 
 
2º Measures 
1. VL 
m = - 3.31 
SD = 1.82 
2. VL < 400 
n = 15 
73% 
3. IMB Scale-
motivation 
m = 2.22 
SD = 7.05 
This adherence 
intervention 
included MI as 
one component.  
Difficult to 
ascertain direct 
effect of MI on 
MA, but IMB is 
promising 
model to 
approach MA.   
 
This 
intervention 
produced 
nonstatistically 
significant 
improvements 
in MA and VL.  
Some factors 
contributing to 
this are the high 
percentage of 
MA prior to 
study, high 
attrition, and low 
statistical 
power. 
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Table A3 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes, 
& 
characteristic
s 
Conceptual 
Framework 
& 
Study Design 
 
Who 
intervened? 
 
 
Intervention & 
Measure(s) 
 
Length of 
Time 
 
# of 
sessions 
 
 
Timing 
 
  
Krummen- 
Acher, 
Cavassini, 
Bugnon, & 
Schneider 
(2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n = 104 
 
HIV + adults 
 
Age 
m = 39  
 
Gender 
43% =male 
61%=female 
 
Ethnicity 
44%= black 
54%=white 
SCT 
 
Observation-
al study 
Pharmacist In-person 
semi-
structured MI 
sessions 
 
Measures 
1˚= MEMS 
2˚= VL 
Avg. 35 
min/visit 
 
Total study 
period=4yrs 
(8/04-4/08) 
# visits 
different 
per client,  
total of 
1388 visits 
for all 
clients 
avg.= 0.9 
per 
month 
Overall 
adherence 
rate= 83% at 
end of study 
period.   
 
Logistic 
GEE 
results:  
 
variable time 
x time 
indicated 
adherence 
increased at 
end of study, 
Z= 2.14 
95% CI 
(.0007, 
.0152) 
p = .0321 
% with VL 
undetectable 
@ endpoint  
 
Tx Naïve: 
n = 24 
88% 
p = 0. 000 
 
New ART @ 
start: 
n = 23 
74% 
p = 0. 000 
 
No ∆ in ART 
during study 
period: 
n = 45 
71% 
p = 0. 001 
 
Changes in 
ART regimen: 
n = 12 
58% 
p = 0. 002 
MI used as 1 
of 4 
components 
in adherence 
intervention 
shows 
promise in 
increasing 
adherence. 
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Table A3 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group sizes  
& 
   Characteristics 
Conceptual 
Framework 
& 
Study 
Design 
 
Who  
intervened? 
 
Intervention 
& 
Measure(s) 
 
Length of 
Time 
 
 
# of 
sessions 
 
 
Timing 
 
  
Maneesri-
wongul, 
Prajanket, 
& Saeng- 
charnchai, 
(2012) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n = 90 
 
MI group 
n = 30 
mean age = 40 
yrs 
73.3% male 
Education 
Group 
n = 30 
mean age = 
42.3 yrs 
66.7% male 
Usual Care 
n = 30 
mean age = 
39.3 yrs 
73.3% male 
 
Adult HIV + 
patients from 
Thailand 
Based on MI 
principles 
 
RCT 
Pretest-
posttest 
design with 
3 
intervention 
groups 
Nurse Group 1: 
MI counsel-
ing + UC 
 
Group 2 
HIV 
educational 
video + UC 
 
Group 3 
UC only 
 
Measures 
1. AATVAS 
2. HAKLQ 
3. HBRAQ 
 
Session 1 
40 min. 
Face-to-
face 
 
Session 2 
25-30 min. 
Telephone 
 
Session 3 
30 min. 
Face-to-
face 
 
3 Q 2 
wks 
Adherence Within-group 
Results 
 
MI Group       Education Group 
Pretest                     Pretest 
m = 85.6              m = 86.7 
SD = 11.6            SD = 14.1 
Posttest                Posttest 
m = 97.1              m = 98.7 
SD = 3.3              SD = 1.6 
t = 5.44                t = 4.83 
p < 0.001             p < 0.001 
 
Between-group Posttest 
Mean Scores 
Group 1 = 97.1 
Group 2 = 98.7 
Group 3 = 89.8 
F = 18. 58, p < 0.001 
Between-group Mean 
Differences 
Group 1 = 11.5, Group 2 = 12.0 
Group 3 = 2.9 
F = 31.97, p = 0.001 
 Both the MI 
and education 
interventions 
produced 
positive 
adherence 
outcomes.  
There was no 
significant 
difference 
between these 
two groups on 
adherence. 
 
This study 
produced 
short-term MI 
effects.  It 
would be 
interesting to 
test the long-
term effects of 
MI compared 
to education 
on adherence. 
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Table A3 (Continued) 
 
 
 
Author  
&  
Year 
 
 
STUDY DETAILS INTERVENTION DETAILS RESULTS  
 
Comments 
 
Group size  
& 
Characteristic 
Conceptual 
Framework 
& 
Study Design 
Who  
intervened 
Intervention 
& 
Measure(s) 
Length 
of 
Time 
 
# of 
sess-
ions 
 
 
 
Timing 
 
Intervention group Control/ 
comparison group 
Pradier 
et al. 
(2003) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adult HIV + 
in SE France 
 
 (I) = 123  
Age: 
Mdn = 40y 
 
Gender: 
87% male 
 
40% HS 
graduate 
 
41% 
undetect-
able VL 
 
(C) = 121 
Age: 
Mdn = 38y 
 
Gender: 
91% Male 
 
36% HS 
graduate 
 
40% 
undetect-
able VL 
Based on MI 
principles 
 
RCT 
Nurses Combined 
MI 
counseling 
and HIV 
education 
sessions 
 
Measures 
1. propor-
tion of 
patients 
with 100% 
adherence 
@ 6 mo. 
 
2.  ∆ in VL 
b/w 
baseline 
and 6 mo. 
 
3. % of 
patients 
with  
VL < 40 
copies/mL 
@ 6 mo. 
45-60 
min. 
3 Q 2 
months 
@ 6 mo. 
1. proportion 
adherent: 
75%, p = 0.04 
*Participants 
receiving 3 sessions 
(n =59) had higher 
adherence 
compared to 
patients receiving 1 
or 2 sessions (83% 
vs. 63%,  
p = .05) 
 
2. ∆ in VL: 
Within Group 
m = - 0.22, SD = 
0.86 
p = 0.013 
Between Group 
m = -0.22, p = 0.002 
 
3. % patients w/ VL 
< 40 copies/mL: 
47%, p = 1.00 
Subgroup 
Analysis 
Mean difference of 
VL b/w baseline and 
6 mo. in pts w/ HIV > 
40 copies/mL @ 
baseline: 
m = -0.48, p = 0.001 
@ 6 mo. 
1. proportion 
adherent: 
61% 
 
 
 
 
 
 
2. ∆ in VL: 
Within Group 
m = 0. 12 
SD = 0.90 
p = 0.14 
Between Group 
m = 0.12 
 
3. % patients w/ 
VL < 40 
copies/mL: 
48% 
p = 1.00 
 
Subgroup 
Analysis 
Mean difference of 
VL b/w baseline 
and 6 mo. in pts 
w/ HIV > 40 
copies/mL @ 
baseline: 
m = 0.15 
This was a 
combined MI and 
education 
intervention, 
making it difficult 
to ascertain the 
true MI effect.  
Nevertheless, the 
intervention 
appears to be 
successful in 
increasing self-
reported HAART 
adherence.  It may 
be more beneficial 
in patients with 
detectable 
baseline viral 
loads.  Finally, this 
study suggests 
that the more 
intervention 
sessions the 
greater the 
outcome. 
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Appendix B 
 
Permission to Use IMB Model 
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Appendix C 
Motivational Interviewing Survey 
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Appendix D 
Demographic Form 
Please circle your answer to the following questions. 
 
1. Gender: Female  Male 
 
2. Job Role:       Clinician  Non-Clinician 
(For the purpose of maintaining confidentiality, role categories have been designated to 
de-identify those staff members who serve as the only member of their professional 
discipline.  If you are a physician, pharmacist, nurse practitioner, or nurse, please circle 
CLINICIAN.  If you are a case manager or administrator, please circle  
NON-CLINICIAN. 
 
3.  Length of Employment at this HIV clinic: 
 
0-3 years  4-6 years  7-9 years  > 9 years 
 
4.  Have you ever used motivational interviewing?  Yes  No 
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Appendix E 
Permission to Use the Motivational Interviewing Survey 
 
! 173!
 
Appendix F 
 
ORCA Tool 
II. Context Assessment 
 
For each of the following statements, please indicate how frequently you have observed 
the following sets of behaviors, from 1 (very infrequently) to 5 (very frequently). 
 
How frequently have you observed 
senior leadership/clinical 
management in this clinical practice 
setting: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) reward clinical innovation and 
creativity to improve patient care 1 
2 3 4 5 
 
99 
b) solicit opinions of clinical staff 
regarding decisions about patient 
care  
1 2 3 4 5 
 
99 
c) seek ways to improve patient 
education and increase patient 
participation in treatment 
1 2 3 4 5 
 
99 
 
  
How frequently have you observed 
staff members in this clinical practice 
setting: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) have a sense of personal 
responsibility for improving patient 
care and outcomes 
1 2 3 4 5 
 
99 
b) cooperate to maintain and 
improve effectiveness of patient 
care 
1 2 3 4 5 
 
99 
c) are willing to innovate and/or 
experiment to improve clinical 
procedures 
1 2 3 4 5 
 
99 
d) are receptive to change in clinical 
processes 1 
2 3 4 5 
 
99 
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How frequently have you observed 
senior leadership/clinical 
management in this clinical practice 
setting: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) provide effective management for 
continuous improvement of 
patient care 
1 2 3 4 5 
 
99 
b) clearly define areas of 
responsibility and authority for 
clinical managers and staff 
1 2 3 4 5 
 
99 
c) promote team building to solve 
clinical care problems 1 
2 3 4 5 
 
99 
d) promote communication among 
clinical services and units 1 
2 3 4 5 
 
99 
 
  
How frequently have you observed 
senior leadership/clinical 
management in this clinical practice 
setting: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) provide staff with information on 
the clinic’s performance measures 
and guidelines 
1 2 3 4 5 
 
99 
b) establish clear goals for patient 
care processes and outcomes 1 
2 3 4 5 
 
99 
c) provide staff members with 
feedback/data on effects of 
clinical decisions 
1 2 3 4 5 
 
99 
d) hold staff members accountable 
for achieving results 1 
2 3 4 5 
 
99 
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How frequently have you 
observed opinion leaders in 
this clinical practice setting: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) express belief that the 
current practice patterns 
can be improved 
1 2 3 4 5 
 
99 
b) encourage and support 
changes in practice 
patterns to improve patient 
care 
1 2 3 4 5 
 
99 
c) demonstrate willingness to 
try new clinical protocols 1 
2 3 4 5 
 
99 
d) work cooperatively with 
senior leadership/clinical 
management to make 
appropriate changes 
1 2 3 4 5 
 
99 
 
 
In general in this clinic, when there is 
agreement that change needs to 
happen, how frequently have you or 
your colleagues: 
very 
infrequently  
 
infrequently  
neither 
frequently 
nor 
infrequently 
frequently very frequently 
Don’t 
know/ 
Not 
Applicable 
a) had  the necessary support in 
terms of budget or financial 
resources 
1 2 3 4 5 
 
99 
b) had  the necessary support in 
terms of training 1 
2 3 4 5 
 
99 
c) had  the necessary support in 
terms of facilities 1 
2 3 4 5 
 
99 
d) had  the necessary support in 
terms of staffing 1 
2 3 4 5 
 
99 
 
 
 
 
 
 
 
 
 
 
 
! 176!
 
III. Facilitation Assessment: 
 
For each of the following statements, please rate the strength of your agreement with 
the statement, from 1 (strongly disagree) to 5 (strongly agree). 
 
For this project, senior 
leadership/clinical management have: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) proposed a project that is 
appropriate and feasible 1 
2 3 4 5 
 
99 
b) provided clear goals for 
improvement in patient care 1 
2 3 4 5 
 
99 
c) established a project schedule and 
deliverables 1 
2 3 4 5 
 
99 
d) designated a clinical champion for 
the project 1 
2 3 4 5 
 
99 
 
 
The project clinical champion: strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) accepts responsibility for the 
success of this project 1 
2 3 4 5 
 
99 
b) has the authority to carry out the 
implementation 1 
2 3 4 5 
 
99 
c) is considered a clinical opinion 
leader 1 
2 3 4 5 
 
99 
d) works well with the intervention 
team and providers 1 
2 3 4 5 
 
99 
 
 
 
Senior leadership/clinical 
management/staff opinion leaders: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
Leadership roles in support 
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a) agree on the goals for this 
intervention 1 
2 3 4 5 
 
99 
b) will be informed and involved in the 
intervention 1 
2 3 4 5 
 
99 
c) agree on adequate resources to 
accomplish the intervention 1 
2 3 4 5 
 
99 
d) set a high priority on the success of 
the intervention 1 
2 3 4 5 
 
99 
 
 
The implementation team members: strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) share responsibility for the success 
of this project 1 
2 3 4 5 
 
99 
b) have clearly defined roles and 
responsibilities 1 
2 3 4 5 
 
99 
c) have release time or can 
accomplish intervention tasks within 
their regular work load 
1 2 3 4 5 
 
99 
d) have staff support and other 
resources required for the project 1 
2 3 4 5 
 
99 
 
 
The implementation plan for this 
intervention: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) identifies specific roles and 
responsibilities 1 
2 3 4 5 
 
99 
b) clearly describes tasks and 
timelines 1 
2 3 4 5 
 
99 
c) includes appropriate 
provider/patient education 1 
2 3 4 5 
 
99 
d) acknowledges staff input and 
opinions 1 
2 3 4 5 
 
99 
 
 
 
 
 
 
Implementation team roles 
Project champion roles 
Implementation plan 
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Communication will be maintained 
through: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) regular project meetings with the 
project champion and team 
members 
1 2 3 4 5 
 
99 
b) involvement of quality management 
staff in project planning and 
implementation 
1 2 3 4 5 
 
99 
c) regular feedback to clinical 
management on progress of project 
activities and resource needs 
1 2 3 4 5 
 
99 
d) regular feedback to clinicians on 
effects of practice changes on 
patient care/outcomes 
1 2 3 4 5 
 
99 
 
  
Progress of the project will be 
measured by: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) collecting feedback from patients 
regarding proposed/implemented 
changes 
1 2 3 4 5 
 
99 
b) collecting feedback from staff 
regarding proposed/implemented 
changes 
1 2 3 4 5 
 
99 
c) developing and distributing regular 
performance measures to clinical 
staff 
1 2 3 4 5 
 
99 
d) providing a forum for 
presentation/discussion of results 
and implications for continued 
improvements 
1 2 3 4 5 
 
99 
 
 
Communication 
Assessment 
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The following are available to make the 
selected plan work: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) staff incentives 1 2 3 4 5  99 
b) equipment and materials 1 2 3 4 5 
 
99 
c) patient awareness/need 1 2 3 4 5  99 
d) provider buy-in 1 2 3 4 5 
 
99 
e) intervention team 1 2 3 4 5  99 
f) evaluation protocol 1 2 3 4 5 
 
99 
 
 
Plans for evaluation and improvement 
of this intervention include: 
strongly 
disagree disagree 
neither 
agree nor 
disagree 
agree strongly agree 
Don’t 
know/ 
Not 
Applicable 
a) periodic outcome measurement  1 2 3 4 5  99 
b) staff participation/satisfaction 
survey 1 
2 3 4 5 
 
99 
c) patient satisfaction survey 1 2 3 4 5  99 
d) dissemination plan for performance 
measures 1 
2 3 4 5 
 
99 
e) review of results by clinical 
leadership 1 
2 3 4 5 
 
99 
 
 
 
IV. Respondent information: 
 
 
 
The Organizational Readiness to Change Assessment (ORCA) was developed by the 
Ischemic Heart Disease Quality Enhancement Research Initiative of the Veterans 
Health Administration. For more information contact Christian Helfrich, 
christian.helfrich@va.gov or (206) 277-1655.  
Project resources 
Evaluation 
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Appendix G 
 
Permission to Use the ORCA Tool 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 181!
 
Appendix H 
 
Request for the Motivational Interviewing Survey Reliability Scores 
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